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Purpose. The absolute clarity of the lens ofthe eye is vital in the visual system. The unique 
structural and physiological properties of the lens are tightly integrated with highly ordered 
protein content to allow the lens to remain transparent. Consequently, any alteration or 
disturbance of these highly ordered proteins can affect the optical properties of the lens. In 
humans, cataracts are the major cause of blindness, yet the exact aetiology of cataract 
formation (cataractogenesis) is not fully understood. The purpose of the current research was 
to investigate whether deregulation of the Ca2+-dependent enzyme, calpains, following 
changes in lens Ca2+ homeostasis, is a key mechanism leading to undesired cleavage of a 
number of proteins that are linked with maintaining lens transparency and contributing to 
cataractogenesis. 
Methods. An ovine lens culture (in vitro) system and the heritable ovine cataract (in vivo) 
model were used to test the research hypothesis. The Ca2+ ionophore, ionomycin, was used to 
induce a Ca2+ overload and in vitro opacification during lens culture. Opacity in the lens was 
graded by a computer image analysis program. Protein profile (SDS-PAGE, 2-DE and 
Western detection), calpain activity (casein zymography), lens structure (microscopic view) 
and cytotoxicity level (LDH l~akage assay) were analysed in Ca2+-induced opaque lenses. 
The involvement of calpain during opacification was further examined by applying synthetic 
exogenous calpain inhibitors to the in vitro system. Two novel exogenous calpain inhibitors 
were also assessed for their therapeutic potential in preventing the progression of cataracts in 
the in vivo cataract model by topical administration of the inhibitor direct to the sheep's eye 
over a 11 week period. HPLC was used to detect the penetration of these compounds into 
ocular tissues. 
11 
Results. Sustained Ca2+ influx into cultured lenses caused dense opacification. The opacity 
was characterised by formation of a turbid fraction and cell death in the outer cortex of the 
ovine lens. There was increased calpain autolysis associated with the progress of 
opacification, indicating increased calpain activity. Major degradation ofthe cytoskeletal 
proteins, spectrin and vimentin, was observed whilst there was limited degradation ofthe lens 
structural soluble proteins, crystallins, in response to a Ca2+ flux. Lens proteins were 
protected from degradation by adding synthetic calpain inhibitors to the culture medium. 
Topical administration of novel anti-calpain molecules failed to retard the progression of 
cataractogenesis in the ovine inherited cataract model. Further investigation of drug 
penetration showed that efficacy of inhibitory compounds was limited by permeability of 
these molecules across the cornea and the ability of the molecules to reach and penetrate into 
the lens. 
Conclusion. The ovine lens Ca2+-induced opacification (OLCO) model in this thesis has 
provided a model to understand the role of Ca2+ homeostasis in lens transparency. With 
sustained intracellular Ca2+ level, the degradation of cytoskeletal elements is highly correlated 
with calpain activity. Cataractogenesis is the pathological response to the loss oflens Ca2+ 
homeostasis in this model. The current results support the hypothesis that the deregulation of 
calpain activity is an trigger for a series of cascading events, leading to death of the cells in 
the lens. 
Keywords: Cataractogenesis, Ca2+ homeostasis, proteolysis, calpain, cytoskeletal proteins, 
crystallins, calpain inhibitors, ovine lens, culture system, OLCO model, cell death and the 
inheritable ovine cataract model. 
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Chapter 1: Literature Review 
1.1. Vision and Cataract 
The lens of the eye is a vital component of the visual system. Its physiological function, in 
connection with the cornea, is to focus images on the retina by transmitting light through its 
transparent body. Its absolute clarity is essential as an optical component ofthe eye. When 
the lens loses its clarity and becomes opaque through the appearance of white or yellow 
cloudiness, it is called a cataract. Cataract initially affects distance vision and causes 
problems with glare and, consequently, a reduction in optical performance. 
Fully opaque lenses lead to complete blindness, without any pain. Today, surgical 
replacement of the cataractous lenses with clear artificial ones is the only treatment for 
cataract. This is expensive and not readily available to everyone with a cataract. As a 
consequence, cataracts still account for the majority of cases of treatable blindness in the 
world. According to data from The Fred Hollows Foundation (2002), cataracts account for 
blindness in at least half of the estimated 45 million blind people worldwide. 
Many internal and external factors have been identified as causing cataract. Among these are 
hereditary alterations in proteins, metabolic abnormalities, toxins, metal ion deposits, 
radiation, malnutrition, complications of other diseases (i.e. diabetes and glaucoma), physical 
injury and aging (Harding & Crabbe, 1984; Newell, 1992). In many cases, multiple factors 
are responsible for the development oflens opacity (cataractogenesis) and the biological 
mechanisms involved are complex. Consequently the exact aetiology of cataract formation is 
not fully understood (Hammond, 2001). 
Extensive research is being pursued to understand the physiology oflens transparency and, 
therefore, to clarify the exact mechanisms by which cataracts form. The underlying 
mechanism that leads to cataractogenesis will provide the platform on which to develop a 
non-surgical therapeutic treatment to treat cataract. 
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1.2. Eye 
The eye is an organ that detects light. The mammalian eye rests in a bony cavity (socket, or 
orbit) on the frontal surface of the skull. The structure ofthe mammalian eye is designed to 
focus light onto the retina. All of the individual components through which light travels 
within the eye before reaching the retina are therefore transparent. 
The anterior outer covering of the eye is a transparent tissue, the cornea, which is continuous 
with the sclera that is visible as the white ofthe eye. A delicate membrane, the conjunctiva, 
covers the visible portion of the sclera. The cornea is richly supplied with sensory nerves that 
function to protect it and help maintain its transparency. 
The cornea is continually kept wet and nourished by basal tears that lubricate the eye and help 
to keep it clear of dust. Tears are formed by tiny glands that surround the eye. The tear film is 
comprised of three layers: oil, water, and mucous. The lower mucous layer serves as an 
anchor for the tear film and helps it adhere to the eye. The middle layer is comprised of 
water. The upper oil layer seals the tear film and prevents evaporation. 
Underneath the sclera is the second layer of tissue, the choroid, composed of a dense pigment 
and blood vessels that nourish the tissues. The choroid layer fonns the ciliary body, which 
contains the smooth muscles. The ciliary body participates in changing the lens shape to 
focus light from different target distances to the innermost layer of tissue in the eyeball, the 
retina. The ciliary body in turn merges with the iris, a diaphragm that regulates the size of the 
pupil. 
Between the cornea and iris (anterior chamber) and between the iris and lens (posterior 
chamber) are small spaces filled with aqueous humour (Newell, 1992). Aqueous humour has 
a refractive index of 1.335 and its density is slightly greater than that of water (reviewed by 
Davson, 1990). The large cavity behind the lens, iris, and ciliary body is filled with vitreous 
humour. Vitreous humour is a transparent jelly-like substance, consisting of 99% water. The 
remaining 1 % is mostly collagen, cartilage matrix glycoprotein and hyaluronic acid (Balazes, 
1994; Haddad, 1990). The microscopic fibres embedded within the gel of vitreous humour 
give rigidity to the spherical form of the eye, support the retina, and contribute to its 
attachment to the choroid. 
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1.3. Lens in Eye 
The lens is a transparent, biconvex body of the eye that is encased in the lens capsule. It is a 
completely avascular tissue. The lens sits between the aqueous and vitreous humours and is 
held by suspensory ligaments from the ciliary body attached to the anterior and posterior lens 
capsule around its equatorial region (Figure 1.1). 
The cellular structure is symmetric about an axis passing through its anterior and posterior 
poles, but asymmetric about a plane passing through its equator (Figure 1.2). The anterior 
epithelium ofthe lens is in contact with transparent nutritive fluid, the aqueous humour, and 
the posterior differentiating cells of the lens are in contact with the vitreous humour. 
The lens is encased in a basement membrane, called the lens capsule, that is tightly attached 
to the epithelium. Type IV collagen and other extracellular matrix material are structural 
components of the lens capsule, and are synthesised by lens epithelium (Brinker et ai., 1985; 
Bron et ai., 2000) 
Aqueous 
Humour 
Lightpath .. 
Posterior 
chamber 
Suspensory 
Vitreous 
Humour 
nerve 
Sclera 
Figure 1.1 Cross-section of a mammalian eye showing the position of the lens, which functions to 
focus incoming light on the retina (diagram modified from an Anatomical Chart, Skokie, 
lllinois, 1986). 
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Epithelium and fiber cells of the tens 
The lens is composed of two types of cells; a single layer of epithelial cells on the anterior 
surface of the lens and a larger number of highly differentiated elongated fiber cells making 
up the bulk of its mass (Figure 1.2, A) (Manko, 2002). The lens epithelium is divided into 
central, pre-equatorial and equatorial zones. In general, cells of the central zone are 
mitotically quiescent whilst cells of the pre-equatorial are proliferative and produce new cells 
that migrate towards the equatorial zone where they terminally differentiate to form fiber cells 
(Francis et at., 1999; Paterson & De1amere, 1992). 
(A) Anterior 
Posterior 
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(Bow) region 
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(B) 
- Anterior Y suhre 
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Figure 1.2 (A) Schematic drawing of cross section of the adult human lens (Gupta et al., 2005). The 
anterior surface of the lens is lined by a single layer oflens epithelial cells. Fiber cells constitute the 
central major mass of the lens and do not possess cell organelles or nuclei. The lens is enclosed in a 
lens capsule. (B) Arrangement oflens fiber cells and sutures in human lens (adapted from Brown, 
2001). 
The process of differentiation involves a large increase in cell volume due to cellular 
elongation, an increase in the concentration of the soluble structural proteins, crystallins, and 
the loss of cellular organelles and nuclei (Bassnett, 2002; Bassnett & Beebe, 1992; Manko, 
2002). These are accompanied by the expression of an extensive range of fiber-specific 
proteins, cytoskeleta1 proteins like CP49 and filensin (Pitz & Moll, 2002), membrane 
associated proteins like MIP (Gorin et at., 1984) and MP20 (Grey et at., 2003; Louis et at., 
1989), and the gap junction proteins, connexin46 and connexin50 (Lin et at., 1997; Paul et at., 
1991). 
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The newly produced layers of fiber cells are laid over pre-existing fiber cells. This growth 
process continues throughout life, consequently, the lens consists of concentric layers with 
older fibre cells densely packed toward the centre of the lens (nucleus), and a gradient of 
young fibre cells, at different stages of differentiation, towards the outer layers (the cortex) 
(Hess et al., 1998) (Figure 1.2). The dominant structure at the poles is the suture lines, which 
are the junctions of fiber cells from opposite sides of the lens (Figure 1.2, B). The sutures 
maintain cellular diffusion and communication (Kuszak, 1995). 
1.4. Components for the Transparent Lens 
In order to focus the visual light on the retina, the lens must be crystal clear to transmit light 
without absorption or scattering, and have a relatively high index of refraction (Augusteyn 
and Stevens, 1998). 
As the bulk of the lens mass is composed of elongated fiber cells, the regular arrangement of 
the lens fiber cells with minimal extracellular space provides a lens with small spatial 
fluctuations comparable to the wavelength oflight (Bettelheim, 1985). Disorganisation of 
fiber cells, such as abnormalities of the fibre cell membranes and separation between fibre 
cells, leads to light scattering. The lens membrane is, however, only 5% ofthe total volume 
of the lens (Bettelheim, 1985). This means that the transparency of the lens is largely based 
on the transparency of the cytoplasm of fiber cells. 
The highly differentiated fiber cell structure filled with the soluble proteins eliminates any 
fluctuation in refractive index between cells and creates a transparent lens environment. The 
spatial arrangement of lens cytoplasmic proteins (crystallins and cytoskeletal elements) and 
absence of light-scattering elements are vital factors contributing to lens transparency. 
Lens soluble structural proteins, crystallins 
The properties of the crystallins, a family of proteins, largely determine the transparency of 
the lens, and their high concentration in the lens fiber cells generates a high refractive index 
(Delaye & Tardieu, 1983; Horwitz et al., 1999). Crystallins are the major structural 
components of the lens comprising up to 70% of its dry mass in vertebrate lenses (Augusteyn 
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· & Stevens, 1998). There are three major classes of crystallins found in all mammalian lenses; 
a-, B- and y-crystallins (Harding, 1991). 
The predominant crystallins in mammalian lenses are the a-crystallins. The a-crystallins are 
distributed throughout the lens. They exist as large aggregates (Mw around 800 kDa) of the 
subunits (polypeptides), aA1, aA2, aBl and aB2 (Mw ranging from 20 to 30 kDa) in all 
vertebrate species. These highly conserved proteins are members of a small heat-shock 
protein family (Ingolia & Craig, 1982) and function as molecular chaperones to prevent 
thermal aggregation of a number of enzymes and other lens structural proteins such as p- and 
y-crystallins, by refolding partially denatured proteins (Derham & Harding, 2002; Horwitz, 
1992). Hydrophobic surface interaction with a-crystallins may protect other proteins by 
kinetic competition between aggregation and interaction of unfolding proteins with a-
crystallins (del Valle et al., 2002; Lindner et al., 2001). 
Both B- and y-crystallins are largely restricted to the lens fiber cells (Cvekl & Piatgorsky, 
1996), although some B- and y-crystallin expression has been recently reported in adult 
mammalian lens epithelial cells (Wang et al., 2004). B-crystallins are the second most 
abundant group of proteins in the lens, but their proportion and properties vary with 
development. The B-crystallins comprise a complex group ofheteropolymers from different 
types of subunits, the acidic (BA1, BA2, BA3, and BA4, Mw from 23 to 25 kDa) and the basic 
(BB1, BB2 and BB3, Mw from 26 to 32 kDa) polypeptides. 
y-Crystallins are monomeric with molecular weights of 20 kDa, and are related to B-
crystallins (reviewed by Augusteyn & Stevens, 1998). In most mammalian species, the 
production of y-crystallins ceases at birth so high levels of y-crystallins are observed in the 
centre of the lens, and they are absent in the cortex. The exception is rodent lenses where y-
crystallin synthesis persists after birth, but at a reduced rate (reviewed in Augusteyn and 
Stevens, 1998). y-Crystallin distributions are the mirror image of the B-crystallins. 
The normal folding of crystallins and their interactions are regulated in the peripheral region 
of the lens, where their rapid production occurs to provide the concentration necessary for the 
high refractive index of the lens (McAvoy, 1978; Piatigorsky, 1981). High concentrations of 
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the cytoplasmic proteins, largely crystallins, are packed into a glass-like short range spatial 
order, between crystallin and crystallin, as well as water and crystallin interfaces (Delaye & 
Tardieu, 1983; Zhao & Bettelheim, 1995). These close packing arrangements of cry stall ins 
within the cytoplasm are essential for the non-fluctuation in refractive index between 
crystallins, which forms the basis of lens transparency. Because of the lack of protein 
turnover in the lens, there are gradual increases in protein concentrations and, consequently, 
in the refractive index and hardness of the core area of the lens (Young & Fulhorst, 1966). 
Post-translational modification of u- and p-crystallins by phosphorylation, truncation and 
deamidation, for example, occur during lens maturation and aging processes (David et al., 
1994a; Miesbauer et aI., 1994; Ueda et al., 2002). For instance, aA-crystallin becomes 
progressively phosphorylated with increasing age in the soluble fraction of mouse lens, with 
the phosphorylation form comprising more than one third of the total aA-crystallin by age 51 
weeks (Ueda, 2002). Truncation of p-crystallins was observed during normal maturation in 
the rat lens (David et al., 1994a). Deamidation is a common post-translational modification, 
resulting in conversion of a asparagine resides to a mixture of isoaspartate and aspartate 
(Harding et al., 1984). Previous studies of proteins from the normal human lens have shown 
that deamidation of specific asparagine and glutamine residues occur during the aging process 
(Lampi et al., 1998; Lund et al., 1996; Takemoto & Boyle, 1998). 
Lens cytoskeletal elements 
In the cytoplasm of the cell, a complex network of fibrous proteins, the cytoskeleton, controls 
the overall organization of the cell. The cytoskeleton has an important role in stabilizing cell 
structure as the fiber cell differentiates. The cytoskeleton of mammalian cells consists of 
three different filament systems; micro filaments (diameter, 5-8 urn), intermediate filaments 
(10 nm) and microtubules (20-25 nm), with various associated proteins that crosslink these 
filament systems to each other and to other cell organelles (Bershadshky & Vasiliev, 1988; 
Pitz & Moll, 2002; Shoeman & Traub, 1990). 
Microfilaments are the actin-containing filament system that helps maintain the cell structural 
framework, and playa role in the movement of cell components. Intermediate filaments 
contribute to cell stability, strength, cell structure, maintenance of cell-cell contacts, and 
nuclear structure (Pitz & Moll, 2002). Tubulin, the major protein of micro tubules, provides 
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structural support and assists in intra-cellular locomotion and transport. All filament systems 
have a wide variety of associated proteins, e.g. microtubule-associated proteins (i.e. MAP1 
and MAP2) and intermediate filament-associated proteins (i.e. spectrin and fodrin (brain 
spectrin», that confer unique properties to the complexes and give rise to a variety of skeletal 
and dynamic structures (Shoeman & Traub, 1990). 
In the ongoing process of lens development and differentiation, cytoskeletal elements are 
involved in coordinated proliferation and differentiation of lens epithelial cells into fiber cells. 
In differentiated fiber cells, cytoskeletal elements playa critical role in the stability of the lens 
cytoplasmic gel through their interaction with membrane proteins and crystallins. During the 
differentiating period, interactions of the prominent cytoskeletal proteins with the rapidly 
produced lens crystallins are necessary to establish the short-range order of crystallins in the 
lens cytoplasm and provide an environment favourable for a transparent cell structure 
(Matsushima et aI., 1997). Clark (1990) suggested that weak non-covalent interactions are 
responsible for the transparent organization of cytoplasmic proteins. Consequently, the 
simplest modification in the proteins or their environment could influence the transparency or 
opacity of differentiating lens fibres. 
Spectrin is the maj or protein component of the membrane skeleton and is composed of an alp 
heterodimer which forms a 200 nm extended tetramer filament (Bershadshky & Vasiliev, 
1988). It cross-links actin micro filaments into an isotropic meshwork that is attached to the 
membrane. The spectrin-actin membrane skeleton underlies the plasma membranes of all 
cells and is important for cellular shape, membrane stability and deformability, as well as the 
formation of membrane sub domains (Morrow et at., 1997). Proteolysis ofa-spectrin (aII-
spectrin, non-erythroid a-spectrin, or a-fodrin) to discrete fragments is implicated in changes 
in cell shape and membrane morphology which occur in many cell types, including during 
terminal differentiation and aging of lens fiber cells (Lee et ai., 2001). 
Intermediate filaments undergo dramatic changes in subcellular distribution during the 
differentiation/maturation of the fiber cells. A type III intermediate filament protein, 
vimentin, is found in both the epithelial and differentiating fiber cells but is absent in mature 
fiber cells (Rammaekers et aI., 1980). Vimentin is localised mainly in the cell cytoplasm and 
is highly conserved in a wide variety of species (Ellis et ai., 1984). 
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Some cytoskeletal and filamentous structures may need to be eliminated as they are large 
enough to contribute to light scattering (Siew & Bettelheim, 1996). In the bovine lens, 
vimentin undergoes a dramatic reduction as indicated by immuno- histochemical staining, at a 
discrete stage during fiber differentiation, after the complete loss of the nucleus (Sandilands et 
al., 1995b). How the elements of the intermediate filament network are selectively removed 
is unknown, but the process may be influenced by post-translocational modifications and 
interactions with intermediate filament-associated proteins. 
The beaded filaments are a lens-specific cytoskeletal structure composed of two fiber cell-
specific intermediate filaments, named filensin (CP95 and CP115 in rat and bovine lens 
respectively) and phakinin (CP49) (Carter et aI., 1995; Ireland & Maisel, 1984; Maisel & 
Perry, 1972). Filensin and CP49 are both proteolytically processed in the lens during fibre 
cell differentiation but, unlike the abrupt disappearance of vim entin, are retained in all fiber 
cells (Sandilands et al., 1995a). The control and regulation of these extensive proteolytic 
processes are important in models of cataractogenesis and lens function (Sandilands et al., 
1995b). 
Intermediate filament-associated proteins function as dynamic regulators of intermediate 
filament assembly (Hermann & Aebi, 2000). One important group of intermediate filament-
associated proteins is the a-crystallins, where the solid-phase support of the beaded filaments 
facilitates the chaperone activity of the a-crystallin assemblies (Nicholl & Quinlan, 1994). 
Mutation in the CP49 gene in human (Conley et al., 2000; Iakobs et al., 2000) or knockout of 
CP49 in mouse (Sandilands et aI., 2004) demonstrated a stabilising role of the beaded 
filaments in the lens, which is important for maintaining lens transparency. 
Elimination of lens organelles 
A striking feature of lens fiber cell differentiation is the abrupt degradation of intracellular 
structures that are large enough to scatter light, such as nuclei, mitochondria, Golgi bodies and 
the endoplasmic reticulum (Bassnett & Beebe, 1992; Piatigorsky, 1981). As a result, the 
terminally differentiated and aged fiber cells in the core of lens have no organelles, with very 
little active membrane transport and a low level of metabolic activity. 
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Mitochondria and endoplasmic reticulum disappear abruptly (Bassnett & Beebe, 1992), while 
nuclear breakdown is a relatively slow process, although functional inactivation is probably 
much more rapid. Caspases and nucleases have been suggested to play an important role in 
organelle degradation, which is different to apoptosis (Bassnett, 2002). Unlike apoptosis 
which would inevitably lead to a disruption in the unifonn reflective index of the tissue, 
organelle degradation in the lens is tightly regulated and selective. It has been proposed that 
proteolysis of the gap junction proteins, connexins (Lin et al., 1997) and the cytoskeletal 
protein spectrin (Lee et al., 2001) accompany the sudden organelle breakdown. 
1.5. Microcirculation 
The continuous flow of aqueous humour supplies most of the metabolic needs for the lens 
through the epithelial cells and the network of gap junctions. The avascular lens is 
maintained mainly by the external circulation to the lens by the aqueous humour and the 
internal circulation system within the lens. 
Aqueous humour is a transparent nutrient fluid fonned by the ciliary body processes: 
diffusion, ultrafiltration, and active secretion. The aqueous humour enters the posterior 
chamber of the eye and flows through the pupil into the anterior chamber, and then leaves the 
eye via the Canal of Schlemm- a circular canal situated at the juncture of the sclera and cornea 
(Martini, 1992). The circulation of the aqueous humour in the anterior chamber is driven by a 
convective flow that results from the temperature difference between the iris and cornea. The 
rate of aqueous humour fonnation equals the outflow, so the intraocular pressure is 
maintained at a relatively constant level. The water and salts within the vitreous humour are 
in constant exchange with the aqueous. It has a very low flow rate compared to the aqueous 
humour (reviewed by Blazes, 1994). 
The internal circulation system of the lens is thought to be generated by Na+, entering the lens 
extracellularly at all surface locations and flowing inward, crossing extracellular spaces at 
both anterior and posterior surfaces (Gao et al., 2004). The physiological role of the 
circulating current is to create circulatory system, or microcirculation, in the lens (Mathias et 
al., 1997). The flow ofNa+ drives the flow of water in the same direction. The inward flow 
provides the cells of the lens with fluid, ions and metabolites. 
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The current around a lens is directed inwards at the anterior and posterior poles and outward 
at the equator (Robinson & Patterson, 1983). The outward flow directed toward the equator 
removes waste metabolic products and creates a well-stirred intracellular compartment. 
The driving force for the inward flux is the electrochemical gradient between surface cell 
membranes and inner fiber cell membranes. The angular flow from equator to poles appears 
to be directed by the angular distribution of gap junctions in the outer shell of differentiating 
fiber cells (Mathias et al., 1991; Mathias et al., 1997). 
(A) Anterior Pole (B) 
Equator 
Posterior Pole 
Surface of lens 
Core of lens 
Epithelium 
Peripheral shell of 
fiber cells 
Interior fiber cells 
Figure 1.3. (A) Internal ionic current flow around and through a nonnallens (first suggested by 
Robinson and Patterson, 1983, diagram adapted from Mathias et al., 1997). Fluid movements were 
proposed to follow the same direction (Mathias et al., 1997). Angular current flows along the axis of 
fiber cells, rarely crossing a gap junction, while radial current flows across the fiber cells via gap 
junctions. (B) Lens Na + transport. Na + enters the lens along the extracellular spaces between cells and 
moves down its electrochemical gradient into fiber cells, where it returns to the surface via gap 
junctions. Three physiological zones; epithelium, peripheral shell of fiber cells and interior fiber cells 
are presented in italic letters (diagram adapted from Gao et al., 20Q4). 
In the vertebrate lens, cells are coupled to their neighbours through the extensive network of 
gap junctions, which are clusters of transmembrane channels allowing small molecules (Mw:::; 
1000 Da), such as metabolites, ions and second messengers, to translocate from cell to cell 
(Bennett & Goodenough, 1978). The structural components of gap junctions are members of 
a family of membrane proteins known as connexins, which consist of four conserved 
transmembrane domains and two conserved extracellular loops. In the mammalian lens, three 
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, connexins have been identified; Cx43 in epithelial cells (Kumar & Gilula, 1996) and Cx46 
(Paul et al., 1991) and Cx50 (White et al., 1992) in differentiating fiber cells. 
This intercellular pathway provides fibre cells with a low-resistance pathway for rapid 
diffusion to all cells, especially between the peripheral lens cells and the interior fiber cells 
(Donaldson & Kistler, 1993; Mathias et al., 1997). The differentiating fibre cells have their 
gap junction coupling conductance concentrated in the equatorial region. The distribution of 
gap junctions directs the intercellular current to the equatorial surface of epithelial cells. At 
the equatorial surface, highly concentrated Na+fK+-ATPase activity can transport the 
intracellular flux ofNa+ out ofthe lens, and complete the circulating current (Figure 1.3) (Gao 
et al., 2000; Tamiya et aI., 2003). 
The circulatory system can be regulated by modulation of the peripheral gap junctional 
conductance or membrane Na+ conductance in the lens. The lens possess some receptors 
which could provide signal transduction for physiological regulation (Gupta et al., 1994; 
Ireland et aI., 1994; Jacob et al., 1992). Systemic hormones and circulating neurotransmitters 
could therefore regulate the internal circulatory system and adjust the lens to the physiological 
state of the organism. As the lens is not innervated, adjustment would be slow relative to 
many physiological responses. 
1.6. Physiological Zones in the Lens 
Lens fiber cells function like a syncytium (a large region of cytoplasm that is not separated 
into individual cells, as in muscle fiber cells), as they appear to be electrically and dye 
coupled (Cohen, 1965). The degree and nature of the coupling in fiber cells, however, 
depend on location (Mathias et al., 1997). This suggests, in the lens, that there are three 
physiologically distinct zones: the anterior epithelium, the peripheral shell of fiber cells and 
the interior fiber cells. 
The outer peripheral shell of fiber cells contains young differentiating fibre cells expressing a 
new complement of cytoplasmic and membrane proteins. Intracellular compartments, 
including organelles, still remain in this region. The degree of coupling between fiber cells is 
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not un iform, the highest cell-cell conductance is at the equator and the lowest towards the 
poles (refer to Figure 1.4.). Overall, gap junctiona l conductance is sensiti ve to intracellular 
pH on the outer peripheral shell , so the fiber cells in thi s region are uncoupled by a reducti on 
in intracellular pH. 
Then there is an abrupt transition at the sca le o f 0.7 radi al di stance (r) from the centre of the 
lens p lotted over the lens radius (ria, propoltion o f the lens radius). At th is point, organelles 
and nuclei suddenl y di sappear at the final stages oflens cell differenti ati on (Bassnetl & 
Beebe, 1992), and the gap junction channels abruptly lose their sensiti vity to changes in pH to 
become unjforml y coupled with the interi or fiber cell s (Baldo & Mathi as, 1992). 
(A) Anterior Pole (8) ADtel'iar Pole 
Equator 
Equator 
Posterior Pole Posterior Pole 
Figure 1.4 (A) Lens morphology. Schematic diagram of lens morphology showing equatorial and 
axial sectioned planes and the dispersion of fiber cell nuclei. Directional axes indicated by white 
arrows aid in orientation in large-scal e expression studies (a = lens rad ius, r = radia l di stance from the 
centre of the lens, c = circumferentia l, z= z-ax ial) (adapted from Jacob e/ al., 2004). ria = I at the 
lens periphery and ria = 0 at the lens centre. (n) Idea l construction of the degree of coupling between 
fi ber cell s by the intensity of shading where the lighter shade represents highest cell-to-cell coupling 
conductance (adapted [rom Mathias et al. , 1997). Cells of the outer shell (ria > 0.7) are rapidly and 
reversi bly uncoupled in response to decreased pH, whereas in terior fiber cells (ria < 0.7) are 
insensiti ve to pH changes (Jacob et aI., 2004; Mathias el aI., 1997) . 
Cleavage of cytoplasmic tails o f Cx50 by ca lpain is attribu ted to the loss of pH sensiti vity at 
th is trans ition region (Bassnett, 2002; Gong et al., 1998; Jacob et at., 2004). These modifi ed 
connex in proteins keep chamlels open between the interi or fiber cells (Figure 1.4) as the 
anaerobi c metaboli sm o f fiber ce ll s generate a rad ial pH gradient in the lens with the acidity 
increasing toward the core of the fiber cell s (Math ias et aI., 199 1). 
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The lens core is composed of anucleated fiber cells with no organelles and forms a functional 
syncytium (Shestopalov & Bassnett, 2000). It was proposed that neighbouring fiber cells are 
joined by a cytoplasmic bridge, providing a path by which large solutes (too large to permeate 
gap junctional channels) can slowly travel throughout the core of the lens (Kuszak et al., 
1985; Mathias et aI., 1997). This arrangement could facilitate the delivery of newly 
synthesized protein components to the aged and metabolically quiescent cells in the centre of 
the lens. 
1.7. Ca2+Regulation 
Ca2+ is the most common intracellular signal transduction element in cells. The free cytosolic 
Ca2+ concentration, directly or indirectly, regulates many cellular functions, including cell 
proliferation, cell motility, contraction, secretion and gene transcription/expression (Berridge 
et aI., 1998; Berridge et al., 2000; Clapham, 1995). Unlike many other secondary messenger 
molecules, Ca2+ can not be metabolised. Its prolonged high level within the cell is one ofthe 
important components in the cascade of events leading to pathological conditions and to cell 
death (Nicotera & Orrenius, 1998; Rizzuto et al., 2003). Therefore the cell tightly regulates 
intracellular Ca2+ levels through numerous binding and specialised extrusion proteins, so that 
any exogenous or internally generated Ca2+ load is rapidly controlled to maintain Ca2+ 
balance. Some cellular proteins have been adapted to bind Ca2+ tightly to lower or buffer free 
Ca2+ levels (i.e. calsequestrin) or to trigger secondary messenger pathways (i.e. calpain and 
calmodulin) (Baimbridge et al., 1992; Clapham, 1995; Heizmann & Hunziker, 1991). 
In the human lens, a large fraction of Ca2+ was found to be in the bound or non-diffusible 
form (Duncan & van Heyningen, 1976), where free Ca2+ was approximately 1 % of total Ca2+ 
(Duncan et al., 1989). A considerable amount of Ca2+ in the human and rat lenses was located 
in intercellular spaces, where it was bound to the outer leaflet of the bilayer (van Marie et al., 
1997; Vrensen et al., 1995). The normal free intracellular Ca2+ level around 100 nM can be 
increased as much as 10-fold following cell-surface receptor stimulation for its cellular 
function, while extracellular Ca2+ levels can be found up to 2 mM (Berridge et al., 2000). 
Ca2+ is involved in cell-signalling in lens epithelium and in the superficial fibers (reviewed in 
Duncan et al., 1994). Ca2+ enters the cells through a store-operated Ca2+ channel pathway by 
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a store-mediated Ca2+ entry (SMCE) mechanism, which is Ca2+ specific (Rosado & Sage, 
2000). The intracellular Ca2+ concentration can be increased in lens epithelial cells by 
agonists (Williams et al., 1993) or mechanical stimulation (Churchill et al., 1996). In the 
epithelial cells of the rabbit lens, agonists that mobilize Ca2+, whether by acting through G-
protein or tyrosine kinase receptors, can modulate lens cell growth (Duncan et ai., 1996). 
SMCE also mobilises Ca2+ from thapsigargin-sensitive intracellular stores into the cytoplasm. 
The Ca2+ entry in SMCE is controlled by the filling state of the stores (putney, 1990). For 
regulating Ca2+ levels during normal Ca2+ signalling, there is a continuous shuttling of Ca2+ 
between the endoplasmic reticulum (ER) and mitochondria in many cells. Those two 
organelles often serve as a Ca2+ buffering system for the cell. Normally the ER stores most of 
Ca2+ and there is very little in the mitochondria (Parekh & Putney, 2005). The high levels of 
Ca2+ in the ER are essential as a signal reservoir and also regulate synthesis and processing of 
proteins in the ER. 
The intracellular Ca2+ concentration ([Ca2+M must be very tightly regulated in time, in space 
and in amplitude to be an effective cellular signalling mechanism. The consequence of the 
loss of intracellular Ca2+ homeostasis leads to various diseases, as demonstrated by the 
mutation or abnormalities of many of the proteins involved in Ca2+ regulation (Missiaen et ai., 
2000). Some mammalian proteins that are associated with [Ca2+]i are listed in Table 1.1. 
Table 1.1 Examples of Mammalian Proteins Triggered by Ca2+ (adapted from Clapham, 1995) 
Tropclnln C 
calmodulin 
Clllrollnln, rodnln. vI,lnln 
CaJcrn.urln B 
CIlIpll/n 
Inoallol plmphollplcl-<sp....:ifio PlO 
.. -Actinin 
Annexln 
PhoaphoJipjl,$\> A2 
Protei ... k1n_ C 
Galaolln 
ea"-activllted K+ chaMsi 
InaPt Receptor 
Rvarlodlne r_blor 
Na'/Ca" exchanger 
Ca"ATPase 
ea" anlfporl91S 
BOPCAR 
OoIdm1mon 
Vlliln 
At",elln 
8100(1 
Qa/rollculln 
f>arvalbumln 
Catbfndln 
Calaoquestrln 
ea"-6ru:Irng 
SIte 
EFhM<I 
EF hand 
EF rw,d 
EF hand 
EF hand 
EF hlUld 
EF hand 
EFhand 
EF hand 
Protein Function 
Modulator Of mUsCle conlfllction 
UbIquitous modulator of protein klnases and omer enzymes (MLCK. OaM kll1asell, 
adenylyl aye/ate I) 
AcUVtltor 01 "~M cyclase 
PhoIIphlllUe 
Protease 
Ge"",,,tor oIIII&P. and diacylglycerol 
Aclin-bundlin" protein 
Implicated In endOo and exocytoar., InhlbUIon 01 PLAo; Ion ciwlnel? 
Produoer I)' ataehIdonlc aeid 
Ubiquitous pmleln klnese 
AClIlWI8vtfing pfOl~n 
Elfealor of membl'lllllt hyparpolarlzatlon 
Effector of Intracellular Ca" relGase 
Effector of Inlrece11u11U Calf ",111_ 
Elfealor of thllllllCl1anga Of eat< lot Nah 8CIosS the plasma membrana 
Pump of Ca" aerO&8 II14Imbrallft 
Exchlll1Q8r 01 Oa" for morm\llllool 10m! 
G protaln-lInJcad Ca"'-l!anslng recaptor 
Rogufalor 01 mUGCIo OOntrDOIlon 
Actin organizer 
TarmlnalOr of phOlOreceplor roapOruIII 
UnknOwn 
Cat> bUlferlmodulll.tor 01 l'IuclelU hormone roc&ptor 
Ca" buller 
ea" buffer 
Ca" buffGr 
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Ionomycin 
Ionomycin (Mw 747.07, C41H70Ca09) is an antibiotic that acts as a Ca2+ ionophore. In crystal 
forms, ionomycin is joined in pairs by two hydrogen bonds to form a 'dimeric' globular 
structure having primarily lipophilic surfaces (Toeplitz et al., 1979). This allows the 
ionomycin to transport divalent cations across biological and artificial membranes by a 
carrier-type mechanism (Fasolato & Pozzan, 1989). The divalent cation selectivity order for 
ionomycin was determined by ion competition experiments to be: Ca > Mg» Sr = Br (Liu & 
Hermann, 1978). Ionomycin is electroneutral, where Ca2+ is exchanged for 2 H+ resulting in 
no net charge movement (Dolber, 1981; Fasolato & Pozzan, 1989). Ionomycin binds Ca2+ in 
the 7.0-9.5 pH range resulting in a complex exhibiting intensive UV absorption at 254 run 
(Liu & Hermann, 1978). Ionomycin complexs and transports Ca2+ in a one-to-one 
stoichiometry. Ionomycin is more effective than another ci+ ionophore, A23187, as a 
mobile Ca2+ carrier (Liu & Hermann, 1978) . 
Ca2+ ionophores are valuable tools to manipulate intracellular ionic homeostasis. They allow 
movement of Ca2+ between the major membrane-bound compartments ofthe cell, 
extracellular space, cytosol, endoplasmic reticulum, and mitochondria, by equilibrating the 
Ca2+ gradient (Abramo v & Duchen, 2003). It was first suggested that calcium ionophores 
directly translocate Ca2+ across the plasma membrane (pressman, 1975). The character of the 
increase in [Ca2+]j can be different depending on the type of cells and the ionophore 
concentration (Galitzine et al., 2005). Recent studies demonstrated that low concentrations 
(submicromolar concentrations) ofionomycin mobilizes Ca2+ stores and subsequent Ca2+ 
influx via SMCE pathway (Dedkova et al., 2000; Morgan & Jacob, 1994). 
1.8. Lens Ca2+ Homeostasis 
Although animal cell membranes have a low permeability to Ca2+, they do have some small 
baseline Ca2+permeability. In the lens, the diffusible Ca2+ is located in the intercellular spaces 
(Paterson & Delamere, 1982/1983; van MarIe et al., 1997; Vrensen et al., 1995). Non-
specific cation channel mechanisms, that are present in lens plasma membranes, are 
responsible for a slow leak of inward passive diffusion ofCa2+ (Duncan et al., 1989). 
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The free Ca2+ concentration of lens epithelium cells is maintained within the order of 100-200 
nM by the cell transport processes ofthe plasma membrane Ca2+-ATPase activity pump and 
plasma membrane Na+/ Ca2+ exchangers (Duncan et aI., 1993; Williams et al., 1993). futemal 
sequestration ofCa2+ is also carried out by endoplasmic reticular Ca2+-ATPase pump activity 
to shift Ca2+ into the ER which functions as an intracellular Ca2+ store (Churchill & Louis, 
1999; Duncan et al., 1993). 
A model of Ca2+ homeostasis in the lens is proposed to explain how the interior fiber cells 
(mature fiber cells) maintain low [Ca2+]i in the absence of cell transporters to remove diffused 
Ca2+ (Borchman et al., 1989a). The circulating current in the lens brings Ca2+ into 
intercellular spaces and then back to the surface via gap junctions in the same manner as Na+ 
(see Figure 1.3.). On the surface of the lens, the Na+/Ca2+ exchange and Ca2+-ATPase activity 
transport the Ca2+ out of the lens (Gao et ai., 2004; Paterson & Delamere, 2004). For 
instance, the increased entry of Ca2+ into clear lenses is offset by an increase in the activity of 
the Ca2+-ATPase pumps (Borchman et ai., 1989b). 
Recent studies of Ca2+ regulation have exhibited a sustained elevation in [Ca2+]i in 
differentiating fiber cells, with [Ca2+]i three-fold higher than in epithelial cells (Churchill & 
Louis,2002). The studies showed that the persistent Ca2+ elevation was due to an increased 
Ca2+influx. Cells with prolonged elevated resting [Ca2+]i are usually associated with disease 
states (Missiaen et al., 2000). Churchill and Louis (2002) proposed that the sustained 
elevation in the resting [Ca2+]i in the lens fiber cells may playa role in lens cell differentiation 
as a part ofthe normal development ofthe intact lens. 
The circulatory system through the fiber cells, coupled with an active Ca2+ regulatory 
mechanism by surface epithelial cells, is critical for maintaining Ca2+ homeostasis of the lens 
and lens clarity. Disturbance in pathways connected to the regulation of Ca2+ homeostasis, 
therefore, can lead to Ca2+ pathological conditions of the lens, such as cataractogenesis. 
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· 1.9. Ca2+ Homeostasis and Cataract 
Cataract is any opacity occurring in the lens, and is the universal pathological response to a 
variety of insults to the lens. It was first reported almost a century ago that there were marked 
changes in the normal ion levels of many human cataractous lenses. They have higher levels 
oflenticular Na+ and Ca2+ and lower K+ content than normal lenses (Burge, 1909). Since 
then, a number of in vivo and in vitro studies have shown that the opacification is associated 
with cytosolic Ca2+ levels (Azuma et al., 1990; Duncan & Bushell, 1975; Hightower & 
Farnum, 1985; Marcantonio et al., 1986; Robertson et al., 2005; Sanderson et al., 2000; 
Truscott et al., 1990). 
In many ageing tissues, increased [Ca2+]i has been observed (Blalock et al., 1994; Ouanounou 
et al., 1999; Romero et al., 2002). With cataractogenesis, early studies showed that the 
elevation of total lens Ca2+ (Duncan & Bushell, 1975) was associated with the development of 
cortical opacification during ageing (Duncan & Jacob, 1984). Many cortical cataracts are 
highly localised in nature, leaving much of the lens intact and transparent (Duncan & Jacob, 
1984; Gandolfi et al., 1990; Harding et al., 1982; Hightower et al., 1989). A degree of 
uncoupling between the fiber cells has been linked to the existence of clear and light-
scattering areas within localised cortical opacities of human lens. Localised opacities show an 
increase in free Ca2+ content and no change ofNa+, which has been correlated with structural 
disruption (Duncan & Jacob, 1984; Harding et al., 1982; Hightower et al., 1989). 
Duncan et al. (1989) showed that the ageing human lens exhibited increased membrane 
electrical conductance and depolarisation of the membrane potential. The authors proposed 
that the activation of some non-selective cationic pathways occurred with ageing, which 
increased the permeability of the lens to ions. This process accounts for the catastrophic 
increase in lens Na + and Ca2+ in human cortical cataractous lenses and is dependent on the 
membrane lipid composition (Borchman et al., 1989a; Delamere et al., 1991). 
The lipid composition changes as lens age (Zeng et al., 1999) and with cataractogenesis 
(Borchman et al., 1993; Gooden et al., 1983; Paterson et al., 1997). Unlike lens Na+, K-
ATPases activities, which are independent of the lipid composition (Dean et al., 1996), the 
lens Ca2+-ATPase, an important component ofCa2+ regulation, is dependent on the membrane 
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lipid composition (Borchman et al., 1989a; Delamere et al., 1991) and is sensitive to 
oxidative damage (Ahuja et al., 1999). It was reported that lens Ca2+-ATPase activity was 
reduced by about 50% in human cortical cataracts (Paterson et al., 1997). 
High [Ca2+]i is one factor (along with trans-junctional voltage and intracellular pH) which is 
known to acutely affect gap junctional conductance (Cooper et al., 1991; Crow et ai., 1994). 
Disruption in the Ca2+ homeostasis affects internal networks essential for the microcirculation 
of the lens. Elevated Ca2+ uncouples lens epithelium cells, which are connected with 
numerous gap junctions by Cx43 (Cooper et al., 1991). In bovine lens epithelial cell studies, 
the rise of micromolar levels of [Ca2+]i induced by the presence of Ca2+ ionophores reduced 
the permeability of gap junctions (Crow et al., 1994). The rise of [Ca2+]i also increased the 
internal electrical resistance in the fiber cells, resulting in uncoupling of the fiber cells by a 
mechanism that is dependent on Ca2+ and calmodulin (Gandolfi et al., 1990) 
Disruption of Ca2+ homeostasis in cells also compromises the regulation of Ca2+ -dependent 
protein activities (Table 1.1). Increased [Ca2+]i triggers the activity ofCa2+ dependent 
enzymes and induces changes in the protein profiles of various tissues. In the lens, where 
protein turnover is slow, the modification of proteins can lead to cataract. 
Two important Ca2+ -dependent enzymes in the lens are the calpains (intracellular non-
lysosomal cysteine proteases) (Murachi, 1983) and the transglutaminases (acyl-transferases) 
(Folk, 1980). They are both activated by the increase in [Ca2+]i in the lens (Lorand et al., 
1998). They often compete for the same endogenous substrates, but one promotes the 
appearance of high molecular weight proteins by cross-linking (Clement et al., 1998; Folk, 
1980; Lorand et al., 1991; Lorand et al., 1981; Shridas et al., 2001), whilst the other promotes 
the production of lower molecular weight forms by proteolytic degradation (David & Shearer, 
1986, 1993; David et al., 1993; Shoeman & Traub, 1990; Yoshida et al., 1984). 
1.10. The Calpain Proteolytic System 
Calpains (EC 3.4.22.17, Clan CA) are found in nearly all animal tissues, with an absolute 
requirement for Ca2+ for activation (reviewed in Goll et aI., 2003). There are at least 14 
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different calpain isoforrns identified in mammals (reviewed in Huang & Wang, 2001). Some 
isoforrns are ubiquitously expressed while others are tissue-specific. 
In the lens, there are five cal pains: ubiquitous calpain I, calpain II and cal pain 10, and lens 
specific calpain Lp82 and Lp85 (reviewed in Biswas et aI., 2004). Enzymatic, immunological 
and mRNA studies have shown that calpain II is the predominant isoforrn in the lens tissue of 
human (Shih et aI., 2001), cow (Yoshida et aI. , 1985), rat (David & Shearer, 1986), mouse 
(Fukiage et aI. , I 997a), guinea pig (Fukiage et aI. , 1997a), rabbit (Fukiage et aI. , 1997a) and 
sheep (Robertson et ai, 2005). 
Active site 
D-llb 
D·lla 
D-V 
D-I 
D·III 
D-VI --'" 
"'-
--- O-IV 
Figure l.S X-ray crystal structure of calcium-free (inactive) human calpain II. A substrate binding 
cleft in the active site (circled) is located between two catalytic sub-domains of D-I1 (D-lla and DIlb). 
Cys-l05 (D-IIa), His-262 (D-IIb) and Asn-286(D-Ilb) are the catalytic residues (adapted from Strobl 
et ai, 2000). 
Lens cal pain II from bovine and rat have a native molecular weight of approximately 110-120 
kDa, and display characteristics similar to the cal pain II isolated from other tissues (Murachi, 
1983). Calpain II is a heterodimer with a variable large (80 kDa) catalytic subunit containing 
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an active site with four domains (Domain D-I, -II, -III and -IV) and a small (28 kDa) 
regulatory subunit with two domains (Domain D-V and D-VI) (reviewed in Goll et aI. , 2003). 
The amino acid sequences of calpains from vertebrate species are highly conserved with over 
90% homology among the mammalian calpains sequenced thus far (Goll et al., 2003). The 
heterodimeric structures for human cal pain I and calpain II have recently been determined. 
There are close three-dimensional similarities between the two isomers, although they are 
encoded by different genes (J ia et al., 2001; Reverter et aI. , 2001). 
Calpain activation 
(a) 
Cy~£105 Hi,..z62 l1 b 
lie 
, 
+ 
+ 
N, 
.. 
Lipid bodies 
or membrane 
(b) 
_ C8~ 
CYS;I.Q5H1 •• l6~b 
Ita 
N, 
- Ca" 
Figure 1.6 Calpain n activation in vivo in the presence of cl+ and lipid bodies or membrane (adapted 
from Reverter et 01., 2001) . 
In the absence of Ca2+, structural constraints in cal pain II hold two sub-domains lIa and lIb 
apart, thus maintaining the active site in a disassembled state (a, Figure 1.6). In the presence 
of Ca2+, Ca2+ binds to the EF hand motifs of domain IV and disrupts a salt bridge between 
Lys-7 (domain I) and Aps-154 (domain VI). This results in the liberation of the N-terminal of 
domain I and thereby initiates structural movement of IIa and lIb into close proximity. 
Consequently, Cys-I 05 (sub-domains Ua) can interact effectively with His-262 and Asn-286 
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(sub-domains lIb) to fonn a calpain active site, which facilitates or even triggers sub-domain 
fusion (b, Figure 1.6). This process could be assisted by Ca2+ binding to negatively charged 
residues on both sides of the active-site cleft and lipid- and/or membrane-mediated Ca2+ 
binding to a negatively charged loop in domain III. Also, Ca2+ binding to domain IV is 
associated with lipid- and/or membrane-mediated activation of calpain II to promote other 
features of enzyme activation, including autolysis and subunit dissociation. 
Table 1.2 Characterising functions of six domains of ubiquitous calpain I and calpain II (reviewed in 
Sorimachi, et al., 1997). 
Subunit Domains Key function 
I Proteolytic activity 
II Proteolytic activity 
Calpain I or III Ca2+ binding, Lipid bodieslMembrane 
Calpain II Large subunit targeting 
IV Containing EF hand motifs for Ca:l+ binding 
V Regulatory 
Small subunit VI Containing EF hand motifs for Ca2+ binding 
Limited proteolysis by calpain 
Cellular activity of calpain is closely regulated through Ca2+-induced confonnational changes 
in the calpains and by interaction (more detail discussed in sectionl.12) with its specific 
endogenous inhibitor, calpastatin. The modulation of calpain activity by phospholipids and/or 
membranes and protein activators has also been reported (reviewed in Molinari & Carafoli, 
1997). 
Calpain I and calpain II have the same substrate specificity but differ in their affinity for Ca2+. 
Calpain I and calpain II require approximately 3-50 JlM and 400 -800 JlM Ca2+ for half 
maximal activation respectively, based on data largely from bovine skeletal calpains . 
(reviewed by Goll et al., 2003). Both calpain I and II auto-proteolyze when incubated with 
Ca2+ (Cong et al., 1989; Dayton, 1982) without any affect on the specific activity of either 
enzyme (Edmunds et al., 1991). Auto-proteolysis reduces the mass ofthe 80 kDa subunit of 
calpain II to 78 kDa, and the 28 kDa subunit to 20.5 kDa (Graham-Siegenthaler et at., 1994). 
The auto-proteolysis (or autolysis) reduces the Ca2+ concentration required for half maximal 
proteolytic activity of calpain II from 400-800 JlM to 50-150 JlM Ca2+, and for calpain I from 
3-50 JlM to 0.5-2 JlM Ca2+. The physiological significance of autolysis remains controversial, 
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. since both the autolysed and unautolysed calpains are capable of proteolytic activity. It has 
been reported that the peptides released during autolysis of subunits of calpain I have some 
chemotactic activities on neutrophiles (Kunimatsu et al., 1989) or immunocytes (Kunimatsu 
et aI., 1995). 
Lp82 is a splice variant of the muscle specific calpain, p94 (or calpain 3), but the structural 
changes make Lp82 more stable than p94 (Ma et at., 1998). Lp82 is expressed in foetal 
bovine and rat lenses (Ueda et at., 2001) but not in human lens. Lp82 levels rapidly decrease 
as the lens matures (Shearer et at., 1998). Lp82 enzymatic activity is the highest in the 
nucleus of the immature rat lens with a requirement of 30 JLM Ca2+ for half maximal activity 
in vitro (Shearer et aI., 1998). 
Calpain-catalysed proteolysis proceeds in a limited manner, producing large polypeptide 
fragments rather than small peptides or amino acids (Goll et aI., 1992). This limited cleavage 
by calpains results in alteration and modification of its substrate proteins, which leads to 
changes in their biochemical and morphological parameters. The calpains have a subsite 
specificity, preferentially cleaving peptide bonds having a leucine or valine residue (reviewed 
by Murachi et al., 1987). Other studies also indicate that the subsite specificity of the 
calpains is governed by conformation of the polypeptide chain (Croall et al., 1996; Stabach et 
at., 1997). 
Another proposed role of calpains is the removal of damaged lens proteins, as proteins within 
the lens have a very slow rate of turnover (Taylor & Davies, 1987). The limited proteolysis 
may also facilitate further degradation ofthe substrate proteins, as the initial modification of 
the given protein by calpains can destabilize its structure and increase sensitivity to the attack 
from other cellular proteases. The complete degradation of proteins to amino acids is a 
concerted action between calpains, which convert proteins into polypeptide fragments, and the 
proteasome and lysosomal enzymes, which degrade polypeptides into amino acids (Goll et 
at., 1999). 
The function of the calpains in the lens under normal physiological conditions is not well 
understood. Consequently, the physiological sites and targets of calpain action in cells and 
tissues can be important in understanding its functions. In the epithelium and cortical region 
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· of the bovine lens, calpain II is the most dominant isofonn of the calpains (Yoshida et al., 
1985). A large portion of the substrates are proteins that are closely associated with 
membranes, including the cytoskeletal and other cytoplasmic proteins (Saido et al., 1994; 
Shoeman & Traub, 1990). Therefore it was suggested that proteolysis by calpains may playa 
role in eliminating filaments, organelles and cytoskeletal elements during lens development 
(David et al., 1994a; Marcantonio & Duncan, 1991; Marcantonio & Sanderson, 1997). In the 
nucleus of intact rat lenses, limited proteolysis of ~-crystallins by calpain II was also observed 
during nonnallens development (David et at., 1994a). The author suggested that this 
proteolysis may be required to increase the protein solubility and to increase both the 
refractive power and structural integrity of the lens. 
Casein zymography for cat pain activity 
Detecting calpain activity in culture cells or tissue samples has been difficult due to the 
presence of various calpain isofonns and the presence of an excessive amount of the 
endogenous inhibitor calpastatin. Resolving the problem required chromatographic 
separation (Karlsson et at., 1985). More recently, a zymographic assay for calpains has been 
developed which separates calpains on casein-containing polyacrylamide gel under non-
denaturing condition (Raser et at., 1995). Samples are loaded and electrophoresed into the gel 
under non-denaturing conditions, which ensures that different calpain isofonns in the sample 
are separated primarily according to their differing charge properties. This is in contrast to 
the size-dependent separation characteristic of SDS-PAGE. Calpain II runs into the middle of 
the non-denatured gel, whereas calpain I and Lp82 always stay within the top quarter of the 
gel, suggesting that calpain II has a greater negative charge. 
The separated calpains are activated by incubating the gel in the Ca2+ -containing buffer upon 
the completion of the electrophoresis. Calpain activation causes the casein in the region to be 
digested into small fragments, which diffuse out of the gel. Calpain itself is also degraded by 
autolysis. Therefore staining the gel with protein-sensitive blue dye results in a blue gel with 
clear bands. The size and brightness of the cleared bands on the gel are dependent on the 
amount of calpain present in the loaded sample. 
Casein zymography of calpain is also useful for studies to distinguish between reversible and 
irreversible inhibitors of calpain. When the irreversible inhibitor, E64, was incubated with 
calpain II, casein remained intact at the point of the calpain migration (Raser et at., 1995). 
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1.11. Cataract and Calpain 
There have been several studies which have implied that the deregulation of calpains in the 
lens contributes to cataract formation. For example, uncontrolled calpain regulation was 
illustrated by increased calpain activities in the lens during aging without any change in their 
overall expression (Avema et al., 2001a; Benuck et al., 1996; Ibrahim et al., 1994; Kennessy 
et al., 1990; Manya et aI., 2002; Saido et al., 1993b). Studies on human cortical cataractous 
lenses have revealed that the degree of the disruption in the lens ionic balance was correlated 
with the loss of protein and a loss of dry weight of cataractous lenses (Duncan & Bushell, 
1975). In many instances, this was accompanied by the degradation of proteins which are 
substrates of calpains as shown in in vitro assays (Goll et al., 2003; Shoeman & Traub, 1990). 
Calpain II was first shown to be present in lens cells by Yoshida et al.(1984). Subsequently, a 
number of experimental models have shown that there is a tight correlation between the 
products of calpain proteolytic degradation and the high Ca2+ content in organ cultured rat 
(Clark et al., 1999; Hightower et al., 1987; Sanderson et al., 1996; Truscott et aI., 1990), 
bovine (Marcantonio & Duncan, 1991) and human lenses (Sanderson et al., 2000). 
Calpain II-induced proteolysis and the precipitation of crystallins contribute to the underlying 
mechanism of cataract development in rodent lenses (David et al., 1993; David et al., 1994b; 
Kadoya et aI., 1993), induced with selenite (David & Shearer, 1993), galactose (Azuma et al., 
1990), diamide (Azuma & Shearer, 1992), Ca2+ ionophore A23187 and xylose (Shearer et al., 
1991). These cataract models provide evidence for the calpain-associated degradation oflens 
proteins, including the major lens soluble structural proteins, u- and p-crystallins, and some of 
the cytoskeletal and membrane proteins, that account for lens opacification (David & Shearer, 
1986, 1993; David et al., 1993; Shoeman & Traub, 1990; Yoshida et al., 1984). 
The proteolytic products of crystallins resulting from calpain-specific cleavage have been 
identified in both cataract models and mature lens animal models in extensive research by 
David and Shearer and their colleagues (David & Shearer, 1993; David et al., 1992; David et 
aI., 1993; David et al., 1994a). The accelerated loss of the N-terminal extensions ofP-
crystallins by calpain II in selenite cataractous lenses of young rats resulted in opacification, 
compared to the slow continuous cleavage of p-crystallins in lenses of normal rats (David et 
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al., 1994a). It was suggested that it was not the quantity of insoluble proteins, but the rate at 
which insolubilization occurs that actually detennined the transparency or opacity. 
Truncation of the N-tenninal extensions on ~-crystallins made these crystallins less stable. 
Consequently, the truncated subunits precipitated and caused light scattering (Shearer et al., 
1997). The removal of the N-tennini caused a possible loss of hydrophilic regions and 
exposed the buried residues that are susceptible to oxidation (Lampi et al., 2001; Nakamura et 
aI., 1999a) and deamination (Lampi et al., 2001). 
The degraded products of a-crystallin produced by calpain II proteolysis in in vitro 
experiments were also found in in vivo selenite and sugar-induced cataract lens in studies 
conducted by Shearer and his colleagues (Azuma et al., 1995; Shearer et aI., 1997). 
Truncation of the C-tenninal of a-crystallins by calpain is known to cause the loss of the 
chaperone function of the a-crystallins (Horwitz, 2003). The truncated a-crystallins did not 
bind as well to the hydrophobic patch exposed on truncated ~-crystallin, consequently, the a-
crystallin fragments became entangled in the resulting insoluble pellets. Early studies have 
indicated that the chaperone activity of a-crystallin decreases upon in vitro treatment with 
calpain II, in senile and induced cataract in vivo, and in old human lenses (Cheri an & 
Abraham, 1995; Kelley et aI., 1993). 
Major protein subunits of the cytoskeleton network are substrates for calpains, and as a 
consequence the cleaved cytoskeletal proteins have a reduced ability to cross-link (reviewed 
by Shoeman and Traub,1990). In the lens, vimentin, spectrin and filensin, are cleaved rapidly 
by the calpains (Lee et al., 2001; Marcantonio, 1992; Truscott et al., 1990). In particular, the 
calpain-mediated cleavage of a-spectrin results in the rapid appearance of 150 kDa and 145 
kDa degradation products (Fox et al., 1987; McGinnis et al., 1999; Wang, 2000). The calpain 
proteolysis of a-spectrin has been associated with a number of cataract models (Fukiage et al., 
1998; Kilic & Trevithick, 1998). 
Several studies have suggested that a substantial proportion of the calpains are associated with 
subcellular structures rather than existing as free calpains in the cell cytoplasm. In skeletal 
muscle, these structures are myofibrils (Kumamoto et al., 1992), whereas in other cells they 
may be cytoskeletal (actin) filaments (Lane et al., 1992). Ca2+ elevation in the diabetic and 
the actin depolymerization-induced-opacity model trigger calpain proteolysis of aII-spectrin 
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and result in cortical opacification (Kilic & Trevithick, 1998). Human lenses, with age-
related nuclear cataracts, display a higher density of finger-like membrane projections than 
transparent lenses of the same age (Bolyle & Takemoto, 1998). 
Animal models for calpain-proteolysis in cataract 
Selenite-induced cataractogenesis is a well-characterised cataract in vivo model. The rapid 
formation of a dense nuclear cataract is produced by a single subcutaneous injection of an 
overdose of sodium selenite to suckling rat pups aged 10-14 days (reviewed in Shearer et aI., 
1987). The oxidation of membrane sulfhydryl groups by selenite (a potent oxidizer of 
sulfhydryl groups) leads to impaired calcium homeostasis. The proposed mechanism is that 
calpain proteolysis causes changes in epithelium metabolism, Ca2+ accumulation and 
crystallin precipitation (Shearer et aI., 1987; Shearer et aI., 1992; Shearer et aI., 1997). 
Recently, connexin (Cx46) knockout (Gong et al., 1997; White et al., 1998) and (Cx46 for 
Cx50) knockin (White, 2002) mouse models have demonstrated there is a direct relationship 
between the rise of cytosolic Ca2+ levels and cataract formation. In these models, gap 
junction coupling conductance between mature fibres and the lens surface was modulated 
either up (Cx46 for Cx50 knockin mouse lenses) (Martinez-Wittinghan et al., 2003) or down 
(in Cx46 knockout mouse lens) (Gong et al., 1998). The absence of gap junction protein 
(Cx46 knockout) caused the loss of coupling of mature fiber cells. As a consequence, the 
efflux path for Ca2+ was blocked and Ca2+ accumulated in the mature fibre cells in a time-
dependent manner, resulting in the development of a dense central opacity (Baruch et al., 
2001; Gao et aI., 2004). The mechanism of opacification was suggested to be over-activation 
ofthe lens specific calpain, Lp82, located in the central region of the mouse lens that produce 
cleaved crystallin, and protein aggregation for light scattering (Gong et al., 1997; Baruch et 
al., 2001). 
The Shumiya cataract rat is a hereditary cataract model in which lens opacity appears 
spontaneously in the nuclear and perinuclear portions at 11-12 weeks of age (Shumiya & 
Nagase, 1988). Calpain-mediated proteolysis contributes to lens opacification during 
formation of this cataract (Inomata et al., 2001). Oral administration of amino guanidine (an 
inhibitor of inducible nitric oxide synthase) to the Shumiya cataract rat suppressed the 
development of lens opacity and inhibited the calpain-mediated proteolysis of crystallins. The 
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author proposed that the amino guanidine prevented cataract by suppressing Ca2+ influx into 
the lens cells. 
The ovine cataract was the first reported occurrence of an inherited cataract in New Zealand 
Romney sheep (Brooks et al., 1982). The ovine cataract is an autosomal dominant trait in 
which partial cortical opacities can be detected within 1-2 months of birth (Brooks et al., 
1982; Robertson et al., 2005). The pathology of the inherited cataract of sheep was 
investigated by Brooks et al. (1983), who showed that fibre cells underwent progressive 
swelling and lysis during cataract development. Cytoplasmic vacuolation of anterior 
epithelial cells was a notable feature. Progressive increases in water, Na+ and Ca2+ and 
decreases in K+ and Mg2+ were observed in ovine cataractous lenses. Cytosolic Ca2+ levels in 
mature ovine lenses were 10-fold higher than in normal lenses (Robertson et al., 2005). The 
presence of Ca2+ -dependent proteases were identified in the ovine lenses, and there was 
evidence that calpain-dependent proteolysis is important in this cataract (Robertson et al., 
2005). 
1.12. CaJpain Inhibitors 
Endogenous calpain inhibitor and calpain regulation 
The most specific calpain inhibitor is the endogenous inhibitor protein, calpastatin. 
Calpastatin is a reversible inhibitor of calpain I and calpain II (Murachi, 1983). It is normally 
present in the cell in large excess compared with calpains. Calpastatin contains 4 repeated 
inhibitory domains of about 140 amino acids, and an N-terminal Domain L (110 amino acids) 
which lacks inhibitory activity (Croall & McGrody, 1994; De Tullio et al., 1998; Emory et 
al., 1987). The conserved residues within each of the four domains cluster into three regions 
called, A, Band C (Maki et al., 1991). Cells and tissues contain multiple forms of 
calpastatin, deriving from both post-transcriptional and post-translational modifications (Cong 
et al., 1998; Lee et al., 1992; Takano et al., 1999). 
Ca2+ is required for calpainlcalpastatin interaction and the Ca2+ requirement is thought to 
originate from the calpain molecules (Cottin et al., 1981; Otsuka & Goll, 1987). The most 
effective inhibition of the calpains by calpastatin requires that all calpastatin subdomains (A, 
28 
· B and C) bind to the calpains at three sites on the calpain molecules; Domain N, VI, and an 
area near the active site (domain II) (reviewed in Goll et at., 2003). 
The in vitro Ca2+ concentration required for calpastatin to bind to calpain is much higher than 
the 50-400 nM free Ca2+ concentrations which exist in living cells (Becker et at., 1989; Berlin 
& Konishi, 1993). Hence the binding of calpastatin to calpain molecules may be poised to 
prevent any inappropriate or inadvertent calpain activity. The Ca2+ concentration required for 
calpastatin to bind to calpain is, however, less than that required to initiate calpain proteolytic 
activity in vitro (Kapprell & Goll, 1989). Most immunolocalization studies found that calpain 
I and II and calpastatin are located exclusively intracellularly and that they are frequently co-
localized in cells (Goll et at., 1992; Kumamoto et at., 1992). 
One mechanism of retaining calpain activity in the presence of calpastatin is thought to 
involve re-Iocating calpain from a widely dispersed cellular distribution to a preferred 
location near the cell periphery. This occurs in response to a cellular signal, such as Ca2+ 
influx (Goll et at., 2003). This mechanism would translocate the calpains away from the 
calpastatin whose location does not change (Gil-Parrado et at., 2003). Calpastatin remains in 
an aggregated form and normally localized close to the cell nucleus (De Tullio et at., 1999). 
Other studies have suggested that the cell localization of calpastatin may be correlated with 
the regulation and activation of calpain (A vema et at., 200 1 b). In the latter studies, it was 
shown that cAMP-dependent phosphorylation was responsible for the aggregation. Following 
an increase in intracellular Ca2+, the dephosphorylation of calpastatin released it from its 
association and it became a soluble protein again. The authors proposed that this reversible 
phosphorylation process mediates the amount of calpastatin available for calpain inhibition. 
Exogenous inhibitors 
As a biochemical tool for understanding the detailed role of calpain-mediated cellular events 
and as a therapeutic agent for calpain-induced diseases, an ideal calpain inhibitor is required 
to have high selectivity towards calpain, possess good cell-permeability characteristics and 
low toxicity attributes. Most ofthe chemical structures being claimed as calpain inhibitors in 
the patent literature are peptide analogues. Calpain inhibitors have been designed from 
naturally occurring sources or by semi-synthetic and fully synthetic procedures. 
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· One polypeptide inhibitor, mimicking the natural calpastatin, is a 27-residue peptide inhibitor 
derived from sub domain lB of the repetitive domains of human calpastatin (Betts et at., 
2003). This polypeptide calpain inhibitor displayed calpain specificity and was a potent 
inhibitor of calpains but its ability to penetrate the plasma membrane was poor. Recently, a 
new derivative (27-residue peptide with 11 poly-arginine peptides) has displayed effective 
penetration across the plasma membrane of neurons (Wu et at., 2003). 
Almost all of the calpain inhibitors reported in the literature are small in molecular size and 
are designed to be active-site-targeted peptide analogues with calpain specificity. Early 
calpain inhibitors were the epoxysuccinyl peptides, including E64 (Azuma et at., 1991; 
Kadoya et at., 1993) and its analogues (Azuma et at., 1992). Irreversible covalent binding 
between the electrophilic centre of the inhibitors and the thiol group of the cysteine residue in 
the active site of calpain, blocked the proteolytic action of the calpain. E64 demonstrated 
some inhibitory effect to reduce cataract in in vitro and in vivo rodent models. There was, 
however, poor selectivity towards calpains and membrane permeability was low (Azuma et 
at., 1991; Kadoya et at., 1993). E64d, a structurally modified version ofE64, with improved 
membrane permeability and increased calpain inhibitory activity, prevented induced cataract 
formation in the in vitro rat model (Azuma et at., 1992). 
Peptide aldehyde calpain inhibitors function as competitive inhibitors of calpains, by binding 
calpains in a reversible Ca2+-dependent way. Examples are leupeptin (Murachi, 1989), cBz-
Val-Phe (MDL28170) (Mehdi et at., 1988), calpain inhibitor I, calpain inhibitor IT, and 
calpeptin (cBz-Leu-nLeu) (Tsujinaka et at., 1988). The electric centre within these inhibitors 
reacts with the thiol group of the active-site cysteine of calpains. The aldehyde end group of 
the inhibitor binds the sulfhydryl group of the active site cysteine to trap the calpain. In 
leupeptin, the presence of the positively charged arginine residue reduces its cell permeability. 
cBz-Val-Phe (MDL28170) and calpeptin (cBz-Leu-nLeu) have improved membrane 
permeability and calpain selectivity over leupeptin and E64 groups, and exhibit better 
inhibitory effects on calpain-mediated cataractogenesis in in vitro rodent models (Sanderson 
et at., 1996). Unfortunately, they have limited selectivity for calpain over other proteases 
(Sorimachi et at., 1997). They are also pharmacologically unsuitable as anti-cataract agents 
due to their low water-solubility and toxicity towards lenses (Biswas et at., 2001; Sanderson 
et at., 1996). 
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Chapter 2: Experimental Rationale 
2.1. Introduction 
The unique structural and physiological properties ofthe lens are tightly integrated with the 
properties of lens proteins, in order to maintain its transparency. Any alteration or 
disturbance in this sophisticated system can affect the optical properties of the lens. 
In ageing and many ageing related diseases, there are post-translational modifications of 
proteins leading to unfolded or mis-folded proteins. Both older lenses and those with cataract 
have shown post-translational modifications oflens proteins (Harding, 2002). 
Altered Ca2+ homeostasis (i.e. excessive increase in [Ca2+]i) has frequently been linked to both 
age-related and non-age-related diseases, as Ca2+ is vital for regulating normal cellular 
functions. Among all other Ca2+-dependent enzymes (Table 1.1), calpain has been implicated 
in a variety of important physiological processes, including signal transduction in cell 
proliferation and differentiation (reviewed by Ono et al., 1998). The consequence of 
uncontrolled calpain activation or a deregulated cellular calpain system, following the loss of 
cellular Ca2+ homeostasis, is the development of a number of pathological tissue conditions. 
In many ageing tissues with elevated intracellular Ca2+ levels, impairments to the proteolytic 
system leading to undesired protein cleavage or inefficient protein removal have been 
proposed to be a key aspect of cellular ageing (Nixon, 2003). Ageing is the most common 
factor in human cataract formation. 
There is increasing evidence that experimentally induced and naturally occurring cataracts 
proceed along common pathways (Figure 2.1) (Harding, 2002). A rise in [Ca2+]i has been 
reported in lenses obtained from a number of animal cataract models and from humans with 
cataracts. In such studies, the rise of intracellular Ca2+ level was correlated with proteolytic 
products from a limited cleavage of a number of proteins that have been linked with 
maintaining lens transparency. 
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2.2. Hypothesis for Current Research 
The current research has been designed to investigate cataract fonnation associated with the 
loss of Ca2+ homeostasis in the lens and to examine the involvement of calpain in 
cataractogenesis. 
It is proposed that (i) Ca2+ homeostasis is vital for lens transparency, (ii) the loss of Ca2+ 
homeostasis leads to a malfunction in the regulation of calpain activity, and (iii) deregulation 
of calpain activity is one of the key mechanisms contributing to cataract fonnation. 
Internal & 
external insults Ageing 
Post translational 
modification of proteins 
Unfolding of Proteinr / 
~ \ 
Malfunction or 
Impaired membrane 
function 
~ 
I Disrupted altered kinetics short-range of Na, K-ATPase order ~ Ionic imbalance 
fSyneresis Transglutaminase 
crosslin king 
Aggregation 
~ 
)4== *Over-activated 
,.. .. Calpains 
Figure 2.1 A modified diagram of the changes seen in human cataract (adapted from Harding, 
2002). This thesis investigates the role of Ca2+ homeostasis and the involvement of calpain-
activated proteolysis in the development of the cataract*. t Syneresis is exudation of the liquid 
component of a gel. 
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2.3. Research Methods: Ovine Lens Models 
The use of ovine lenses in an in vitro system is a novel approach for the close examination of 
cataractogenesis. Unlike rodent lenses which are completely spherical and hardly 
accommodating, bovine and ovine lenses resemble the biconvex shape of human lenses 
(Augusteyn & Stevens, 1998). From the properties of the lens and the anatomy of its 
suspensory structure, it would be expected that bovine and ovine lenses are capable of 
accommodation. An intra-capsular accommodation mechanism is involved with active 
participation of metabolic processes. It is thought that lenses with accommodating power, 
like ovine and human lenses, share a metabolic pattern similar to muscle (ratio ATPI ADP > 
8), whereas the non-accommodative lenses, like rodent, correspond to the metabolic pattern of 
the liver (ratio ATP/ADP < 3) (Wegener et ai., 1995). 
The larger size ofovine lens (average wet weight Ig for 3 - 9 months old sheep) compared 
with rodent lenses has the advantage of providing a valuable in vitro model for studying 
cataractogenesis. For example, in the lens culture system (in vitro model), a single intact 
ovine lens can be sustained and provide material for analysing biochemical and physical 
changes. There is also the advantage, at Lincoln University, of accessing intact ovine lenses 
from freshly killed animals, and delivering, with minimal time, the intact lenses to the in vitro 
culture system. 
In addition, the in vitro cataractogenesis studies with ovine lenses at Lincoln University are 
cross-referenced to the naturally occurring ovine hereditary cataract flock maintained at 
Lincoln University (Brooks et ai., 1982). The ovine cataract is bilateral (affecting two eyes 
equally) and progresses to full maturity within a year. The ovine hereditary cataract is a 
cortical cataract, which is a common type of human cataract (Duncan & Bushell, 1975; 
Robertson et aI., 2005). It has a predictable cataract development, where the progression of 
the cataract formation in the lens can be monitored and examined by visual inspection with 
the same ophthalmologic equipment used for human patients. Assessment of whether calpain 
is associated with the development of cataracts in the ovine hereditary flock was investigated 
by applying calpain inhibitors to one eye of the sheep (Robertson et ai., 2005). This in vivo 
ovine model has been a useful non-rodent model to examine the role of calpains in the 
mechanism of cataractogenesis (Robertson et ai., 2005). 
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2.4. Outlines of Research Chapters 
An ovine lens culture (in vitro) system and the inheritable ovine cataract (in vivo) model have 
been used to test the hypothesis ofthe involvement of Ca2+ and calpain in cataractogenesis. 
This involved visual measurements, biochemical and physiological analysis of changes 
occurring in Ca2+ -induced cataract, including analysis oflens proteolysis, calpain activity, 
microscopic changes and testing the efficacy of calpain inhibitors (including novel 
compounds) in the in vitro system. Novel calpain inhibitors were applied to the in vivo ovine 
model and their therapeutic potential assessed. There are four major experimental chapters 
(Chapter 3 to 6) in this thesis to test the hypothesis, followed by general conclusions with 
future research directions (Chapter 7). A brief description of each chapter follows: 
Chapter 3 Viability of the intact ovine lens in culture system 
An in vitro organ culture system was adapted as a major research tool for investigating the 
hypothesis, as the unique avascular nature of the lens makes the culture system an alternative 
controlled model for investigating the mechanism of cataractogenesis. The components of the 
culture media, as a replacement of the aqueous humour, are vital for sustaining intact lenses. 
It was imperative to assess the optimum requirements to sustain the ovine lens during the 
experiments, as the 'in vitro' ovine lens is a novel approach. Two culture media were 
assessed for measuring lens viability based on a LDH leakage assay. A culture system 
protocol was developed as a benchmark system for future research. 
Chapter 4 Ionomycin induced opacity in ovine lens culture 
The loss of Ca2+ homeostasis within the lens was induced by culturing intact ovine lenses with 
the Ca2+ ionophore, ionomycin. The characteristics of opacification were closely investigated 
and their linkage to proteolytic activity by calpain assessed to provide experimental evidence 
for the mechanism of cataractogenesis. Ca2+ -overloaded lenses in the culture system have 
produced a model to support the concept that certain lens proteins are essential for 
maintaining transparency and that Ca2+ homeostasis is important in maintaining the 
physiology of the normal lens. 
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Chapter 5 Application of calpain inhibitors to cataractogenesis models 
In this chapter a calpain inhibitor, SJA6017, was used to confirm the involvement of calpain 
in Ca2+-linked in vitro cataractogenesis models. Two models were used and compared in 
relation to assessing the potency of calpain inhibitors in these cataract models. Novel calpain 
inhibitors were also tested for their efficacy in preventing opacification. Two novel inhibitors 
were then selected for application in the in vivo inherited sheep model. For the therapeutic 
application of desirable anti-cataract drugs, young sheep with inherited cataract were topically 
administrated with eye-drops during their natural progression of cataracts. The progress of 
inherited cataracts was not prevented over the period of the trial. There was no evidence that 
the inhibitors penetrated into different parts of the eye. 
Chapter 6 Drug profile of the novel calpain inhibitor, CatO059 
The data from Chapter 5 revealed that the inhibitory effects of novel anti-calpain drugs in the 
inherited ovine model were limited by their poor bioavailability in the lens. In this chapter, 
biological barriers in the eye were considered separately for testing the bioavailability of a 
novel drug administrated topically. The uptake of the drug by the lens in vitro was 
investigated by measuring its permeability through the cornea and assessing the binding 
factors within aqueous humour and lens homogenates. 
2.5. Outline of General Conclusion Chapter 
Chapter 7 General conclusions and future directions 
Highlights of experimental evidence in each experimental chapter are discussed in relation to 
the hypothesis. The research results contributed from the current studies have added to our 
existing knowledge (Figure 7.1). The application of calpain inhibitors, their contribution to 
the calpain hypothesis and the potential of calpain inhibitors as therapeutic agents in calpain-
associated disorders are discussed. Overall conclusions are outlined along with suggestions 
for future research. 
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Chapter 3: Viability of the Intact Ovine Lens in Culture System 
3.1. Introduction 
The avascular lens has a specialised circulatory system to meet the metabolic needs of all its 
cells. The aqueous humour, which is in contact with the anterior region of the lens, provides 
nutrients and removes waste from the circulatory system within the lens. Due to this unique 
feature oflens physiology, an intact lens can be removed from the eye and sustained in a non-
biological condition; an organ culture system which baths the lens in a synthetic media at its 
physiological temperature with the CO2 level set in a sterilised chamber. Unlike a cell culture 
system which provides a group of viable cells to study, the intact lens in an organ culture 
system closely resembles its biological and physiological condition within the eye. 
To date, in vitro lens cultures have provided an alternative and controlled model to understand 
the mechanism of cataractogenesis, mostly with rodent (Sanderson et al., 1996; Truscott et 
al., 1990), bovine (Marcantonio & Duncan, 1991; Marcantonio et al., 1986) and human lenses 
(Hightower & Farnum, 1985; Sanderson et al., 2000). Many studies have shown that there 
are species differences, especially in aqueous humour dynamics and its composition (Aihara 
et al., 2003; Baeyens et al., 1997; Berman, 1991; Mermoud et al., 1996). Despite the success 
with animal lens culture systems, there is little information on the dynamics of the ovine lens 
aqueous humour and its linkage to the lens. Since the influence of aqueous humour dynamics 
on the lens in vitro conditions is vital, it is important to assess the viability of ovine lenses in 
culture systems. 
Furthermore, it is vital to establish whether a culture medium can replace the aqueous humour 
and sustain viable intact lens within a culture system. Eagle's minimum essential medium 
(EMEM or MEM) is one ofthe most widely used synthetic cell culture media (Eagle, 1976). 
It is complex but a defined system without serum or growth factors. A simpler medium, 
artificial aqueous humour (AAH), was formulated originally based on the analysis of human 
aqueous humour (Davies et al., 1984). 
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In addition to selecting the type of medium, there are other factors which may influence the 
viability of the lens in the culture system. For example, minimizing the time between death of 
the donor and delivery of the lens to the culture system is important for successful culture. 
Sanderson et at. (1996) found that in human lenses the time had to be less than 48 h if the 
lenses were to remain viable over a 2 week culture period in EMEM (Sanderson et at., 1996). 
In addition, isolated lens must be maintained under a sterilised condition in order to prevent or 
limit growth of fungus. Removal of wastes from the lens, by changing the culture media 
regularly, is also important. 
Cell viability is assessed by monitoring signs of cell death, which are normally evaluated by 
the quantification of plasma membrane damage. Lactate dehydrogenase (LDH) is a stable 
cellular cytoplasmic enzyme but it is rapidly released into cell culture media if the plasma 
membrane is damaged. Consequently, the amount ofLDH activity detected in the culture 
medium correlates to the proportion oflysed cells (Decker & Lohrnann-Mattens, 1988; Martin 
& Clynes, 1991; Masanet et at., 1988; Szekeres et at., 1981). 
The ovine lens is a novel experimental animal model in cataractogenesis studies. Assessment 
of the viability of the ovine lens in a organ-culture system is an important step to determine 
whether the culture system can be adopted to study the physiological status of the lens in a 
cataractogenic-induced aqueous environment. In the current chapter, the cell viability of the 
ovine lens was examined by culturing intact ovine lenses in two different culture media, 
EMEM or AAH. From the results, a culture system protocol was developed as a standard for 
future research. 
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3.2. Methods 
Preparation of culture medium 
The EMEM culture medium for normal culture (EMEM, pH 7.4) is a bright-light red solution 
(due to the presence of Phenol Red'Na pH indicator as a component), prepared from 
Minimum essential medium powder (or MEM, purchased from Sigma, product number 
M0643, 2003), 26 mM NaHC03, 0.02 mglmL gentamycin (antibiotic, from Sigma) and 2.5 
j.lglmL amphotericin B (anti-fungal, from Sigma) in dH20. Pre-treatment EMEM solution 
(pre-EMEM, pH 7.4) was prepared with Minimum essential medium powder, 26 mM 
NaHC03 and 1 x Antibiotic Antimycotic Solution (100 units/mL penicillin G, 100 j.lg ImL 
streptomycin and 0.25 j.lglmL amphotericin B, from Sigma) in dH20. 
Artificial aqueous humour (AAH, pH 7.3) culture media is a colourless solution that was 
adapted from the formulation described by David et al (1984): 130 mM NaCI; 5 mM KCI; 
1 mM CaCh; 0.5 mM MgCh; 2.5 mM D-glucose; 20.0 mM HEPES; 5.0 mM NaHe03 . 
All culture media were sterilised immediately using 0.2 j.lm pore size filters (VacuCap® 60 
Filter Unit: 0.2 j.lm pore size Supor® Membrane (hydrophilic polyethersulfone)) into 
autoc1aved bottles. 
Lens sample collection 
Groups of ovine eye globes from 9-12 months old lambs, were collected from a local 
slaughterhouse immediately after slaughter and delivered to the laboratory for lens dissection. 
Pairs of lenses from the eyes of each animal were kept together. Lenses were dissected within 
2 h of death of the animal using the posterior approach. The intact lenses were immediately 
placed in a sterile culture dish containing 10 mL of corresponding culture media per lens (see 
experimental protocols). The entire lens was submerged with its anterior epithelium facing 
upward in the medium. They were then incubated at 37°C, 5% CO2 in a sterilised chamber. 
Experimental protocols for lens viability with two culture media. 
Immediately after dissection, two groups of intact lenses were placed either in EMEM (n = 6) 
or AAH (n = 4) for measurement of spontaneous LDH release. At the same time, another two 
groups of intact lenses were placed either in EMEM containing 2% Triton X-IOO (n = 5) or 
AAH containing 2% Triton X-100 (n = 4) for determining maximum LDH release. Allienses 
were incubated at 37°C, 5% C02 in a sterilised chamber for the total 25 h experimental 
period. A series of media samples (100 ilL per lens) were collected during the experimental 
period. Triplicates of each culture medium sample were analysed in the cytotoxicity assay. 
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· Experimental protocol for lens viability with pre-EMEM treatment. 
Immediately after dissection, each of twelve pairs of intact lenses was placed in 10 mL pre-
EMEM media. After 30 min incubation period, they were transferred to a culture dish 
containing 10 mL EMEM per lens, and were incubated at 37°C with 5% CO2 under sterile 
conditions for the total 48 h experimental period. All media were completely changed at the 
end of the first 24 h period. For the LDH leakage assay, 5 mL of EM EM medium per lens 
were collected at the end of each 24 h incubation. Ttriplicates of each culture medium sample 
were analysed in the cytotoxicity assay. 
Visual monitoring of cultured lenses 
Lenses were photographed using a digital camera (Sony Cybershot DSC-F505V) fitted to a 
stand (Haiser R 3 XA). A transparent flat bottom culture dish containing a lens and medium 
was placed on black grid lines (1 x 1 mm) with a white background light (Radiographic 
Supplies, Christchurch, New Zealand). Images of the anterior epithelium of the lens were 
taken with an image resolution of 1856 x 1392 pixels as a RGB true colour JPEG image. 
Lens opacity grade scoring using an image analysis system 
The software used to grade the opacification captured was Image Pro-Plus v4.1. A macro 
script was created to automatically analyse the digital images of lenses (pixel size 1856 x 
1392) placed on a Imm x Imm black grid. The grading system was developed on the basis of 
selecting predefined pixel RGB values, after area defining and sharpening of the image. 
Part 1: The programmed system predicts total blobs (which are clear squares formed by the 
Imm x 1 mm black grid) from the total lens area. Due to the consistent measurements ofthe 
camera position and settings, the measurement of pixels/cm is a constant. This allows the 
macro to analyse multiple user-specified images automatically. Part 2: The system sharpens 
the image using a sharpening filter built into the software. The macro identifies the actual 
blobs visible through the opaque parts of the lens by selecting predefined pixel RGB values. 
Part 3: From the constant pixel/cm ratio, the macro is able to compare the calculated actual 
blobs against the total predicted blobs calculated from the size of the lens. This value is 
shown as a percentage and used as the score of the lens. Full opaque lens are graded as 100, 
while clear/transparent lens are graded as 1. 
Lens viability assay- cytotoxicity detection 
Cell viability was measured by LDH levels in the culture media, using a cytotoxicity 
detection assay kit (Roche Applied Science, Cat. No.1 644 793). Evaluation of cell 
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cytotoxicity required infonnation on the LDH activity level in the assay media (AAH or 
EMEM (background control», LDH activity level released from the lenses in nonnal medium 
(spontaneous LDH release), and the amount ofLDH released from lenses in EMEM or AAH 
with 2% (v/v) of non-ionic detergent, Triton X-lOO (iso-octylphenoxypolyethoxyethanol) for 
inducing maximum LDH leakage (maximum LDH release). Triton X-I 00 is one of most 
commonly used non-ionic detergents for solubilizing membrane proteins during isolation of 
membrane-protein complexes (Barbero et ai., 1983; Schubert et ai., 1983). 
Culture medium (100 ILL/well) was mixed with 100 ILL LDH kit reaction mixture in an 
optically clear flat bottom 96 well microplate, then incubated at RT for 30 min in the dark. 
The final concentration of Triton X-100 in the 200 ILL assay volume was 1 % (Triton X-lOO 
does not interference with reagents at this concentration). For quantitative measurement of 
LDH levels in the samples, 1000 U/mL ofLDH (lactic dehydrogenase from bovine heart, 
Sigma) was diluted with assay medium (AAH or EMEM) from 0 (background control) to 
10 mUll 00 ILL to generate a standard curve. All samples were assayed in triplicate. The 
absorbance of the samples at 492 nm was measured and the background at 660 nm subtracted. 
Relative cell LDH leakage levels of the lens in nonnal culture medium (spontaneous LDH) 
over maximum releasable LDH activity level in culture containing 2% Triton X-IOO 
(maximum LDH) were calculated for assessing cytotoxicity in the culture medium. 
Relative percentage of nonnallens cytotoxicity was detennined according to the fonnula: 
% cytotoxicity = [l-(spontaneous LDH - maximum LDH)/ maximum LDH] x 100. 
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3.3. Results 
Ovine lenses in the opacification scoring system 
An ovine lens is biconvex with an asymmetric structure about a plane passing through its 
equator (Chapter I, Figure 1.1 and 1.2). A lens from a 9-12 months old sheep has between 
10-13 mm diameter of surface anterior region (complete circle), with a wet weight range 
between 700 and 1000 mg. Black suspensory ligaments remained attached around the 
equatorial regions of dissected lenses and indicated the outer boundary of lenses fully 
suspended in the culture media. 
The grid can be seen as clear prominent black lines through a transparent lens (Figure 3.1, A), 
or as blurry lines as the lens becomes opaque and scatters light (Figure 3.1 , B and C). 
According to the visual image analysis developed at our laboratory, a score below II 
represents a clear/transparent lens in the EMEM (Figure 3.1 , A), while a score above 90 
indicates a densely opaque lens (Figure 3.1 , C). A score of 50 represents partial opacity 
(Figure 3.1 , B), resulting in a blurry area with semi-dense opacification. This data showed 
direct correlation of the visual assessment of opacification with the digitally analysed score of 
opacification. 
(A) (8) (C) 
Suspensory ligaments 
Figure 3.1 Digital images of three ovine lenses in the culture media (EMEM) on a grid including their 
opacification scores (or relative transparency score system) based on digital visual analysis. 
(A) clear/transparent lens with the score of 8.5, while (8) partially opaque lens with 50 and (C) fully 
opaque lens with the score of 93, both induced by treatment with Ca2+ ionophore, ionomycin, over the 
total 24 h experimental period. 
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Lens transparency 
Apparent black grid lines indicated that lenses cultured in EMEM (n = 5) maintained their 
transparency unchanged after 26 h incubation period with average opacification score of 11.4 
± 2.9 (Figure 3.2, A and B). Lenses cultured in AAH at 5 h were slightly more opaque (18.4 
± 2.0, Figure 3.2, a) than lenses incubated in EMEM but overall they were relatively 
transparent. These lenses, however, became significantly blurry around the equatorial region 
at 26 h (Figure 3.2, b). 
Lenses cultured with 2% Triton X-I 00 for 26 h were swollen and developed a strong eggy 
odour with approximately 35% and 45% opacification in AAH and EMEM media 
respectively (Figure 3.2, C and c). The colour ofthe EMEM medium changed from light red 
to yellow, indicating a fall in pH of the EMEM as a result of acid production from lysed cells 
induced by 2% Triton X-IOO. All lenses treated with 2% Triton X-IOO for inducing 
maximum LDH release displayed the formation of blurry opacification within the inner fiber 
cells (white arrows in Figure 3.2). A distinctive barrier between the outer-shell of the cortex 
fiber cells and the inner shell of nuclear fiber cells is obvious in these lenses. 
TS T26 T26 
EMEM 
AAH 
Figure 3.2 Digital images of transparency of ovine lenses and their opacification scores (± sd, I = 
clear/transparent lens, 100 = full opacity), after culture in EMEM (A, B. n = 5), AAH (a, h. n = 4 ), 
EMEM containing 2% TritonX-IOO (C, n = 5) and AAH containing 2% Triton X-IOO (c. n = 4) for 5 h 
(T5) and 26 h (T26) experimental period. All lenses were cultured in an incubator at 37°C, 5% CO2. 
White arrows in C and c are pointing to the internally generated barrier in 2% Triton X-IOO treated 
lenses. 
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Cytotoxicity assay 
The spontaneous LDH leakage from lenses cultured in normal media was compared with the 
maximum releasable LDH leakage oflenses by culturing them in the media containing 2% 
Triton X-IOO (Figure 3.3). Lenses cultured in media with 2% Triton X-IOO showed a rapid 
increase ofLDH levels and within a 2-3 h incubation period reached their maximum 
releasable LDH activity. ill comparison, the LDH level from lenses cultured in AAH and 
EMEM were low during the initial 6 h incubation period. 
(A)AAH (B)EMEM 
I- AAH+Triton & AAH I I- EMEM+ Triton & EMEM 1 
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Figure 3.3 A plot of mean LDH leakage levels (mUll 00 ilL medium) released from ovine lenses 
during culturing in AAH (A) or EMEM (B). Spontaneous LDH activity (n = 5) in normal culture 
medium (6) was compared to maximum releasable LDH activity (n = 4) where culture medium 
contains 2% Triton X-IOO (_) (EMEM+Triton or AAH+Triton). 
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The relative cytotoxicity of a culture medium was based on the LDH leakage levels from 
lenses during a 24 h culturing period. Relative cytotoxicity level of lenses cultured in AAH 
gradually increased over the incubation period. At the end of24 h, the LDH levels released 
from lenses cultured in AAH were approximately 50% of their maximum releasable LDH 
activity level (Figure 3.4, A). On the other hand, the relative cytotoxicity levels released from 
lenses cultured in EMEM were unchanged and remained approximately 20% of the 
cytotoxicity over a 24 h incubation period (Figure 3.4, B). 
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Figure 3.4 A plot of relative cytotoxicity (%) of normal ovine lens during culture in AAH (A) and in 
EMEM (B) for 24 h, % Cytotoxicity = [1-(spontaneous LDH - maximum LDH )/ maximum LDH] x 
100, 
Pre-EMEM treatment 
At the end of the first 24 h incubation period followed by a 30 min of pre-EM EM treatment, 
the LDH activity released from lenses (n = 12) was 149 ± 16 mUll 00 pL, At the end ofthe 
second 24 h period, the LDH activity ofthe same lenses were 35 ± 9 mUll 00 ilL. This is 
23% LDH leakage compared to the one measured at the end of the first 24 h culture period, 
The apparent reduction of LDH activity in the second 24 h incubation period indicates that the 
lenses were in steady condition in the culture system over this period, and that the pre-
treatment did not affect lens viability, 
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3.4. Discussion 
Current data have demonstrated the importance of providing the metabolic conditions for 
sustaining intact young ovine lenses in a culture system. Cytotoxicity data in our studies have 
revealed that the culture medium, EMEM, can sustain ovine lenses for a 24 h incubation 
period. The viability of the lenses coincided with maintenance of the transparency of the lens 
over the incubation period. The main ingredient of the culture media (EMEM) is a minimum 
essential medium (MEM) proposed by Eagle (1976). In addition to basic salts components, 
MEM contains high concentrations of amino acids and metabolites to meet the special 
nutrient requirements for facilitating cell growth in mono layers (Eagle, 1976). When the 
viability of human lens in the EMEM was tested by the capacity of intact lens to synthesize 
proteins, the data showed that intact human lens transferred from the eye into the culture 
system had remarkable resilience in the EMEM culture medium (Sanderson et al., 2000). 
Therefore, the EMEM without serum or any additional supplements provides an ideal culture 
environment to maintain the viability and transparent status of intact lens. 
On the other hand, the current data revealed that ovine lenses cultured in artificial aqueous 
humour (AAH) medium developed approximately 50% cytotoxicity by the end of a 24 h 
incubation period. This increased cytotoxicity level coincided with a significant development 
of lens opacification during the same incubation period. The formulation of AAH is 
composed of basic salts with a glucose and buffer component (HEPES) based on analysis of 
human aqueous humour (Davies et al., 1984). However, the AAH media contains only 
glucose to satisfy the basic metabolic needs of the avascular nature ofthe lens. Aqueous 
humour contains various nutrients along with ionic components (reviewed in Berman, 1991). 
For instance, in most mammalian species, the concentration of amino acids in the aqueous 
humour is higher than in plasma, due to the active transport across the ciliary epithelium to 
meet the metabolic needs of avascular tissues including the lens and cornea (Berman, 1991). 
In the eye, aqueous humour is continuously replaced in exchange for a constant supply of 
metabolites and for eliminating wastes from surrounding ocular tissue including the lens and 
cornea (Freddo, 2001). In the culture system, the lenses were placed in 10 -13 fold volume 
media (10 mL per lens) which is in excess ofthe natural volume of aqueous humour 
(approximately 500 to 800 J-tL in 3 - 6 months old ovine eye). Despite the buffering system 
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containing HEPES to minimise changes from pH 7.4, the lens were only viable for a few 
hours. These data show that specific nutrient components, at optimum levels, are needed to 
maintain the viability of ovine lens and their transparency over long-term incubation periods. 
There are two types of intercellular communication, ionic and metabolic (Duncan & 
Worms tone, 2001). It has been shown in several systems, including the lens, that metabolic 
communications can be severed whilst ionic communications remain intact (reviewed in 
Duncan et at., 1998). The AAH culture medium was demonstrated to be effective in 
maintaining a constant level of ions in rat lens for up to 24 h by other research (Davies et at., 
1984; Lucas et at., 1986). 
There are also possible species differences in the extent of communication between different 
regions of the lens, and the pattern of communication can change as the lens develops 
(Duncan & Wormstone, 2001; Mathias et at., 1997). AAH has been adapted to sustain 
rodent and human lenses by Cornish et at. (2002) and Sanderson et at. (1999). In young 
ovine lenses, the metabolic needs for a rapidly developing tissue may be a key factor 
influencing their viability and could possibly explain the importance of adding supplements 
with metabolic characteristics to the culture medium. 
To minimise the infection of the organ culture system, antiseptic treatment techniques have 
been applied to the freshly dissected lens as an initial step to maintain the viability of the lens 
(Sanderson et at., 1996; Sanderson et at., 2000). Current data showed that the 
antibiotic/antimycotic solution treatment prior to transfer to the culture system had a minor 
effect on lens viability. This is thought to be an 'initial response' of the lens taken out ofits 
biological system to a synthetic environment. The LDH leakage level, however, was 
dramatically reduced in the second 24 h period, which indicates the lens subsequently 
stabilises in the in vitro system. Changing the culture medium (EMEM) daily confirmed that 
the lenses needed at least 24-48 h to adjust to new aqueous conditions after removal from the 
eye (Sanderson et ai., 1996). 
Another interesting observation was that two regions in the lens were identified which were 
different in their internal opacity when the lens was treated with the 2% non-ionic detergent, 
Triton X-I00. The proximity and location of the boundary between the two regions closely 
reflect the boundary between the two physiological zones in the lens. One zone is the 
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differentiating outer-shell fiber cells and the other, the interior mature (differentiated) fiber 
cells as described in Chapter 1 (Figure 1.4). At this boundary, between the zones, there is an 
abrupt change in the composition of fiber cell membrane proteins and their membrane 
associated proteins. The connexins, which are important components of the gap junctions in 
the interior mature fiber cells, become less pH sensitive, and more uniform in their 
conductance within this area (reviewed in Mathias et al., 1997). Triton X-100 is commonly 
used for solubilizing membrane proteins. Consequently it promotes cell death and the cells 
leak the maximum releasable LDH from the lens into the culture medium. These data showed 
that cell death promoted by addition of 2 % Triton X-I 00 treatment resulted in the 
identification of two physiological zones in the lens, a peripheral shell of fiber cells and the 
interior fiber cells. 
Taken together, a protocol for ovine lens culture system has been developed in this thesis as a 
standard protocol for future research using cultured ovine lens. The culture system protocol 
has been developed after assessing the viability of lens with different types of culture 
medium. 
The developed protocol for a culture system is: 
1. Within 2 h of the death of the animal, the lenses are dissected using the posterior approach 
and incubated in a pre-EMEM solution (MEM, pH 7.4; 26 mM NaHC03; 0.25 /lglmL 
amphotericin B; 100 unitslmL penicillin G; 100 /lglmL streptomycin) for 30 min in a laminar 
flow hood. 
2. Thereafter, each lens is submerged in 10 mL EMEM (MEM, pH 7.4; 26 mM NaHC03, 
0.02 mglmL gentamycin,· 2.5 /lglmL amphotericin B) and incubated in a sterile chamber 
(37°C with 5% CO2) for a settling period of at least 2 days, prior to the application of any 
experimental treatment. 
3. Daily replacement of the culture media is recommended. 
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Chapter 4: Ionomycin Induced Opacity in Ovine Lens Culture 
4.1. Introduction 
70% of human cataracts are cortical cataracts and are associated with changes in the internal 
ionic content of the lens (Duncan & Bushell, 1975). Culture studies with lenses from rats 
(Clark et aI., 1999; Sanderson et aI., 1996; Truscott et al., 1990), cattle (Marcantonio & 
Duncan, 1991) and humans (Sanderson et ai., 2000) have provided evidence for an 
association between increased level of cytosolic Ca2+ and increased amounts of proteolytic 
products with changes in the optical properties of the lens. These cataract models have 
implied that over-activation of calpain proteolysis is a key mechanism contributing to Ca2+ 
associated cataractogenesis. 
The lens culture system has been subjected to various cataractogenic agents to initiate Ca2+_ 
induced opacification. For example, intracellular Ca2+ levels oflenses have been raised by 
various means such as: a hyper-Ca2+ environment (Biswas et al., 2004; Hightower & Farnum, 
1985), osmotic stress by ouabain (Strophanthidin, a Na+/Ca2+ exchange inhibitor) 
(Marcantonio et al., 1986), mechanical stimulation (Churchill et al., 1996), a Ca2+_ influx 
stimulator (a sulfhydryl reagent p-chloromercuriphenyl sulfonate) (Truscott et al., 1990) and 
Ca2+ ionophores (A23187 and ionomycin) (Marcantonio & Duncan, 1991; Sanderson et al., 
1996; Sanderson et al., 2000). 
Among cataractogenic agents that induce a rise of cytosolic Ca2+ levels, the Ca2+ ionophores 
(A23187 and ionomycin) have been reported as selective and potent Ca2+ transporters (Liu & 
Hermann, 1978; Toeplitz et al., 1979). Unlike other cataractogenic agents which stimulate 
Ca2+ influx indirectly, Ca2+ ionophores elevate cytosolic Ca2+ level directly by transporting 
Ca2+ across biological membranes andlor by store-operated Ca2+ entry pathways. In a cell-
line culture system with various tissues, Ca2+ ionophores have been numerously used for 
manipulating cytosolic Ca2+ concentrations to study Ca2+ signalling systems. However, there 
have been only limited applications of Ca2+ ionophores in lens culture systems reported so far. 
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Figure 4.1 Structure of Ca2+ ionophore, ionomycin with 1: 1 complex with a calcium ion 
(C41H7009Ca2+). 
In comparison to cell cultures comprising single layers of cells, the effect of Ca2+ ionophores-
initiated Ca2+ influx into cells of the lens is largely dependent on the physiological and 
structural properties ofthe lens. The physiological properties of cells in different regions of 
the lens is tightly linked to the unique micro-circulatory mechanism coordinated by the cells 
of the lens. As a consequence, the disturbance of Ca2+ homeostasis could be varied within the 
lens and, consequently, so be the characteristics of the lens opacification. 
In this chapter, we have characterised a Ca2+-induced cataractogenesis, using ionomycin and 
organ-cultured ovine lenses. It is named the ovine lens Ca2+ ionophore-induced opacification 
or OLCO model. The OLCO model has provided us with an important experimental 
modelling system to investigate the correlation between intracellular Ca2+ levels and lens 
proteolysis, leading to cataractogenesis. In the present studies, the characteristics of 
opacification were closely investigated to understand the effect of a sustained high Ca2+ 
concentration on the ovine lens system and to search for a mechanism of cataractogenesis. 
This system provides an opportunity to understand the importance of Ca2+ homeostasis in 
relation to lens transparency and to test the hypothesis that over-activation of calpain-induced 
proteolysis is one of the key mechanism of Ca2+ associated cataractogenesis. 
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· 4.2. Experiment 1: Ionomycin induced opacification in intact ovine lens 
The objective of this experiment is to characterise the opacification associated with increased 
intracellular Ca2+ levels using a Ca2+ ionophore (ionomycin) and a Ca2+ chelator (EGTA) in 
the presence of the Ca2+ ionophore. 
The involvement of calpains in developing opacification was assessed by determining if there 
was any Ca2+ -induced proteolysis of lens proteins and the degree of calpain activity. 
4.2.1. Methods 
Preparation of treatment solutions 
Normal culture medium, EMEM, (MEM, pH 7.4; 26 mM NaHC03, 0.02 mg/mL gentamycin; 
2.5 llg/mL amphotericin B, refer to Chapter 3) prepared and sterilised. This EMEM contains 
1.8 mM Ca2+. An extra 1.8 mM Ca2+ was added to the EMEM to make a total of3.6 mM Ca2+ 
in the medium, labelled as a EMEM-3.6. 
1 mg/mL concentration ofionomycin (C41H70Ca09. Sigma) was prepared by solubilising 
ionomycin in DMSO. For Ca2+ chelated medium solution, 5mM EGTA was solubilised in the 
EMEM-3.6 medium, so that free Ca2+ concentration in the medium is largely restricted (less 
than 1 JlM) (Sanderson et al., 2000). All treatment solutions were prepared under sterile 
conditions. 
Lens culture 
A group of sheep of the same breed (9 - 11 months old) were slaughtered at a local abattoir 
and their eye globes were immediately collected. The lenses were dissected within 2 h of the 
death of the animal using the posterior approach, and cultured in EMEM according to the 
culture system protocol described in Chapter 3. 
Experimental protocol 
After a settling period of 2 days, a number of intact lenses of similar sizes were randomly 
divided into 3 groups for the three experimental treatment groups. Each group of lenses was 
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transferred and cultured for a 48 h experimental period in one of three treatment solutions; 
EMEM-3.6 (Control); EMEM-3.6 + 5 IlM ionomycin (Iono); EMEM- 3.6 + 5 IlM ionomycin 
+ 5 mM EGTA (Iono+EGTA). Lenses with Iono+EGTA treatment were cultured in the 
solution ofEMEM-3.6 with 5 mM EGTA for 30 min, first, to chelate external Ca2+. Then an 
adequate volume ofionophore solution (lmg/mL DMSO) was introduced to the Ca2+-
chelated lenses to make 5 IlM ionomycin concentration in the medium. 
The treatment solution of all the lenses was replaced with fresh solution after the first 24 h of 
incubation. At the end of 48 h treatment period, all the lenses were removed from the 
medium, rinsed with dH20 and carefully rolled on filter paper to remove any adhering non-
lens tissues and vitreous humour. The wet weights ofthe clean lenses were measured and 
lenses were stored at -80°C. Lens transparency was monitored before and at 48 h after the 
application of the treatment. 
Colorimetric calcium assay 
A frozen whole lens was placed in 3 volumes of ice cold Buffer-A (20 mM Tris-HCI, pH 7.5; 
2 mM DTT). This was homogenised using a Polytron PT 3100 homogeniser (Kinematic a 
AG, Littau, Switzerland) with a Polytron PT-DA 30121 2T mm aggregate tip for 20 s 
at 25,000 rpm speed. 200 ilL of the homogenate was immediately collected for colormetric 
Ca2+ assay, using Sigma Arsenazo III Kits (from Sigma). The Ca2+ concentration of all the 
samples was determined at 600 nm using a spectrometer (UNICAM, UV 4-100, England). 
Analysis of lens proteins 
Immediately after the collection of aliquots of the homogenates for the calcium assay, an 
equal volume of ice cold Buffer-B (20 mM Tris-HCI, pH 7.5; 2 mM EDTA; 2 mM EGTA; 2 
mM DTT) was added and mixed. These homogenates were centrifuged in a Beckman J2-MI 
centrifuge for 30 min at 48,500 x g (4°C). The supernatant and pellet (particulate and 
insoluble material) were collected. The supernatant was labelled 'soluble protein'. The pellet 
was re-suspended in dH20 and centrifuged in order to wash off any remaining soluble protein 
residues. Then the pellet was re-suspended again in 2 mL of 6 M urea for the extraction of 
proteins that were bound to the insoluble lens material, and centrifuged in a Beckman J2-MI 
centrifuge for 30 min at 48,500 x g (4°C). The supernatant was collected and labelled 'urea 
soluble protein'. The concentrations of total soluble and urea soluble samples were obtained 
using the BCA Protein Assay Reagent Kit (Pierce, Rockford, IL, U.S.A.). 
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Casein gel zymography 
Calpain activity in the lenses was determined by zymography (Raser et aI., 1995). 
A two-phase casein zymogram mini-gel (a casein gel topped by a stacking gel) was 
prepared. A ten percent non-denaturing polyacrylamide mix (0.225 M Tris-HCI, pH 7.5; 10% 
acrylamide (37.5:1); 0.06% ammonium persulfate; 0.06% TEMED) was co-polymerised with 
pH 7.5,0.05% casein (Hammersten grade, BDH) in a BioRad Mini-PROTEA~ 3 Casting 
Frame at 0.75 mm thickness. Once the casein gel set, a 4 percent non-denaturing stacking gel 
for sample loading was prepared (0.125 M Tris-HCI, pH 6.8; acrylamide (37.5:1); 0.1% 
ammonium persulfate; 0.1 % TEMED). Once the stacking gel set, the gel was pre-run at 4°C 
in zymography running buffer (25 mM-HCI, pH 8.3; 192 mM Glycine; 1 mM EGTA; 1 mM 
DTT) in a Mini -Protean III (BioRad) electrophoresis tank at 125 V for 15 min. 
A known amount of soluble protein sample was mixed with zymogram loading buffer 
(0.04 M Tris-HCI, pH 6.8; 6.5% glycerol; 0.005% bromophenol blue) and was loaded on to 
the pre-run casein gel. All gels were run with the zymogram running buffer at 125 V for 150 
min at 4°C. After electrophoresis, the gel was removed from the tank and incubated with 
gentle shaking overnight at room temperature in calcium incubation buffer (20 mM Tris-HCI, 
pH 7.4; 20 mM Ca2+; 10 mM DTT). Gels were rinsed with distilled water for 15 min then 
stained with Simply Blue ™ Safe Stain (Invitrogen) and destained several times in dH20. 
Transparent bands appeared on a blue stained background gel. 
SDS-PAGE and Immunoblotting (Western detection) 
The urea soluble proteins were separated on an SDS-PAGE gel to assess changes in protein 
profiles. Known amounts of urea soluble protein samples from various treatment groups were 
mixed with SDS sample loading buffer (0.08 M Tris-HCI, pH 6.8; 2% SDS; 10% glycerol; 
0.02% bromophenol blue) and denatured at 95°C for 4 min. After cooling, the samples and 
molecular markers (Precision Plus Protein™ Standards (All Blue) or Precision Plus Protein™ 
Unstained Standard, from BioRad) were loaded onto a NuPAGE® 4-12% Bis-Tris Gel, 1.0 
mm x 10 well (gradient pre-cast gel, Invitrogen) in an X-cell SureLock™ Mini-Cell 
(Invitrogen) electrophoresis tank. NuPAGE® MES SDS Running Buffer (50 mM Tris-HCI, 
pH 7.3; 50 mM MES; 0.1 % SDS; 1 mM EDTA) was added to the tank to run electrophoresis 
at 200 V for 45 min at RT. After the completion of the electrophoresis, the gel was removed 
from the gel cassette and rinsed with distilled water several times. The gel was then stained 
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with the GelCode®Blue Stain Reagent (PIERCE) for 1 h and incubated and destained several 
times in dH20. 
For immunoblotting (western detection), after electrophoresis, the gel was removed and rinsed 
with transfer buffer (25 mM Tris-HCI, pH 8.3; 192 mM Glycine). The gel and PVDF 
membrane (Milipore Corporation, Bedford, MA, USA» were assembled together, and 
proteins from the gel were electroblotted on to the PVDF over 1 hat 100 V in cold (4°C) 
transfer buffer. Once the separated proteins on the gel were transferred onto the PVDF, the 
membrane was incubated with 5% blocking buffer (5% non-fat dry milk in TTBS (20 mM 
Tris-HCI, pH7.5; 500 mM NaCl; 0.05% Tween 20) for 45 min. Then the membrane was 
rinsed several times with TTBS and probed with monoclonal antibody to vimentin (clone V9; 
Santa Cruz) at 1: 1000 in 3% blocking buffer by incubating at room temperature for 1 h. The 
membrane was then washed several times with TTBS and incubated with a mixture of 
secondary antibodies (goat-anti mouse, 1 :2000 and Precision StrepTactin-AP conjugate, 
1 :5000 (from BioRad, for labelling unstained molecular marker» in 3% blocking buffer for 1 
h at RT. The gel was washed with TTBS and followed by TBS for several times to remove 
the Tween20. The detection of protein was visualised with AP Substrate Kit premixed colour 
developing solution (BioRad). 
Two-dimensional electrophoresis (2-DE) analysis 
Proteolysis oflens proteins was assessed by 2-DE. Spots from 2-DE gels were identified by 
comparison with previously mapped lens proteins (Robertson, Thesis 2003). 75 Jlg soluble 
protein sample from a treatment group was re-hydrated in 185 JlL of re-hydration buffer (8 M 
urea, 2% CHAPS, 50 mM DTT, 2% IPG buffer pH 3-10 (Bio-Rad), 2% glycerol, 0.001 % 
bromophenol blue). The first dimension was focussed on an immobilized pH gradient (IPG) 
gel strip (11 cm, pH 3-10, ReadyStripTM IPG Strip, BioRad, USA) in a BioRad PROTE~ 
IEF Cell for 6.5 hat 5000 V (33000Vhr) at 20°C. The IPG strip containing lens proteins was 
incubated twice for 15 min in 10 mL equilibration buffer (6 M urea, 50 mM Tris, 30% 
glycerol, 2% SDS, 0.001 % bromophenol blue; pH 8.8). During the first incubation, the 
equilibration buffer contained 2% DTT, and during the second incubation the equilibration 
buffer contained 2.5% iodoacetamide. The IPG strip was fixed to a 12% Bis-Tris gel 
(Criterion TMXT Precast Gel) with running buffer containing 1 % agarose (PH 8.6) for 
molecular weight separation of proteins from the IPG strip in a BioRad Criterion 
electrophoresis setup. The second dimension gel was run using a power supply (Bio-Rad 
PowerPac 200, Hercules, CA, U.S.A.) for 60 min at 200 V with XP-MES Running Buffer 
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(Bio-Rad). The spots on each gel were stained with Simply Blue™ Safe Stain (Invitrogen), 
and scanned at a resolution of I 00 pixels per inch using an Expression 1600 flat bed scanner 
with a transparent lid (Epson, Long Beach, U.S.A.). 
4.3.2. Results 
Lens opacification induced by ionomycin 
Ovine lenses were cultured for 2 days in culture media alone (Control) or in the presence of 
5 flM ionomycin (lono) or in the presence of 5 flM ionomycin with 5 mM EOT A 
(lono+EOT A) (Figure 4.2). All lenses in the control group remained transparent during the 
48 h experimental period in a Ca2+ concentration (3 .6 mM ci+ ) that was twice the normal 
concentration in the standard culture medium (Control, Figure 4.2). 
Exposure to ionomycin resulted in the complete loss of lens transparency (lono, Figure 4.2). 
The opaque lenses appeared noticeably swollen, and the original firmness of the intact lens 
was largely reduced. A white opaqueness mixed with a slightly pink pigment appeared in the 
opaque lenses indicating fluid uptake by the lens from the surrounding culture medium that 
contains Phenol Red·Na. The involvement of calcium in ionomycin-induced lens opacity was 
investigated by adding the Ca2+ chelator, EOT A, to the medium containing ionomycin and 
Ca2+ (lono+ EOT A, Figure 4.2). The lens opacity was largely inhibited by Ca2+ chelation. 
There was only restricted light scattering around the equatorial region and in the centre of the 
anterior surface region . These lenses (Iono+EOT A) showed no sign of lens hydration and 
their mean wet weight was not different to normal lenses (Table 4.2) 
Control lono Iono+EGTA 
Figure 4.2 Digital images of ovine lens after culture for 48 h in EMEM-3.6 (Control), EMEM-3.6 + 
5 flM ionomycin (lono) and EMEM-3.6 + 5 f1M ionomycin + 5 mM EOTA (lono+EGTA). Note: 
EMEM-3.6 media contains a total of 3.6 mM Ca2+, whilst normal EMEM medium contains 1.8 mM 
Ca2+. 
54 
. .-
, ... ..... -.. _"'-..., ... ~:-_._ .. ...L.., 
Lens wet weights 
Lenses were weighed at the end of the 48 h experimental period (Table 3.1). The mean wet 
weight oflenses cultured with ionomycin was 30% higher than the control lenses (P < 0.001) 
(Table 4.2). The mean weight of lenses cultured in the Ca2+ chelated medium, containing the 
same concentration ofionomycin (lono+EGTA), was not significantly different from the 
mean weight of lenses cultured in the normal media (Control). The dry weights of the lenses 
showed no significant changes between the treatments (Table 4.1). 
Table 4.1 Mean wet weight (n = 6), mean dry weight (n = 3) and mean Ca2+ concentration (n = 6) of 
ovine lenses (± sd) after culture for 48 h in EMEM-3.6 (Control), EMEM-3.6 + 5 11M ionomycin 
(Iono) and EMEM -3.6 + 5 11M ionomycin + 5 mM EGTA (Iono+EGTA). EMEM-3.6 media 
contains total of3.6 mM Ca2+. 
Lens treatment 
Control 
lono 
lono+EGTA 
Two-sample T test, 
Total Ca2+ level 
Average weight (g) Dry weight (g) 
0.774 (± 0.071) 0.313 ( ±O.O 17) 
*0.942 (± 0.043) 0.296 (±0.015) 
0.793 (± 0.023) 0.321 (±0.006) 
*p < 0.001 relative to both control and lono treatlnent group. 
.p < 0.05 relative to both control and 10no+EGTA. 
'i'p < 0.05 relative to Control. 
Cat+ level (mM) 
0.88 (± 0.01) 
~3.17 (± 0.02) 
'111.19 (± 0.01) 
The total Ca2+ level of lenses from various treatment groups was measured at the end of the 
experiment analysed by colorimetric assay (Table 4.1). The correlation of the involvement of 
Ca2+ with lens opacity in the OLCO model was investigated by comparing the changes in 
transparency oflenses treated with ionomycin in Ca2+ chelated medium (Iono+EGTA) to lens 
treated with ionomycin alone (lono). Analysis of Ca2+ levels showed that the mean total Ca2+ 
concentration in ionomycin-induced opaque lenses was three-fold higher than control lenses 
in EMEM, while Ca2+-chelated lenses were only slightly higher than control lenses. 
Calcium-dependent protease activity 
The increase in Ca2+ caused by ionomycin treatment could activate several enzymes including 
the calpains. Zymography was used to determine the amount and types of calpain in the lens 
following each type of treatment. Transparent bands represent Ca2+-activated proteases. 
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As a control, soluble proteins from lung and lenses were separated on casein gels and 
incubated in a buffer containing no calcium (20 mM Tris-HCI, 10 mM OTT, 1 mM EGTA). 
No bands developed in the absence ofCa2+ (Gel-2, Figure 4.3) indicating that the bands 
detected were all Ca2+ -activated proteases. 
's 
Lung Lens Lung Lens 
+Ca++ -Ca++ 
Figure 4.3 Casein zymography of calpains extracted from ovine lung and nonnal ovine lenses 
cultured for 72 h in EMEM. Gel-I (+Ca) on the 'eft side was incubated with Ca2+ buffer (20 mM 
Ca2+), while Gel-2 ( - Ca) on the right side was incubated with I mM EGTA containing no CaH 
Each well was loaded with 100 J.1g of soluble protein and run at the same time. 
As cal pain activation is followed by autolysis, the decreased levels of calpain indicate that 
there was activity during the period preceding analysis. Four distinct bands appeared on the 
casein gel assay from lenses cultured in normal media (Control, Figure 4.4). These bands 
represent three calpain isoforms and an autolyzed form: Lp82, calpain I, cal pain II and 
autolyzed calpain II, which were previously identified by using western blots with antibodies 
for each specific cal pain isoform (Robertson et al. , 2005). According to the intensity of each 
band (Figure 4.4, Control), cal pain II, in both intact and autolyzed forms, was the dominant 
isoform in the ovine lens. The high level of autolyzed cal pain II in these lenses indicated the 
level of protease activity present in the normal cultured lenses. On the other hand, Lp82 and 
cal pain I were relatively minor components of the calpain isoforms. 
Lp82 was present in both lenses cultured with ionomycin and with calcium-chelated 
ionomycin, as well as in normal lenses. The intensity of each Lp82 band was similar between 
the groups, suggesting there is no involvement of Lp82 in the ionomycin-induced 
opacification. On the other hand, cal pain I activity was absent in lenses cultured with 
ionomycin, suggesting activation of calpain I occurred (Figure 4.4). Lenses cultured with the 
Ca2+ chelator and ionomycin contained similar cal pain I activity levels as the normal lenses. 
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Figure 4.4 Casein Zymography of calpains present in 100 Ilg of soluble protein from lenses after 
culture for 48 h in n EMEM-3,6 (Control), EMEM-3,6 + 5 IlM ionomycin (Iono) and EMEM ·3,6 + 5 
J.lM ionomycin + 5 mM EGTA (Iono+EGTA). EMEM-3,6 media contains total of3,6 mM Ca2+. An 
extract of lung was used as control (Lung). Duplicate zymograrn run for each experimental group, 
Calpain II activity levels in the 3 different experimental groups were closely examined by 
loading lower amounts of soluble proteins (25 Ilg) on the casein zymogram from the same 
samples (Figure 4.5), Enzymatic activity by intact calpain II in nonnallenses was similar to 
that in EGTA-ionomycin treated lenses. The intact calpain II activity in ionomycin treated 
lenses was, however, distinctively lower than the other two groupS, With 25 Ilg of soluble 
protein loaded to the gel, no difference was seen in the autolysed cal pain II activity levels 
among all three experimental groups (Figure 4 ,5) , With 100 Ilg of soluble protein loaded to 
the gel (Figure 4 ,4 , lono), the autolysed calpain II activity levels in the lenses cultured with 
ionomycin were higher than the other two groups . 
Lung Control lono lono+ EGTA 
+- Cal pain Il 
. ----, Cal pain II (Auto lysed) 
Figure 4.5 Casein zymography of cal pains present in 25 Ilg of soluble protein from lenses after 
culture for 48 h in n EMEM-3,6 (Control), EMEM-3,6 + 5 J.lM ionomycin (Iono) and EMEM -3,6 + 5 
J.lM ionomycin + 5 mM EGTA (lono+EGTA), EMEM-3,6 media contains total of3,6 mM Ca2+ , An 
extract of lung was used as control (Lung), Duplicate zymogram were run for each experimental 
group, 
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Proteolysis in the ionomycin-induced opacity 
The full opacity induced by 48 h ionomycin treatment did not cause gross changes in the lens 
protein content. There were no significant differences in either the total soluble protein or the 
urea-soluble protein concentrations among the ionomycin-treated lenses, control lenses or 
those exposed to EGTA (Table 4.2). 
Table 4.2 Mean protein concentrations (mg/g, ± sd) of whole lenses after culture for 48 h in EMEM-
3.6 (Control), EMEM-3.6 + 5 flM ionomycin (Iono) and EMEM -3.6 + 5 flM ionomycin + 5 mM 
EGTA (IODO+EGTA). Two-sample T test. 
Experimental group n soluble proteins urea soluble proteins 
(mg/g) (mg/mg) 
Control 6 555 ± 112 8.9 ± 2.4 
lono 6 492 ± 104 6.6±2.0 
10no+EGTA 6 682 ± 143 8.1 ± 0.8 
Cytoskeletal protein degradation 
The cytoskeletal proteins, spectrin, filensin and vimentin, were analysed to examine the 
degree of their degradation in the OLCO model. The urea-soluble protein separated by SDS-
P AGE (Figure 4.6) showed there was complete degradation of spectrin from the ionomycin-
treated lenses, whilst spectrin (280 kDa) remained intact in urea-soluble protein from the 
EMEM control and EGT A control lenses. 
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-
.;:(-- Intact Filensin (115 kDa) 
Figure 4.6 SDS-PAGE analysis of the urea soluble protein from ovine lens (12 flg) . Lane I indicates 
molecular marker (M) (Precision Plus Protein Standards™, All Blue, Bio-Rad, U.S.A.). Lanes 2, 3 
and 4 are lenses after culture for 48 h in EMEM-3.6 ( C ), EMEM-3.6 + 5 flM ionomycin (I) and 
EMEM-3 .6 + 5 flM ionomycin + 5 mM EGTA (IE) respectively. 
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There was evidence of partial degradation of the lens specific intennediate filament, filensin 
( 11 5 kDa, identifi ed in urea so luble fractions extracted fi'om bovine lenses by Marcantonio 
and Sanderson, 1997) in ionomycin treated lenses, whil st the intensity of the fil ensin band 
was stronger in samples from control or EGTA treated lenses. 
Another cytoskeleta l protein , vi mentin was immunoblotted using the urea so luble protein 
fraction of all three experimental groups (Figure 4.7). Lenses from the control and EGTA-
calcium chelated group contained intact vimentin. The lenses fro m the ionomycin treatment 
showed that intact v imentin (56 kDa) was no longer present in the urea soluble fraction. 
Control 1000 1000+ EGTA 
_ Intact Vimentin (56 kDa) 
Figure 4.7 Western detection of urea soluble vi mentin from ovine lens proteins (150 /lg) after culture 
in EMEM-3.6 (Control), EMEM-3 .6 + 5 /lM ionomycin (Iono) and EMEM-3.6 + 5 mM EGTA+5 
I'M ionomycin (Iono+EGTA) for 48 h. Solid arrow represents intact vimentin (56 kDa). 
Crystallin degradation 
Detailed crystallin proteolysis was analysed by 2-DE. The 2-DE analysis showed that some 
degree of degradation of so luble proteins occurred in lenses treated with ionomycin (Iono) 
compared to the control and Iono+EGTA treatment groups (Figure 4.8). 
The ~A3 and the ~A4 crystallins appeared to be reduced in lenses cultured with ionomycin 
compared to ones in control or EGTA treated lenses. a-Crystallin spots from nonnal and 
ionomycin treated lenses were not apparently different. The same spot from EGTA was small 
due to poor separation . Other notable 2-DE spots (oval on Figure 4.8) appeared at around 65-
70 kDa molecu lar weights in all the three treatment groups. It is, however, more intensive 
from lenses treated with ionomycin compared to the other two treatment groups. 
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Overall the 2-DE protein profile of whole lens revealed that the majority of the crystallins in 
ionomycin-treated lens remained intact and similar to the control and EGT A control lenses. 
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Figure 4.8 2-DE protein profiles from 75 ~g soluble protein extracted from ovine lenses after culture 
in EMEM-3.6 (Control), EMEM-3 .6 + 5 ~M ionomycin (lono) and EMEM-3.6 + 5 ~M ionomycin + 
Ca'+ chelator (Iono+EGTA). Molecular marker (Precision Plus Protein Standards™, All Blue, Bio-
RAD) was run along with the sample (displayed here on a Control gel). ~A3 and ~A4 crystallin are 
marked within rectangles. 2-DE spots for phosphorylated aA-crystallins (aA-ph), intact aA-crystallins 
(aA) and vimentin are indicated. 2-DE spots for possible cross-linked proteins are also marked within 
ovals. 
4.4. Experiment 2: Progression of opacity in intact ovine lens by ionomycin 
The objective of this experiment was to visually characterise the progression of opacity in the 
lenses from the ionomycin-induced Ca2+ overloading system with a lower concentration of 
ionomycin (111M) in the normal culture medium over a longer period of culture time. 
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4.4.1. Methods 
Lens sample collection and culture preparation 
Lenses were dissected from slaughtered sheep (9-12 months old) and placed immediately in 
EMEM for a 2 day settling period (refer to the culture protocol, Chapter 3). 
Experimental protocol 
A group of 6 lenses were continuously cultured in the EMEM containing 1.8 mM Ca2+ 
(EMEM), while a second group of 6 were cultured in the EMEM with 1 11M ionomycin for a 
7 day experimental period. All lenses were replaced with a fresh mixture every 24 h. The 
progress of opacification was monitored daily during the experimental period. At the end of 7 
days, all lenses were removed from the medium and detached from any adhering non-lens 
tissues and vitreous humour. The cleaned lenses were then weighed and their wet weights 
were recorded. 
4.4.2. Results 
Monitoring progress of lens opacification 
The progress of opacification was recorded daily on all lenses cultured in normal EMEM and 
in EMEM with ionomycin (Figure 4.9). Lenses cultured in EMEM remained transparent 
during the experimental period of 7 days. 
Lenses (total of 6) cultured with ionomycin developed opacification with a similar pattern 
over the experimental period- the progress of visual light scattering starting from the 
equatorial region. Light scatter was initially apparent in the outermost cortical fiber cells in 
the equatorial regions of the lens (Day 2). The degree of opacity was greater in the equatorial 
regions and the opacification progressed towards the center of anterior surface of the lens 
(Day 3, Day 4 and Day 5). The centre ofthe anterior region of the lens remained partially 
transparent. 
The lens developed full opacification and stayed opaque by Day 6 and Day 7. At Day 7, 
during removal of lenses from the culture system, it was noted again that fully opaque lenses 
were swollen and contained slight pink pigments, as seen earlier (Figure 4.2). 
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Pre-incubated Day I Day 2 Day 3 
Figure 4.9 Digital images of an oyine lens and its progression of opacification monitored oyer 7 day-
culturing in EMEM + I flM ionomycin (Day 1-7), after 3 days pre-incubation in the normal 
EMEM (Pre-incubation). * A control lens cultured in EMEM for 7 days. 
Lens weights 
Lenses were weighed at the end of the 7 day experimental period. Lenses cultured with 
ionomycin had significantly increased wet weights (by 30%) than the control lenses in 
EMEM only (P < 0.001). 
4.5. Experiment 3: Change of calpain II activity levels 
The objective of this experiment was to monitor cal pain II activity levels in lenses during the 
gradual development of opacity due to ionomycin. 
4.5.1. Methods 
Ovine lens collection and the culture preparation 
A group of ovine eye lenses (unknown age, mixture of breeds) were dissected and cultured in 
EMEM within 2 h of the death of the animal (refer to the culture protocol , Chapter 3). 
62 
Experiment protocol 
After 2 days of a lens culture pre-settling period, groups of 3 lenses were cultured with I 11M 
ionomycin for a total experimental period of 68 h. The treatment solution of all lenses was 
replaced daily during the experiment. Every 24 h, all the lenses were harvested and stored at 
-80°C. 
Calpain activity analysis by casein zymography 
The epithelium (containing lens capsule) and the cortex of the lens were dissected, and 
homogenised with 6 volumes of ice cold Buffer-C (20 mM Tris-HCI, pH 7.5; I mM EDTA; 
I mM EGT A; 2 mM DIT). These homogenates were centrifuged in Beckman J2-MI 
centrifuge for 30 min at 48,500 x g (4°C). The supernatant were collected as soluble protein. 
The soluble proteins from each fraction were run in the casein zymogram to examine the 
activity level of each calpain isoform, particularly calpain II (refer to Experiment 1, 4.2.1). 
4.5.2. Results 
It was observed that the opacification were restricted to cortex of the ovine lens (including 
the epithelium), whilst the nucleus remained transparent. Calpain II activity were examined 
on the cortex of the lens. Calpain activity of the cortex of the ovine lens (including the 
epithelium) from both non-cultured lenses (CI) and cultured lenses (C2) for approximately 5 
days (2 days pre-incubation + 68 h) were compared by zymography assay (Figure 4.1 0). 
IlC 
.. 
mC CI C2 24 h 
. . .. ,. .----. 
~----------~~-
44 h 
.. ,. 
68h 
• 
Intact cal plan II 
.... Autolysed calpain 1I 
Figure 4.10 Casein zymography of calpains present in 25 Ilg of soluble protein from the cortex of the 
ovine lens (including epithelium) harvested at 24, 44 and 68 h after culture in EMEM+ 1 11M 
ionomycin. Calpain I (/le) and calpain II (mC) were extracted from sheep lung. Non-cultured lenses 
(CI) and non-treated control lenses in EMEM for 68 h (C2) were used as controls. Lenses exposed in 
I 11M ionomycin for 24 h, 44 hand 68 h are labelled as 24 h, 44 h and 68 h. 
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There was no enzymatic activity level difference between the two control groups (Figure 4.10, 
JLC and mC), suggesting the lens culture system for the total of 5 days did not influence the 
calpain activity level of the intact lenses. 
The change in calpain activity level during progression of the ionomycin-induced 
opacification revealed a decrease in intact calpain II activity of ionomycin treated lenses 
during the 68 h experiment (Figure 4.10). Autolysed calpain II became more abundant as the 
opacification progressed. 
4.6. Experiment 4: Cytotoxicity and morphological changes in the OLCO models. 
The objective ofthis experiment was to investigate cytotoxicity level in the ionomycin-
induced opaque lenses and to determine ifthere was a correlation between the effect of 
ionomycin-induced Ca2+ influx and the loss oflens transparency. 
Difference in cytotoxicity (LDH leakage assay) between control lenses and Ca2+-chelated 
lenses were first established to determine the effect of ionomycin without any Ca2+ 
involvement. Then difference in cytotoxicity levels between ionomycin-treated lenses and 
Ca2+ -che1ated lenses were examined to test the effect of Ca2+ influx into the lenses and the 
relationship with the progression of lens opacification. 
4.6.1. Methods 
Lens sample collection & culture preparation 
A group of eye lenses from sheep (9 - 11 months old) were dissected and cultured in a normal 
culture medium, EMEM (refer to the culture protocol, Chapter 3). 
Preparation of treatment solution 
Ionomycin was solubilized in 2 mg/mL DMSO, and mixed with a normal EMEM 
(containing1.8 mM Ca2+) or EMEM + 1.8 mM Ca2+ (containing 3.6 mM Ca2+) to make a 
final ionomycin concentration of 5 ~M. For the Ca2+ chelated conditions, 5mM ofEGTA was 
added to EMEM under sterile conditions. 
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Experimental protocol 
After 2 days oflens culture pre-settling period, groups of 5 or 6 lenses were cultured for 44 h 
underfour experimental conditions: EMEM (Control); EMEM + 5 JlM ionomycin (lono-
1.8); EMEM + 1.8 mM Ca2+ + 5 JlM ionomycin (lono-3.6); EMEM + 5 JlM ionomycin + 5 
mM EGTA (Iono+EGTA). Lenses in the Iono+EGTA group were pre-cultured in 5 mM 
EGTA for 30 min to chelate external Ca2+before 5 JlM ionomycin was introduced. Lenses in 
Iono-1.8 and Iono-3.6 groups were paired, while Control and Iono+EGTA groups were 
unpaired. 
At the end of 44 h treatment period, all lenses were rinsed with dH20 and removed from the 
medium and any adhering non-lens tissue and vitreous humour. The wet weights were 
determined and the lenses immediately frozen and stored at -80°C. Lens transparency was 
monitored over the experimental period. 
Ca2+ assay by atomic absorption analysis 
Whole lenses were dissected into different parts and subjected to freeze drying. Dry weights 
were recorded. Nitric acid (69%, Aristar, 10 mL) was added to each sample and mixed 
thoroughly before sonication for 45 min (Elma Transonic T460 sonic bath) and overnight 
digestion. The samples were analysed without further dilution on a GBC Avanta atomic 
absorption spectrophotometer using emission mode plus a C2H21N20 gas mixture. Standards 
were made from Spectrosol calcium nitrate AAS standard (1000 ppm) and double deionised 
water acidified with RN03. Data were analysed by ANaVA and then individual treatments 
were compared by Students t-test. 
Cell viability assay with a cytotoxicity detection kit. 
Aliquots of culture medium were taken from all experimental groups at 30 min, 1 h, 2 h, 4 h, 
7 hand 44 h after exposure to the treatment solution and stored at 2 - 5°C for LDH leakage 
assay (cytotoxicity assay). The details of the procedure are in Chapter 3 (2.2. Method). 
Microscopic view of ionomycin-treated lenses 
Lenses harvested from treatment were washed with dH20 and each lens was immediately 
placed in approximately 10 mL of 4% paraformaldehyde in 1 x PBS for 6 days cell fixation. 
The lenses were then embedded in paraffin, sectioned through the equator, and processed for 
standard histological staining (Haematoxylin and Eosin stain) as described by Windle (1976). 
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Nuclei are stained in dark purple/blue, while cytoplasmic components of cells are bright 
pink/light red. The stained cell slices were examined under a light microscope (Lieca 
Microscope, model No. 2.2.1, Diagnostic Instrument Inc., U.S.A.). 
Lens opacity grade scoring by image analysis system 
A digital camera was set directly above the anterior epithelium of the lens. Opacification of 
the lens was graded as described in Chapter 3 (2.2. Method). 
4.6.2. Results 
Cytotoxicity and lens transparency 
This experiment demonstrated that cytotoxicity occurred in the lenses treated with ionomycin 
and Ca2+ containing medium (Figure 4.11). Within the first 2 h ofthe experimental period, 
the LDH leakage levels from ionomycin-treated lenses (1-1.8 and 1-3.6) increased and were 
significantly higher than the lenses treated with ionomycin in the presence of a Ca2+ chelator 
(El) (P < 0.02) (Figure 4.11). Over the next 24 h experimental period, the difference in the 
LDH leakage level between ionomycin-treated (1 -1.8 and 1-3.6) and Ca2+ chelated (El) 
groups increased dramatically (7 fold). During this experimental period, LDH leakage levels 
of the Ca2+ chelated (El) group remained as low as the control group lenses (Control) (Figure 
4.11). Chelating the external Ca2+ clearly prevents the occurrence of cytotoxicity. These data 
also indicate that ionomycin itself does not cause cytotoxicity. 
Ca2+ chelated lenses (1ono+EGTA) showed a minor degree oflight scattering at the early 
stage of incubation (Figure 4.12). There was, however, no sign of cytotoxicity with the 24 h 
treatment. The LDH leakage (5.29 ± 2.63 mU/mL) ofIono+EGTA was increased at the end 
of the 44 h experimental period compared with control lenses (1.32 ± 1.1mU/mL), but was 
still low compared to the LDH leakage in ionomycin treated lenses cultured for 44 h (average 
37.5 ± 3.5 mU/mL). With 5 /-tM concentration ofionomycin, the progress of cytotoxic level 
in the lenses was not significantly different between the two external Ca2+ environments, 1.8 
mM and 3.6 mM Ca2+, over the entire experimental period. The progress of opacification in 
the ionomycin treated lenses was also similar between these two groups (Figure 4.12). 
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Figure 4.11 A plot of mean LDH leakage levels detected in 4 lens experimental groups over a total 
44 h experimental period. Lenses were cultured in EMEM (Control), EMEM + 5mM EGTA + 5 11M 
ionomycin (EI), EMEM + 5 11M ionomycin (1-1.8) and EMEM+ 1.8 mM Ca2+ + 5 11M ionomycin 
(1-3.6). EMEM + 1.8 mM Ca2+ contains a total of 3.6 mM Ca2+ whilst EMEM contains a total of 1.8 
mMCa2+. 
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Figure 4.12 A plot of mean opacification scores (%, 100 is full opaque, 1 is transparent lens) for 4 
lens experimental groups over total 44 h experimental period. Lenses were cultured in EMEM 
(Control), EMEM + 5mM EGTA+ 5 11M ionomycin (Iono +EGTA), EMEM + 51lM ionomycin 
(Iono-1.8) and EMEM + 1.8 mM Ca2+ + 5 IlM ionomycin (lono-3.6). 
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Changes in the ion contents as determined by atomic absorption analysis 
Total Ca2+, Na+ and K+ levels in the lens were measured by atomic absorption analysis and 
compared between normal (Control), ionomycin treated (Iono-1.8) and ionomycin with Ca2+ 
chelator treated (Iono+EGTA) groups oflenses (Table 4.3). 
The absence of Ca2+ in the external environment resulted in changes in the cellular 
concentration of all three ions, compared to control lenses. The Na+ content of the lenses 
approximately doubled on reducing the external Ca2+ using the Ca2+ chelating agent, EGTA, 
in an ionomycin containing media (Iono+EGTA). The K+ level of the lenses in the 
Iono+EGTA treated group was reduced by approximately 50% compared with the control 
lenses. There were no significant changes in the mean wet weight of the lens from the 
Iono+EGTA treated group compared to control lenses after a 44 h experimental period. 
In contrast, opaque lenses in the ionomycin treated group were approximately 10 fold higher 
in their total mean Ca2+ level compared to the control lenses. The Na+ level increased by 4.5 
fold in the lenses treated with ionomycin compared to the control lenses. The K+ level of the 
lenses in the ionomycin treated group was reduced by approximately 10% compared with the 
control lenses. 
Lenses from the ionomycin treated group showed a 10-16% increase in their mean wet 
weights compared to the control and EGTA treated groups (P < 0.01). 
Table 4.3 Mean total ion concentration (mM) and wet weight of whole ovine lens (g, ± sd) after 
culture in EMEM (Control), EMEM+5 /lM ionomycin + 5 mM EGTA (Iono+EGTA) and EMEM + 
5 /lM ionomycin (Iono-1.8). 
Treatment n 
Control 6 
Iono+EGTA 4 
Iono-1.8 3 
Two-sample T test; 
wet weight Ca2+ (mM) Na+ (mM) K+ (mM) 
(g) 
1.016 ± 0.08 0.37 (± 0.05) 19.3 (± 4.5) 47.6 (± 4.6) 
1.086 ± 0.04 bO.13 (± 0.03) v43.3 (± 7.5) x26.3 (± 3.5) 
a1.181 ± 0.07 c3.03 (± 0.15) Y90.3 (± 5.4) xx36.3 (± 2.0) 
'p < 0.01 relatIve to both Control and Iono+EGTA. 
bp < 0.001 relative to Control, cp < 0.001 relative to Control 
vp < 0.005 relative to Control, Yp < 0.001 relative to Iono+EGTA 
xp < 0.001 relative to Control, xxp < 0.01 relative to Iono+EGTA 
The major feature of the OLCO model was the appearance of a large volume of turbid liquid 
located between the lens capsule and inner cortex region. This liquid was restricted to the 
intact lens capsule and was isolated from the remainder of the lens (nucleus region), which 
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retained its gel-like structure and maintained its transparency. The disintegrated fiber cell 
fraction is the most likely the source of light scattering in the OLCO model. 
Analysis of the Ca2+ concentration in the liquid fraction revealed that this fraction was largely 
responsible for the increased Ca2+ levels in the whole lens (Table 4.4). When two groups of 
lenses were exposed to the same ionomycin concentration, but two different external Ca2+ 
concentrations, the mean Ca2+ concentration of the liquid fraction in the lenses increased by 
150 - 200% compared to the external Ca2+ concentration in the culture medium. The rise of 
lens Ca2+ level is, therefore, actively induced by the presence of ionomycin in the medium and 
is not a result of an ion equilibrium between the medium and lens. 
Table 4.4. Mean total Ca2+ concentration (mM) in two separated regions of the ovine lens (liquid 
fraction and the remaining solid fraction) after culture in EMEM + 5 11M ionomycin (Iono-1.8) and 
EMEM + 1.8 mM ci+ + 5 11M ionomycin (Iono-3.6) for a 2 days experimental period (± sd). 
EMEM contains 1.8 mM Ca2+ therefore total Ca2+ in EMEM + 1.8 mM Ca2+ is 3.6 mM ci+. 
Treatment n CaH (mM) in the Liquefied Inner most cortex + 
culture medium fraction (mM) nucleus region (mM) 
Iono-1.8 3 1.8 4.29 ± 0.32 1.22 ± 0.10 
Iono-3.6 3 3.6 '8.06 ± 0.24 '-2.03 ± 0.15 
Two-sample T test. - --P < 0.001 relative to Iono-1.8, P < 0.005 relative to Iono-1.8 
Morphological feature 
A cross section of the ovine lens was stained with Haematoxylin and Eosin to examine 
morphological features in the OLCO model. Pink/light-red is the staining colour for the 
cytoplasmic components. The background colour is light green/yellow. Any artificial cracks 
created during fixation or the paraffin slicing preparation are indicated by black arrows in the 
Figures 4.13 by. Black/dark grey dot on the lens surface represent nuclei of epithelial cells, 
and of fiber cells that still contain nuclei (Figure 4.13, A). 
In control lenses cultured in EMEM for 2 days (A), there was no sign of structural breakage 
between the epithelial cells and the rest of fiber cells. In these lenses, staining was consistent 
and uniform across the cells. When lenses were cultured in a Ca2+ chelating media containing 
ionomycin, some fiber cells very near the surface displayed enlarged extracellular spaces 
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(white arrow, Figure 4.13, C). The rest of the fiber cells showed consistent and unifonn 
staining across the cells. 
The microscopic views of the fully opaque lens showed that the structural integrity was no 
longer present in the outer cortex region (Figure 4.13, B). A cluster of some cytoplasmic 
components (red staining) was randomly mixed with discrete areas (grey staining in circular 
shapes, indicated by white arrows on Figure 4.13, B) and empty spaces. Interestingly, this 
region is distinctively separated from the inner region of the lens, where the fiber cells (inner 
fiber cells, Figure 4.13, B) display different structural feature. 
capsule + epithelial cells (nucleus in dark dots) 
fiber cells (A) Control 
-
-
-
II 
(8) lono-3.6 
Outer fiber cells 
Inner fiber cells 
capsule 
(C) lono-3.6 + EGT A 
Figure 4.13 Microscopic views of ovine lens after culture in (A) EMEM ~Control), (8) EMEM + 
1.8 rnM Ca2+ + 5 ~M ionomycin (1ono-3 .6) and (C) EMEM + 1.8 rnM Ca + + 5 ~M ionomycin + 
5rnM EGT A (lono-3.6 +EGT A) for 44 h. Artificial cracks marked by black arrows (A and C). 
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4.7. Discussion 
Opacification in the OLeO model was associated with Ca2+ overload 
Alteration in Ca2+ homeostasis influences the overall ionic homeostasis in the lens. Current 
data showed that both ionomycin and ionomycin-EGTA treatments induced the loss ofK+, 
Na+ and Ca2+ balance in the lens (Table 4.3). The features oflenses cultured with ionomycin 
and Ca2+ (i.e. dense opacity and lens hydration) were largely prevented by chelation of the 
Ca2+. Total Ca2+ level assays showed that the opaque regions of the lens were strongly 
correlated with the elevation of Ca2+ (Table 4.4). That is, increases in intracellular Ca2+ level 
are strongly associated with development of opacity, which is the characteristic of theOLCO 
model. 
The application of the ion selective micro electrode technique by other researchers has 
demonstrated that post extraction cortical human cataract lenses increased their free level of 
Ca2+ which equilibrated with the aqueous humour (1-2 mM). The total Ca2+ of cataractous 
lenses could increase beyond 20 mM (Duncan & Jacob, 1984). Truscott et al. (1990) also 
demonstrated that there was a direct linear relationship between an increase in internal free 
Ca2+ and an increase in cortical opacification. 
In an earlier study with cultured bovine lens, Marcantonio et al. (1986) demonstrated that lens 
hydration was independent of opacification and that an increase in lens intracellular Ca2+ was 
crucial for opacification. Opaque lenses with major swelling were observed in ionomycin-
induced opacification in rat (Iwasaki et al., 1995; Sanderson et al., 1996) and human 
(Sanderson et al., 2000) lenses and in advanced human in vivo cortical cataracts (Heyningen, 
1972). The increase oflens hydration in the OLCO model in this thesis may be an effect of 
opacification. 
Current data reveal that the total Ca2+ concentration of normal cultured ovine lens (1.8 mM 
Ca2+ in EMEM) was approximately 370 flM Ca2+ (Table 4.3). Total Ca2+ concentrations 
determined by atomic absorption techniques in bovine (Marcantonio et al., 1986) and rat 
(Duncan & Jacob, 1984) lenses showed 500 flM and 670 flM Ca2+ respectively. In the current 
study, when the lenses were exposed to a high concentration of external Ca2+ in the medium 
(3.8 mM Ca2+ in EMEM), the total lens Ca2+ concentration was increased (Table 4.1) but lens 
transparency remained intact over a 4 day incubation period (2 day settling period and 2 day 
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experimental period) (Figure 4.2). This result demonstrates the ability ofthe lens to sustain 
its Ca2+ homeostasis despite a two fold increase Ca2+ in the external aqueous environment. In 
clear human lens, lens lipids show a capacity to bind Ca2+ (Tang et al., 2003). There are 
proteins that act as buffers for Ca2+ (Louis et al., 1986) and there are internal compartments 
for sequestering Ca2+ (see Table 1.1) (Clapham, 1995; Duncan et al., 1994). It is documented 
that over 99% of total Ca2+ in the lens is in the bound form and that less than 1 % is free 
(Duncan et al., 1989; van Marie et al., 1997; Vrensen et al., 1995). 
Ca2+ influx by ionomycin and lens physiological zones. 
The microcirculatory system of the lens drives the flow of fluid. The assumption is that 
ionomycin follows the flow and enters the lens through extracellular spaces and then reach the 
core of the lens. There is a considerable amount of Ca2+ located in the intercellular spaces of 
human and rat lenses (van Marie et al., 1997; Vrensen et al., 1995). In the present work with 
young cultured ovine lenses (6-9 months old) the effect of adding ionomycin to the medium 
was restricted to the development of opacity in the cortex, which was associated with an 
increase in Ca2+ concentration within this region. 
Early reports with a Ca2+ ionophore showed that there was limited complexing of Ca2+ ions 
with the Ca2+ ionophore below pH 7.0 (Liu & Hermann, 1978). Transmembrane pH gradients 
also alter the transport properties ofCa2+ ionophores (Erdahl et al., 1995; Wolley et al., 
1995). The inner fiber cells (core of the lens) provide an acidic environment (Mathias et al., 
1991). This acidity may limit the response to a Ca2+ influx action in the core of the lens 
induced by ionomycin. In other tissues, ionomycin also enhances Ca2+influx by stimulating 
store-regulated cation entry (Dedkova et al., 2000; Morgan & Jacob, 1994). Internal Ca2+ 
regulatory compartments, such as the ER and mitochondria, are completely removed during 
terminal differentiation of fiber cells and they are absent in the inner fiber cells. Hence, the 
influx of Ca2+ induced by ionomycin would be limited at the cortical region of the lens which 
contain differentiating fiber cells. 
The cellular response to cataractogenetic insults may be also different between the two 
physiological zones. Current Ca2+ data (Table 4.4) show that the nucleus region had a certain 
degree of Ca2+ influx but still remained transparent, unlike the cortical region which had a 
large influx of Ca2+ and exhibited dense opacity. Adult rat lenses studied by Iwasaki et al. 
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(1995) demonstrated there were large increases in the concentration of insoluble protein in the 
nuclear region that remained transparent under Ca2+ ionophore treatment. Thus, the 
mechanism of opacity development may differ between the cortex and nucleus of the lens. 
The susceptibility of different regions of rat lenses to a cataractogenetic agent also changed 
with increasing age. With ionomycin exposure, young rat lenses (less than 4 weeks old) 
developed dense nuclear opacity (Azuma et al., 1992; Fukiage et al., 1997b; Iwasaki et al., 
1995; Nakamura et al., 2003) but adult rat lenses (12 weeks old) developed cortical cataracts 
(Iwasaki et at., 1995; Sanderson et al., 1996). Young rats (less than 1 week old) injected with 
sodium selenite (selenite cataract, refer to Chapter 1) developed dense nuclear opacity and 
Ca2+ accumulated in the lens nucleus (Shearer et al., 1997). On the other hand, human 
cortical cataractous lenses displayed changes in their internal ionic contents, especially a large 
increase in Ca2+, whilst nuclear cataracts showed no changes in internal ionic content (Duncan 
& Bushell, 1975; Duncan & Jacob, 1984). Such research indicates that there are functional 
and physiological differences between cortex and nucleus regions ofthe lens and the opacity 
development. 
The cause ofthe increase in internal Na+ level in ionomycin-EGTA treated lenses maybe due 
to the opening of a non-selective cation channel in response to the lowering internal Ca2+ level 
(Rae et al., 1992). 
No loss of lens dry weight was observed in the OLeO model 
Early reports with mature human cortical cataractous lenses revealed that the degree of 
disruption in the ionic balance correlated with the loss of protein and, as a consequence, a loss 
in the dry weight of the cataractous lens. Duncan and Bushell (1975) showed that an increase 
in the cytosolic Ca2+ is associated with a decrease in the lens dry weight. Recent human lens 
culture studies (Sanderson et al., 2000) also showed there was a strong link between increased 
Ca2+ levels and the loss of newly synthesized proteins. However, in ovine lenses both the 
protein contents (urea soluble and total soluble protein contents) and the dry weights ofthe 
opaque lenses treated with ionomycin were not significantly different from the control and 
EGTA-treated lenses (Table 4.1 and 4.2). 
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One possible explanation for the difference between these data and others could be the rapid 
progress of opacification in the OLCO model (i.e. 2 - 3 days) due to the traumatic Ca2+ influx 
through the action of ionomycin, compared to several months, as observed in cataract 
formation under in vivo conditions (Robertson et ai., 2005). The bovine lens culture system 
demonstrated there was a catastrophic differential loss of lens proteins, which was only 
apparent after 6 days. This was associated with an increase in lens Ca2+. No protein loss was 
observed in the EGT A treated lenses over 10 day experimental period (Marcantonio et ai., 
1986). 
Ca2+ -activated proteolysis was associated with the opacification 
In the cultured ovine lenses, the maintenance of a lens gel state is more dependent on internal 
Ca2+ than any other cation (Table 4.3 and 4.4). Elevation of Ca2+ in the OLCO model induced 
opacification of the lens. Microscopic cross sections of the opaque lenses revealed a turbid 
fraction, which contained totally disintegrated structures. This fraction readily segregated 
from the rest of the fiber cells. The latter showed no signs of structural disintegration (Figure 
4.13). The formation of turbidity in the outer shell fiber cells was a result of high Ca2+_ 
induced biochemical and morphological changes. The detrimental effects from the loss of 
Ca2+ regulation by the lens illustrate the importance of Ca2+ homeostasis in this region of the 
lens. It is speculated that the loss of Ca2+ regulation in the outer shell fiber cells may trigger 
initial cellular changes and, as a consequence, the cell membrane integrity is disturbed which 
leads to an increase in cell permeability. This results in the loss of water homeostasis and 
cellular ionic homeostasis and, consequently, further membrane degradation. Bettelheim 
(1983) observed morphological degeneration and disintegration of membranes in many 
cataractous processes. The higher Ca2+ levels in the outer shell region compared to the inner 
fiber cells are, therefore, a result ofthe initial Ca2+-driven changes. 
It is a prominent feature ofthe OLCO model that the equatorial region of the lens is the initial 
site for opacity (Figure 4.9) and that the cytoskeletal proteins, vimentin and spectrin, are 
subjected to degradation in the opacification process (Figure 4.6 and 4.7). The equatorial 
region of the lens is composed of young differentiating fiber cells that are enriched with 
cytoskeletal proteins, which assist the differentiation process of the epithelial cells into fiber 
cells (Bassnett & Beebe, 1992; Goodenough, 1992; Prescott et ai., 1994). Proteolytic 
modification is an important process which occurs during normal development of lens 
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transparency. This proteolytic process is tightly regulated under nonnal physiological 
conditions. The data in this thesis show that calpain II is the dominant calpain isofonn 
present in the lens (Figure 4.4). The correlation of calpain II activity with the progress of 
opacification (Figure 4.4 and 4.10) indicated that there is a possible linkage between the 
involvement of calpain II and the rapid protein degradation in the outer shell region. Most 
calpain II activity is detected in the outer shell region and there is little calpain II in the 
nuclear region in bovine (Yoshida et al., 1985) and ovine lenses (Robertson, 2003). 
Many studies have proposed that the degradation of proteins, which are usually involved in 
the maintenance of lens transparency, are induced by over-activation of the Ca2+ -dependent 
proteases or calpains (David & Shearer, 1986, 1993; David et al., 1993; Shoeman & Traub, 
1990; Yoshida et al., 1984). Indeed, some cytoskeletal proteins are calpain substrates. 
Spectrin and vimentin, in particular, are rapidly degraded by calpain (Goll et al., 2003; 
Shoeman & Traub, 1990). Ca2+-induced degradation oflens cytoskeleton proteins has been 
reported in lenses cultured from rats (Sanderson et al., 1996;Vrensen et al., 1995), cattle 
(Marcantonio & Duncan, 1991) and humans (Sanderson et al., 2000). Protein degradation 
was correlated with the loss of lens transparency. 
Taken together, the Ca2+-induced lens opacification in the OLCO model described in this 
thesis is associated with proteolysis. The data support the involvement of the calpain-
activated proteolytic activity, which may initiate the development of opacification. 
Crystallin degradation contributed a minor factor in the OLCO model 
The aggregation and high concentration of partially unfolded proteins lead to the fonnation of 
the insoluble protein characteristics of in vivo cataractous lenses (Harding, 2002). There is 
extensive evidence that the transparency of lens is largely detennined by the properties of 
crystallins. Crystallins are the major lens structural proteins. Limited hydrolysis of the 
crystallins by calpain contributes to the light-scattering characteristics of cataractous lenses 
(Augusteyn, 2004). It is, however, surprising in this thesis that SDS-PAGE protein profiles 
showed no evidence of fragmented crystallins previously identified in opaque lens (Figure 
4.6). The 2-DE profiles showed there were only limited modification of some ~- crystallin 
subunits and no apparent modification of any a-crysallins (Figure 4.8), despite the dense 
opacity in the OLeO model. 
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· The reduced content of the ~-crystallin subunits, ~A3 and ~A4, in the OLCO model provided 
some evidence of partial ~-crystallin degradation (Figure 4.8). Truncation of the N-termini of 
~-crystaI1ins by calpain II specific proteolysis has been identified in rat lens (David et al., 
1992) and unregulated proteolysis causes opacification (David et al., 1994a). ~-Crystallins 
are rapidly expressed during cell elongation in young differentiating fiber cells at the 
equatorial region of the lens (Goodenough, 1992). Crystallin modification occurs as part of 
the normal maturation processes and it was suggested that the site specific proteolysis of ~­
crystallins may serve to initiate tighter packing of crystallins during lens maturation in young 
lenses (Werten et al., 1999). 
a-Crystallins prevent the precipitation of rat crystallins truncated by proteolysis (Shearer et 
al.,1995). Similarly, proteolytic products of human and bovine crystallins are not 
precipitated in the presence of a-crystallins (Shih et al., 2001). Truncation of the C-terminal 
of a-crystallins by calpain is known, however, to cause the loss of its chaperone function 
(Kelley et al., 1993; Takemoto, 1994) and consequently a-crystallin fragments entangle in the 
resulting insoluble pellet as reported for in vitro cataract models (Horwitz, 2003). In 2-DE 
protein profiles (Figure 4.8), examination ofthe soluble fraction of the lens protein revealed 
that intact and phosphorylated forms of aA-crystallin were prominent proteins in the normal 
lens, but they showed no evidence of degradation in opaque lenses. Partial degraded ~­
crystallins with undegraded aA-crystallin may make little contribution to the light scattering 
in the OLCO model. 
A recent study, however, demonstrated the deleterious effect of high Ca2+ concentrations 
upon the chaperone function of a-crystallins without truncation (del Valle et al., 2002). 
Ca2+ decreased the structural stability of a-crystallins by promoting the partial unfolding of 
the protein and, as a consequence, impaired the chaperone function and lowered the protective 
ability of other lens proteins. Thus, the modification of a-crystallins by high Ca2+, without 
cleavage, could have resulted in the intact crystallin profiles shown on both SDS-PAGE and 
2-DE electrophoresis analysis in the data. 
The lack of significant changes in the total protein content and dry weight in the OLCO 
models (Table 4.2 and 4.3) supports the proposal that modification of the crystallins made 
only a minor contribution to the opacification under this dramatic alteration of Ca2+ 
homeostasis. Studies by Truscott et al.(1990) with rat lenses showed that a rapid rise offree 
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Ca2+ was associated with a rapid increase in opacification, a massive degradation ofthe lens 
cytoskeletal proteins and minor crystallin degradation. 
Role of cytoskeletal elements and the maintenance of the lens transparency 
The major finding of this research is that the initial calpain proteolysis of cytoskeletal 
elements is a key factor in cortical opacity in the OLCO model. Bettelheim (1985) proposed 
that lens transparency was physically based on spatial fluctuation in the concentration and 
optical orientation of macromolecules in the lens, and any changes in the fluctuations in 
cataractous lens increase light-scattering. For instance, when lens proteins were extracted and 
a more dilute protein solution prepared than in the normal lens, the protein solution became 
turbid due to the increased separation of the scattering particles, which cause the destructive 
scattering associated with low vision (Bettelheim, 1985). According to the physical basis of 
lens transparency, the formation of turbidity could be due to water uptake leading to diluted 
lens proteins (composed of limited modified crystallins). The water uptake may be a result of 
the initial destruction of cell membranes by calpain proteolysis of the key cytoskeletal 
proteins in the differentiating region of the lens. 
Current data support the significance of cytoskeletal proteins in the lens transparency. The 
importance of interactions between cytostructural proteins and crystallins in the lens was 
proposed by Clark et al.(1999). These interactions are required for the initial organisation of 
lens proteins into the transparent homogeneous structure, which is necessary to provide an 
environment favourable for transparency in normal mammalian lens, especially within the cell 
differentiating zone (Clark et al., 1999). In the absence of a cytoskeletal scaffold, attractive 
interactions between lens proteins may dominate and accelerate the organisation of proteins 
into large light-scattering aggregates without modification ofthe crystallins themselves. 
When the lens are exposed to a high external Ca2+ environment, the degradation of 
cytoskeleton proteins may result in aggregation of crystallins from a single homogenous 
transparent phase into separate cytoplasmic domains of condensed protein aggregates, which 
are responsible for the loss of transparency. 
Non-proteolytic evidence: Cross-linking aggregates 
In addition to the presence of limited proteolysis of crystallins in the OLCO model, the 
presence of non-proteolytic products was also identified in 2-DE protein profiles of opaque 
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lenses (Figure 4.8). Elevation ofCa2+ causes cross-linking of cytoplasmic crystallin and 
membrane proteins to produce the nucleation of large aggregates (Figure 2.1, Chapter 2) 
(Spector et at ,1979). These large aggregates are not degraded forms of any molecules, but 
linked at the intra- or inter- molecular level and cause light-scattering in cataractous lens. In 
ionomycin treated lenses, the intense 2-DE spots around 65 - 70 kDa coincided inversely with 
the weakening of PA3- and pA4-crystallins spots, suggesting they could be some cross-linked 
products of the p-crystallin subunits. 
Transglutaminase is a Ca2+ -activated lens enzyme that is involved in the cross-linking of lens 
proteins (Lorand et at, 1981;1998; Veasco et at, 1990). The activity of trans glutaminase has 
been observed in human lens (Hidasi and Muszbek, 1995). a-Crystallins and vimentin have 
been reported as substrates for lens trans glutaminase (Clement et at., 1998; Shridas et at., 
2001). The Ca2+-dependent cross-linking of vim en tin in human lens (Sanderson et at., 2000) 
suggested a possible role for this enzyme in cataractogenesis. Cross-linking aggregates and 
proteolysis of proteins can disturb the highly organised spatial orientation of macro-
molecules, which results in the loss of water homeostasis and so contributes to light 
scattering. 
Cell death and opacification 
The relationship between opacity and cytotoxicity ofthe opaque lenses demonstrates that the 
opacification accompanies cell death in the lens (Figure 4.11 and 4.12). Cell death is 
associated with elevated Ca2+ level in the lens since the addition of Ca2+ chelating agent to the 
culture media largely prevented LDH leakage (Figure 4.11). 
It is arguable whether cell death, which occurred from the sustained elevation of cytosolic 
Ca2+ levels, was an effect or cause of cataractogenesis in the OLCO model. For example, 
when cells are injured by extreme stress or chemical challenges to the point where they are 
beyond repair, necrotic cell death is associated with massive Na + and Ca2+ influxes, and 
consequently calpain activation occurs (Majno & Joris, 1995; Wang, 2000). It is known that 
calpain activated proteolysis by high intracellular Ca2+ contributes to necrotic cell death in 
neural pathological diseases like ischemic and excito-toxic neural injury (McGinnis et at., 
1999; Wang & Yuen, 1998). An increase in cytoplasmic Ca2+ concentration has also been 
linked with the initiation of apoptosis in both neuronal and non-neuronal tissue studies 
(Joseph et at., 1993; McConkey et at., 1989; Pigozzi et at., 2004; Takei & Endo, 1994). 
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Once a fiber cell loses its physiological homeostasis, cell death could be an inevitable 
outcome as the lens is a unique structure based on a fine physiological balance. The data in 
this chapter imply that degradation oflens cytoskeletal proteins results in the formation of the 
turbidity, which is an outcome of cell death. Conclusively, cataractogenesis leads the lens 
cells to death. It is likely that the sustained influx of Ca2+ into the lens is involved in necrotic 
cell death rather than the apoptotic pathway. 
When the lens was exposed to the prolonged low levels of intracellular Ca2+ (by EGT A 
treatment) there was minor cell death. Microscopic examination of the EGTA treated lenses 
(Figure 4.13) showed that there was some structural modification on the surface of the fiber 
cells. Vrensen et al. (1995) showed that the lowering of intracellular Ca2+ by addition of 
EGTA to the extracellular environment induces the formation of large extracellular vacuoles 
by changes in water homeostasis and Na+ influx. The lowering of intracellular ci+ by 
addition ofEGTA may also cause the release of stored Ca2+, which can elicit caspase-3-like 
protease activity that leads to apoptosis (McGinnis et al., 1999). It is speculated that 
controlled cell death by the lens, like apoptosis, would involve in removing any unnecessary 
cells with minimal change in structure integrity. Apoptosis can prevent triggering any major 
threat to the lens or altering the physiologically balanced status. 
Morphological comparison between the OLGO model and inherited ovine cataracts 
Opacification induced in the OLCO model is initiated from the equatorial region and 
uniformly develops. ill comparison to the OLCO model, the initial stages of in vivo inherited 
ovine cataract is the discrete appearance of opacity alongside clear area in the cortical region 
(Duncan & Jacob, 1984; Gandolfi et al., 1990; Robertson, 2003). The steady increase in Ca2+ 
levels in the in vivo cataract results in cell uncoupling (Loewenstein, 1981), which is probably 
due to the occlusion of membrane communicating junctions (Peracchia & Peracchia, 1980). 
As in other tissues, such uncoupling could act as a protective mechanism, effectively isolating 
damaged fiber cells from the viable parts of the lens. 
However, once the inherited ovine cataract has progressed to a mature stage, this in vivo 
cataract resembles the uniformly dispersed opacity observed in the in vitro OLCO models 
(Robertson et at., 2005). ill the in vivo cortical cataractogenesis, the progress of opacification 
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takes up to several months (Robertson et al., 2005). When lenses in the OLCO model were 
exposed to a rapid increase ofionomycin-induced Ca2+, over a relatively short time period 
(24 h up to 4 days) or the lenses were exposed to sustained Ca2+ for long time period, as in the 
in vivo cortical cataract, the uncoupling mechanisms to protect other fiber cells would still not 
be sufficient. 
4.8. Conclusions 
This chapter illustrates some of the biochemical and structural changes which occur in young 
cultured ovine lens (less than I year old) following the rise of intracellular Ca2+ induced by 
ionomycin. The biological and morphological features of the ovine lens calcium-induced 
opacification (OLCO) system provide a model to understand the role ofCa2+ homeostasis in 
the lens system. The OLCO model demonstrates that cytoskeletal proteins are highly 
susceptible to degradation under the changes in Ca2+ homeostasis. This model supports the 
importance of cytoskeletal proteins in maintaining lens transparency. 
Calpain activation is highly correlated with opacification in this model. Major degradation of 
known calpain substrates, spectrin and vimentin, are a primary feature of the Ca2+ overloaded 
ovine lens. The nature of the opacification of the OLCO model is the turbid fraction with 
increased lens hydration in the cortex. 
Taken together, these data suggest that deregulation of calpain activity induced by high Ca2+ 
levels could directly trigger major cytoskeletal protein degradation, which is part of a cascade 
of events leading to further detrimental effects on lens membrane structural integrity 
impacting on the ionic and water homeostasis of the lens. The loss ofCa2+ homeostasis may 
ultimately lead the lens to cell death and thus cataractogenesis. 
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Chapter 5: Application of Calpain Inhibitors to Cataractogenesis Models 
5.1. Introduction 
Understanding the physiological function of calpains during normal lens development and 
their involvement in cataractogenesis is a challenge for researchers. The application of 
calpain inhibitors to various tissues is a key tool in determining not only the role of calpains 
in normal and pathological processes, but also to assess their potential as therapeutic agents. 
The most specific calpain inhibitor is the endogenous inhibitor of calpain I and calpain II, 
calpastatin (Murachi, 1983). However, this has limited therapeutic potential, as calpastatin 
and its active polypeptide fragments are large molecules and have problems crossing 
membrane barriers. 
As a consequence, the development of exogenous calpain inhibitors has focused on designing 
active-site targeting peptide analogues of calpain substrates with increased membrane 
permeability for their effectiveness as anti-calpain drugs. Several exogenous calpain 
inhibitors have been used to investigate the role of calpains in a variety of human diseases, 
including arthritis (Yamamoto et al., 1992), cerebral and myocardial ischaemia (Wang & 
Yuen, 1994), muscular dystrophy (Bhattacharyya et al., 1991), Alzheimer's disease (Saido et 
al., 1993a) and cataract formation (Azuma et aI., 1991). 
Experimental animal models have also been exposed to exogenous calpain inhibitors to 
determine the role of calpain as the mechanism of cataractogenesis in the progress of 
chemically-induced opacification (Azuma et al., 1991, 1992; Fukiage et al., 1997b; Kadoya et 
aI., 1993; Lampi et al., 1992; Sanderson et at., 1996). 
SJ A601 7 (N -( 4-fluorophenyl-sulfonyl)-L-valyl-L-Ieucinal) is an active-site targeting peptide 
aldehyde calpain inhibitor with better cell permeability characteristics than leupeptin and E64 
(Fukiage et at., 1997b). Data show it inhibits calpain I (ICso = 7.5 nM) and cathepsins (ICso 
<15 nM) better than calpain II (ICso = 78 nM). SJA6017 has no significant effect on the 
activity of many other cysteine and serine proteases (Inoue et al., 2003). The application of 
SJA6017 has been shown to reduce the rate of cataract formation in animal models (Biswas et 
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· at., 2004; Fukiage et ai., 1997b; Nakamura et at., 1999b; Robertson et al., 2005; Tamada et 
al., 2001). 
Despite the remarkable inhibitory effects of these calpain inhibitors in cell-free assay systems, 
many in vitro and in vivo studies have illustrated that the calpain inhibitors have only partial 
inhibitory effects on the progress of opacification. Two in vitro Ca2+-overloading 
cataractogenesis models, the OLCO model (Chapter 4) and the hyper-Ca2+ medium model 
(Biswas et at., 2004; Hightower & Dering, 1984; Hightower & Farnum, 1985), were used in 
the first part of the current chapter to further investigate the role of calpain in cataractogenesis 
by the application of the exogenous calpain inhibitor, SJA6017 to the lens culture system. 
These two culture systems provided variation in the way the opacification developed within 
the lens. Applying the calpain inhibitor directly to the lens culture system resembles the 
uptake of the calpain inhibitors from the aqueous humour to cells of the lens in the intact eye. 
Investigating the efficacy of calpain inhibitors in a lens culture system also indicates their 
potential as therapeutic agents in in vivo cataractogenesis. 
Systemic delivery of the drug to the eye by oral administration or injection can be limited by 
the relatively poor penetration of some groups of agents into the ocular tissues from the 
plasma (Freddo, 2001), and can generate potential side effects (Burstein, 1985). Local 
administration of the drug to the eye has the advantage of achieving relatively high local 
concentrations with only marginal drug exposure to the rest of the body. Topical 
administration has been used as a route of local delivery in treating diseases involving the pre-
corneal tissues, cornea, iris, and ciliary body (Andermann et al., 1978; Burstein, 1985; 
Havener, 1983; Lee & Robinson, 1986; Maurice & Mishima, 1984; Piercy, 1985). Topical 
delivery of anti-cataract agents could be, therefore, the most desirable approach to treating the 
lens. 
The cataract group at Lincoln University and the University of Canterbury, New Zealand, 
have designed novel anti-calpain compounds based on the structure of SJA6017 (Figure 5.6). 
Novel calpain inhibitors were tested for their ability to slow the development of induced 
opacity in the in vitro ovine lens system. Then, the in vivo assessment involved long term 
topical administration of selected novel calpain inhibitors to a flock of sheep with naturally 
developing inherited cataracts. 
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5.2. Experiment 1: Application of calpain inhibitor in the culture system. 
The purpose of this experiment was to confirm the involvement of calpain activity in the 
mechanism ofCa2+-induced cataract formation, by applying a known calpain inhibitor, 
SJA6017, to the ovine in vitro lens culture system. 
Two experiments, experiments I-a and I-b, were designed to investigate the effect of adding 
an inhibitor of calpain to two different cataractogenesis models, the OLCO and hyper-Ca2+ 
incubation media models. 
5.2.1 Experiment I-a: Calpain inhibitor in the OLeO model 
5.2.1.1 Methods 
Lens culture 
Eye globes were obtained from II-month-old sheep immediately after sacrifice. From the 
globes, a group of lenses was dissected within 2 h post-mortem and cultured in EMEM 
(containing 1.8 mM Ca2+) for a 48 h incubation settling period as described in Chapter 3. 
Preparation of treatment solutions 
SJA60 17 was synthesised by the University of Canterbury Chemistry Department and 
solubilised in DMSO. ImglmL ionomycin (Ca2+ ionophore, Sigma) was prepared in DMSO. 
The final concentration of DMSO in the culture media, after the addition of the inhibitor and 
ionomycin, was less than 0.05%. 
Experimental protocol 
After the 48 h pre-settling period in EMEM, intact lenses were divided into three groups for 
the experiment; control group (Control), ionomycin-induced group (Iono) and ionomycin 
treated with SJA6017 group (I+SJA). A group of 6 lenses was cultured under normal 
conditions in EMEM (Control). For inhibitor treatment (I+SJA), a group of 6 lenses was pre-
treated with 100 11M of SJ A6017 for 24 h prior to exposure to ionomycin. 
At the start of the experimental period (t = 0),5 11M ofionomycin was introduced to the two 
groups (lono and I+SJA) to induce opacity. A complete change of culture media with the 
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appropriate compounds was made after the first 48 h of the experimental period (t = 48 h). 
All lenses were monitored over the total 96 h experimental period (t = 96 h). 
Grading of opacification 
Lens opacity was scored and a grade allocated at 48 hand 96 h in the experimental period by 
image analysis system described in Chapter 3 (3.2). 
Analysis of calpain activities and protein profiles 
At the end of the 96 h experimental period, all lenses were harvested and the whole lenses 
were homogenised as described in Experiment 3 (4.5.1), Chapter 4. Soluble proteins were 
used for calpain activity determination using casein zymography. Urea soluble proteins were 
extracted and used for protein profiles by SDS-PAGE as described in Chapter 4 (4.2.1) 
5.2.1.2. Results 
Lens Transparency 
Lens transparency was monitored over a 96 h experimental period (Figure 5.1). The degree of 
lens opacification was digitally analysed to confirm the visual assessment. Normal lenses 
cultured in EMEM remained transparent throughout the experiment. 
During the first 48 h experimental period, the lenses in ionomycin (lono) developed full 
opacity except for some partial clearance in the centre ofthe anterior region. The SJA6017 
treated lenses (I+SJA) were significantly less opaque (P < 0.05). Full opacification was 
restricted to the equatorial region of these lenses. 
All treated lenses (Iono and I+SJA) showed greater opacification by the end of the 96 h 
experimental period. While ionomycin-induced lenses without inhibitor (lono) showed dense 
opacity, the anterior part of lenses treated with SJA6017 (lono+SJA) still remained semi-
transparent (P = 0.055). 
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o 48 h 96 h 96-C 
lono 
7.4±2.3 82.3 ± 5.2 "95.8 ± 4.7 17.3 ± 8.4 
I+SJA 
8.9 ± 2.4 * 66.3 ± 15.6 "87.5 ± 2.9 
Figure 5.1 Digital images of lenses (n= 6) taken at three different time (t= 0, 48 hand 96 h) during 
culturing in EMEM + 5 flM ionomycin (lono), EMEM + 5 flM ionomycin + 100 flM of SJA60 17 
(J+SJA). Normal lenses cultured in EMEM are also displayed at the end of 96 h experimental period 
(96-C). Mean opacification score (± sd) for six lenses of each group is displayed below each image. 
Score of 1 represents a transparent lens. Score of 100 represents a full opacity lens. 
Two sample t-test; 'p < 0.01 relative to lono (48 h) and "p = 0.055 relative to lono (96 h). 
In both lono and I+SJ A groups, lenses were hydrated as their wet weights increased compared 
to the normal lenses (P < 0.05). The hydration of the lenses treated with SJA6017 (I+SJA) 
were similar to the hydration in the lenses without SJA60 17 (lono) (Table 5.1). 
Table 5.1 Mean wet weight (±sd) of ovine lenses after culture for 96 h in in EMEM (Control), EMEM 
+ 5 11M ionomycin (Iono), EMEM + 5 M ionomycin + 100 flM ofSJA6017 (l+SJA) 
Treatment No of lenses Lens wet weight (g) 
Control 6 '1.05 ± 0.05 
lonomycin (Iono) 5 1.37 ± 0.30 
lonomycin + SJA6017 (I+SJA) 6 1.43 ± 0.24 
Two sample t-test; "p < 0.05 relative to 1 and 10no+SJA. 
Proteolysis of lens proteins 
At the end ofthe 96 h experimental period, calpain II activity of whole lenses was assayed 
with casein zymograms (Figure 5.2), although the opacities were mainly in the cortical region 
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of the lens. Intact calpain II activities of both SJA6017 treated and SJA6017 non-treated 
lenses in the presence of ionomycin were lower than the intact cal pain II activities in the 
control lenses. 
The urea soluble protein profiles oflenses by SDS-PAGE, however, indicated partial 
protection by SJA6017 of spectrin in the ionomycin-induced lenses incubated with the 
inhibitor (Figure 5.2, (B». In contrast, ionomycin treated lenses contained no intact spectrin 
in the urea soluble proteins. There was some evidence of protection of the lens specific 
intermediate filament, filensin (lIS kDa) by SJA6017 in the ionomycin treated group with the 
inhibitor, compared to ionomycin treatment lenses without the inhibitor. 
(A) 
L C 1000 I+SJA 
(8) Mm C 1000 I+SJA 
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Figure S.2 (A) Casein Zymography of calpains present in 100 flg of soluble protein from ovine lens 
after culture in three treatments for 96 h. Purified calpain II, extracted from ovine lung, was loaded in 
the first lane (L). Lanes 2,3 and 4 contained soluble proteins from a control lens (C), a lens treated 
with 5 ).1M ionomycin (1000) and a lens treated with 5 ).1M ionomycin with 100 ).1M SJA601 7 (I+SJA) 
respectively. Solid and broken arrows indicate intact calpain II and autolysed cal pain II respectively. 
(8) SDS-PAGE of (15 ).Ig) urea soluble protein in ovine lens at the end of the 96 h experimental 
period. The molecular marker was loaded in the first lane (MOl, Precision Plus Protein Standards™, 
All Blue, Bio-Rad). Lanes 2,3 and 4 contained urea soluble proteins from a control lens (C), a lens 
treated with 5 ).1M ionomycin (1000) and a lens treated willi 5 ).1M ionomycin with 100 ).1M SJA6017 
(I+SJA) respectively. Black arrows indicate intact spectrin (280 kDa) and intact filensin (115 kDa) 
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5.2.2. Experiment I-b: Calpain inhibitor in the hyper-Ca2+ medium model 
5.2.1.2. Methods 
Lens culture 
Pairs oflenses were cultured in EMEM (containing 1.8 rnM Ca2+) for a 48 h incubation 
settling period according to the culture protocol described in Chapter 3. 
Preparation of treatment solutions 
2 M Ca2+ was made in sterilised dH20, and added to 10 mL culture medium to make a final 
concentration of 5 rnM Ca2+ per lens. SJA6017 in DMSO was prepared as described in 
5.2.1.1. The final concentration of DMSO in the culture medium, after addition of the 
inhibitor, was less than 0.05%. Same volume ofDMSO (less than 0.05% in EMEM) was 
added to the media containing 5 rnM Ca2+ so there were no effects attributed to DMSO . 
Experimental protocol 
Three pairs of lenses were used for inhibitor treatment. One lens from each pair was pre-
incubated with 0.8 flM SJA6017 for 2.5 h whilst the other lens from the same pair remained 
in EMEM. Then 16 flL of 2 M Ca2+ solution was added to all three pairs of lenses. The final 
concentration ofCa2+ per lens was 5 mM Ca2+. All the treated lenses were cultured for 24 h. 
At the end of the 24 h treatment period, digital images of the lenses were taken, and all lenses 
were immediately harvested and cleaned with dH20. The wet weight of the individual lens 
was recorded, prior to being stored at -80°C. 
Analysis of calpain activity and protein profiles 
Lenses were thawed and dissected into cortical (outer fiber cells including lens capsule and 
epithelium, approximately 30% of total wet weight) and nuclear regions (core region of fiber 
cells, 70% of total wet weight). These samples were immediately homogenised and soluble 
proteins and urea soluble proteins were obtained as described in Experiment 3 (4.5.1) and 
Experiment 1 (4.2.1) in Chapter 4 respectively. Soluble proteins were used to run casein 
zymography as described in Experiment 1 (4.2.1), Chapter 4. Urea soluble proteins were used 
to run SDS PAGE, Western detection for a-spectrin (a-fodrin, Affiniti) and 2-DE for 
proteolysis analysis as described in Experiment 1 (4.2.1), Chapter 4. 
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5.2.2.2. Results 
Lens transparency 
During the 24 h incubation period, the lenses in 5 mM Ca2+ containing medium showed even 
light scattering in the superficial region ofthe lens (Figure 5.3). The rest of the lens remained 
transparent. There were no visual signs oflens hydration. 
The light scattering was completely prevented in the lens from the same pair cultured in the 
presence of SJA60 17 in the hyper-Ca2+ medium. All three pairs of treated lenses showed 
consistent results. The calpain inhibitor, SJA6017, significantly reduced the development of 
lens opacification induced by the high Ca2+ containing medium (P < 0.05). 
Control SJA6017 + Ca2+ 
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16.2 ± 3.2 19.5 ± 4.4 *49.5 ± 6.1 
Figure 5.3 Digital images of ovine lenses on a grid at the end of24 h experimental period: a lens in 
EMEM (Control) and a pair of ovine lenses exposed to 5 mM Ca' + containing 0.8 flM SJA6017 
(SJA6017 + Ca') and 5 mM Ca' + only (Ca') . Mean opacification score (± sd) of each treatment is 
displayed correspondingly. Score of I represents clear transparency of lens, while 100 represents full 
opacity oflens. *Paired t-test (p < 0.05) of Ca'+ group of 3 lenses relative to SJA60 17 + Ca' +. 
Protein content in cortex region 0/ lens 
The wet weights of the high Ca2+ treated lens pairs (1 .016 ± 0.021 g) were not significantly 
different to the wet weights of normal lenses (1 .039 ± 0.083 g) at the end of 24 h treatment 
period. The total soluble protein contents of the cortical fiber cells were not significantly 
different between lenses with and without SJA6017 under the hyper Ca2+ condition after a 24 
h experimental period. The analysis of urea soluble proteins from the pellet of the cortex 
showed, however, that under high Ca2+ there was less urea soluble protein in lenses treated 
with SJA6017 than in the lenses without SJA6017 (*P < 0.05, Table 5.2). 
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Table 5.2 Mean soluble protein and urea soluble proteins concentration (mg/g, ±sd) from the cortex 
region of the lenses after culture for 24 h in three different treatments. A pair of ovine lenses were 
cultured for 24 h in EMEM + 5 mM Ca'\Ca', and EMEM + 5 mM Ca'+ + 0.8 !1M SJA60 17 (Ca2+ 
with 8JA6017) . 
Treatment n Soluble protein Urea soluble protein 
CaH with SJA6017 3 441.7 ± 2204 2.6± 0.9 
CaH 3 423.5 ± 53.9 *3.8 ± 0.6 
H + 
*Palred t-test of urea soluble protem In Ca wIth SJA6017 group to Ca group (P < 0.05). 
SDS-PAGE and Western detection 
Intact spectrin in urea soluble protein fractions was closely examined by SOS-P AGE (Figure 
504, A) and western analysis (Figure 504, B). According to the SOS-PAGE technique, lenses 
treated with high Ca2+ contained less intact spectrin, as the intensity of the intact spectrin band 
was weaker than that found in the control and ionomycin treated lenses. This results provide 
evidence that proteolysis occurred in the lenses incubated in a hyper-Ca2+ medium. 
(A) Mm C 8 Ca2+ (B) 
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Figure 5.4 Urea soluble protein profiles of ovine lenses after culture for 24 h in EMEM (C), 
EMEM + 0.8 flMSJA6017 + 5 mM Ca'+ (8), and EMEM + 5 mM Ca'+ (Ca',. (A) SOS-PAGE 
analysis of 10 !1g urea soluble proteins extracted from cortex fiber cells. Mm is a molecular marker 
(kDa) with Streptactin (from Bio-Rad). (B) Western detection of a-spectrin (a-fodrin, Affiniti) with 
15 !1g urea soluble protein from cortical fiber cells. Solid arrows indicate intact spectrin (280 kDa) 
and broken arrows indicate breakdown products of a-fodrin spectrin. 
Evidence for proteolysis was confirmed by Western analysis of a-spectrin. The intensity of 
the intact spectrin band of the lenses treated in high Ca2+ was less than the control and 
SJA6017 treated lenses. Lenses treated with SJA6017 in the presence ofionomycin showed 
there were no changes in the intensity of spectrin using both SOS-PAGE and western u-
spectrin analysis. Three major fragments of intact u-spectrin appeared in the urea soluble 
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fractions in all the three treatment groups (indicated by broken arrows in (8), Figure 5.4). 
The intensity ofthe bands in all treatment groups was similar. 
Two-dimensional electrophoresis (2-DE) 
Soluble proteins were extracted from the cortex region of all treatment lenses to examine the 
profiles of the lens soluble protein, crystallin. Data showed there was a reduction in intact 
~A3- and ~A4-crystallins from the lens treated with 5 mM Ca2+ compared to lenses incubated 
with EMEM (control) or 5 mM Ca2+ with SJA60 17. 
All lenses contained phosphorylated <lA-crystallin in the soluble fractions of the cortical 
region. There was, however, a high level of modified phosphorylated <lA-crystallin in the 
high Ca2+ treated lenses compared to the control lenses or the calpain inhibitor treated lenses. 
Mm 
50 kDa 0 Control 37 kDa aA-ph aA e- f3A3 
-.It 
-.It 25 kDa • 
20kDa 1'\ 
\0 kDa f3A4 
o SmMCa2+ 
\t 
o Inhibitor + SmM Ca2+ 
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Figure 5.5 2-DE protein profile of 50 I1g soluble protein extracted from cortex region of ovine lenses 
after culture in EMEM (A), EMEM + 5 mM Ca2+ (8) and EMEM + 5 mM Ca'+ + 0.8 11M SJA6017 
(C), for 24 h. Intact aA-ph (phosphorylated (lA), f3A3 and f3A4 crystallin are marked by solid arrows 
(A). Mm are molecular markers (precision Plus Protein Standards™, All Blue, Bio-Rad). A broken 
arrow in (8) indicates modified phosphorylated (lA-crystallin. 
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5.2.3. Discussion 
Application of SJA6017 to the OLeO models 
SJA6017 partially protected ovine lenses from opacification. The centres ofthe lenses treated 
with SJA6017 was clearer than the lenses without SJA6017 treatment. Thus the presence of 
this calpain inhibitor slowed the progress of cortical opacification. Partial prevention of the 
loss of transparency coincided with the partial protection of intact spectrin from degradation. 
A fiber specific intermediate filament, filensin, also remained intact in the presence of 
SJA6017 with ionomycin, and was protected from partial degradation (Figure 5.2). Some 
cytoskeletal proteins are prime substrates for calpain degradation, and are excellent 
biochemical markers for calpain activation (Shoeman & Traub, 1990; Truscott et al., 1990). 
In rat lens models, degradation of these cytoskeletal elements has been prevented by SJA6017 
(Fukiage et al., 1997b) and calpain inhibitors (Azuma et at., 1992; Sanderson et al., 1996). 
E64 and SJA6017 have been effective in reducing Ca2+ ionophore-induced nuclear cataract 
formation in cultured young rat lenses (age between 5 days-4 weeks old) (Azuma et al., 1992; 
Fukiage et al., 1997b; Iwasaki et al., 1995; Nakamura et al., 2003). In contrast, E64 failed to 
prevent cortical opacity in adult rat lenses (Iwasaki et al., 1995), and calpeptin and 
MDL28170 (Sanderson et al., 1996) were able to partially protect against developing cortical 
opacity induced by Ca2+ ionophores in adult rat lenses (age between 10-12 weeks). These 
studies concluded that cortical opacification may not be due to proteolysis by calpain since 
inhibition of cortical B-crystallin proteolysis by the calpain inhibitor, E64, did not reduce 
opacification (Iwasaki et al., 1995). This study suggested that cortical opacification was due 
to water and electrolyte uptake. On the other hand, the study by Sanderson et al. (1996) 
demonstrated that calpain activation is involved in experimental cortical cataracts in mature 
rat lenses. These researchers argued that the partial protection of lens transparency was 
explained by ionomycin-induced opacity condition, where the cortex region of lens faces 
osmotic stress after initial disruption ofthe submembrane cytoskeleton by calpain-induced 
proteolysis. Subsequently, complete protection of cytoskeletal elements is impossible under 
the sustained Ca2+ increase in the lens. 
In a whole lens system, lens permeability to calpain inhibitors must be considered when 
investigating the role of calpains in cataractogenesis. The ability of a molecule to penetrate 
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· cells is a factor determining the apparent potency of the inhibitor (Burstein, 1985). Thus, 
despite SJA6017 having a low ICso value (approximately 80 nM, personal communication 
with Janna Nicole, The University of Canterbury) in an in vitro assay, the penetration of 
SJA6017 into lenses may limit its effectiveness. Consequently, there is only partial protection 
against changes in lens transparency. In contrast, E64d, one ofthe E64 derivatives, showed 
improved penetration to the lens and improved protection against Ca2+ ionophore-induced 
nuclear opacity, even though it had weaker inhibition of calpain II activity than E64 in an in 
vitro assay (Azuma et al., 1992). In addition, when the ICso of calpain inhibitors was 
determined in a cell-free system with rat lenses, it was also found that the ICso values of 
calpain inhibitors were substrate dependent and in sub-micromolar ranges (Sanderson et al., 
1996). 
Increased calpain activation occurred in both the ionomycin-treated and the ionomycin plus 
SJA6017-treated lenses based on the casein zymography. There were no differences in 
calpain activation levels between the lenses with and without the SJA6017 treatment. This 
could be explained as there was nearly full opacity in both treated lenses by the end ofthe 96 
h experimental period. The analysisofwhole lenses, instead of the opaque cortex regions, 
probably reduced any differences in localised calpain activities. 
Ovine lenses in the OLCO model were exposed to a continuous influx of Ca2+ by the 
ionomycin treatment. The continuous influx of Ca2+ resulted in lens opacity and cell death 
(see Chapter 4). In Chapter 4, it was proposed that cytoskeletal degradation by calpain-
induced proteolysis is the cause of the opacification. It is speculated that the protection of 
intact cytoskeletal elements by the calpain inhibitor may only be effective in the early stage of 
opacification, but would not be sufficient enough to sustain cell membrane integrity under the 
constant influx ofCa2+ in the OLCO model. The present calpain inhibitor study confirms that 
the cortical opacification is a result ofthe complex pathological conditions under the 
chronically high Ca2+ environment, which is followed by cross-linked aggregation, uptake of 
water and electrolytes, and cortical cell death (Chapter 4). 
Application of SJA6017 to the hyper-Ca2+ medium opacification 
The nature of the opacification induced by hyper- Ca2+ medium is different to the OLCO 
model. For example, the hyper-Ca2+ medium results in the opacification on the superficial 
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. area of the lens and there is no sign of lens hydration. This sub-capsular nature of the 
opacification has also been observed in rabbit (Hightower et at., 1985) and human (Hightower 
& Farnum, 1985) lenses cultured in Ca2+-rich medium. 
In early studies on rabbit lenses, Hightower et al. (1985) demonstrated an increase in free 
Ca2+ levels after culturing lenses in HEPES buffered medium with 20 mM Ca2+ for 20 h at 
22°C. That study showed little change in Na+ content and no hydration in the cultured lens, 
but the entire surface of the cortex was opaque at the end of the incubation period. The 
interesting feature of the reported studies was that subsequent culturing ofthese opaque lenses 
in culture medium (TC 199) at 37°C restored their transparency and electrochemical 
gradients. When human lenses were exposed to the same Ca2+ -rich medium under the same 
culture condition as the rabbit lenses (Hightower & Farnum, 1985), the human lens developed 
localised opacities often observed in human cataracts. The opacity was confined to the outer, 
superficial regions of the lens cortex and limited to the sub-capsular regions. The process in 
the opaque human lens was, however, irreversible. 
In the current research with ovine lenses, the complete protection by the calpain inhibitor, 
SJA6017 ofthe development of opacification (Figure 5.3) supports the involvement ofCa2+-
induced proteolysis in the opacification process. A recent study with porcine lenses showed 
that applying the calpain inhibitor, SJA6017, protected the lens from hyper-Ca2+ medium-
induced opacification (Biswas et al., 2004). The presence of SJA60 17 had no significant 
effect upon Ca2+ uptake by porcine lenses but slowed the early stages of opacification. The 
ability of SJA6017 to retard cataractogenesis in porcine lenses may be due to its ability to 
inhibit calpains, which have been activated by the elevated levels of lens Ca2+. 
The results in this thesis also demonstrate that the protection of lens transparency is 
accompanied with a reduction in insoluble lens proteins (Table 5.2) and lens protein 
degradation (Figure 5.4 and 5.5). Previous research has reported that high Ca2+ levels 
decrease the chaperone capacity of a-crystallins by altering their structural integrity, and 
increasing the susceptibility of other crystallins to proteolytic degradation (del Valle et at., 
2002). The addition of SJA60 17 to the culture media reduced the partial degradation of intact 
PA3 and PA4, and there was no sign of degradation of phosphorylated aA-crystallins. In this 
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respect, opacification induced by the hyper- Ca2+ medium is the result of Ca2+-activated 
proteolysis, which is prevented by calpain inhibitors. 
Despite the reduction of crystallin degradation, treatment with SJA6017 did not change the 
total amount of soluble proteins compared to the lenses treated in the hyper- Ca2+ medium 
without SJA6017. This observation is similar to the results with the OLCO model (Chapter 
4), where broad opaque areas were displayed in the lenses and there was no evidence of 
changes in the soluble protein fractions. 
Although there was a reduction of intact spectrin in the urea soluble fraction from the hyper-
Ca2+ treated lenses (Figure 5.4.), the profiles of the a-spectrin fragments were similar to those 
from the control lenses (cultured with no treatment) and lenses treated with Ca2+ plus 
SJA6017. Previous research has shown that insoluble proteins from fresh (non-cultured) rat 
lens exhibited 145 and 150 kDa molecular weight fragments along with intact a-spectrin 
(Fukiage et al., 1997b). There was no change in their concentration after the lenses were 
cultured in normal medium for 5 days. Proteolysis of a-spectrin to discrete fragments has 
been associated with changes in cell shape and membrane morphology, which occur in many 
cell types (Morrow et al., 1997). In the lens, the cleavage ofa-spectrin to 145 and 150 kDa 
fragments has also been observed during terminal differentiation and in ageing fiber cells (Lee 
et al., 2001). It is possible that the appearance of 145 and 150 kDa fragments in the cortical 
region of the normal ovine lenses is a part oflens differentiation. It has also been reported 
that a-spectrin fragments are more abundant in supernatant fractions than pellet fractions (Lee 
et al., 2001). It is apparent that the degradation of spectrin must be investigated in the total 
proteins of the lens, soluble (supernatant) and insoluble (pellet + urea soluble) fractions. 
The lens has limited extracellular spaces. This limits penetration of compounds into the lens 
and potentially reduces their effectiveness. In rats, the lens epithelium and cortex is where 
most of the calpain II activity resides (Ma et al., 1998). Studies have reported that SJA6017 
(lCso = 80 nM) is a potent calpain inhibitor compared to E64 (2.31 IlM) or leupeptin (0.49 
IlM) (Fukiage et al., 1997b). Effective inhibition of spectrin from proteolytic degradation 
was achieved by low concentration of calpain inhibitor in blood cells (Mehdi et al., 1988), 
where the cell structure is different to the lens. In the present research, the total protection by 
SJA6017 against lens opacification induced by the hyper-Ca2+ culture medium could be due 
94 
to the limited penetration to the surface opaque site of the lens by the calpain inhibitor with a 
low IC50 value. Thus, the efficacy of calpain inhibitors as retarders of cataractogenesis 
probably depends on the permeability of the drug and the nature of the opacification to which 
it is applied. 
Overall, the two Ca2+-induced cataractogenesis models with the calpain inhibitor, SJA6017, 
demonstrated that calpain was involved in the development of opacity in ovine lens. The data 
suggest that the hyper- Ca2+ medium induced opacification lens culture system is a useful 
assessment system for testing the efficacy of novel calpain inhibitors as potential candidates 
for retarding the progression of cataract in in vivo lenses. 
5.3. Experiment 2 Assessment of novel inhibitors in vitro and in vivo 
A study on the structural activity relationships of SJA6017 and its analogues revealed that for 
potent inhibition of calpain, an aromatic group at the P3 position and a bulky amino acid 
residual aldehyde at PI is favoured (Inoue et al., 2003) (Figure 5.6). Calpains were found to 
prefer leucine or valine in the P2 position of small peptide substrates. The reactive aldehyde 
forms a hemithioacetal with the active site cysteine thiol in a Ca2+ dependent manner (Sasaki 
et ai., 1984). P3 is a N-terminal protecting group (Inoue et ai., 2003). Therefore the potential 
exists for the synthetic modification of small peptide aldehyde compounds such as SJA6017 
to produce novel structures with calpain inhibitory activity. 
Figure 5.6 The structure of dipeptide calpain inhibitor, SJA6017 (N-(4-fluorophenylsulfonyl)-L-
valyl-L-Ieucinal). Ph P2 and P3 in grey areas are positions counted from the point of cleavage, and 
represent positions of L-Ieucine, L-valine and N-4-Fluorophenylsulfonyl respectively. 
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Two dipeptide-based compounds, labelled as Cat0059 and 4583, were developed and 
synthesised by the University of Canterbury-Chemistry department. Primary structures of the 
two novel compounds were related to the structure of SJ A60 17, where PI, P2 and P3 positions 
were modified to improve solubility characteristics and inhibitory effect. 
Initially, in vitro assays were conducted by the University of Canterbury Chemistry 
Department. Using BODIPY-fluorescent labelled casein as a substrate for calpain II 
(BODIPY assay) (Jones et al., 1997; Thompson et al., 2000), the two compounds displayed 
effective inhibitory activity to purified calpain II from ovine lungs. Consequently, they are 
potential novel calpain inhibitors. 
5.3.1. Novel calpain inhibitors in an in vitro culture system 
In this experiment, Cat0059 and 4583 were assessed for their efficacy as calpain inhibitors in 
the in vitro culture system, with the subsequent objective of applying the inhibitor to retard 
the progression of cataract in the in vivo cataract inherited ovine model. 
5.3.1.1. Methods 
Lens culture 
Globes were obtained from sheep aged younger than one year old. Pairs of lenses were 
dissected from the globes and immediately placed in the culture system (using EMEM) as 
described in Chapter 3. 
Preparation of treatment solution 
2 M Ca2+ in sterilised dH20 was added to 10 mL culture medium to make a final 
concentration of 5 mM Ca2+. Two calpain inhibitors (Cat0059 and 4583) were also 
solubilized in DMSO. The final concentration ofDMSO in EMEM, after the addition of the 
inhibitor, was less than 0.05%. Adequate amounts ofDMSO was added to the medium 
containing 5 mM Ca2+ so there was no effect attributed by DMSO. 
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Experimental protocol 
After a 48 h pre-incubation period, 3 pairs oflenses were used to assess the inhibitory effect 
of each of the two novel calpain inhibitors at 0.8 11M concentration, against the development 
of the opacification induced by 5 rnM ci+. One of each of the paired lenses, was pre-
incubated with one of the inhibitors in EMEM for 2.5 h, whilst the other was cultured in 
EMEM. Both lenses were subsequently exposed to a final concentration of 5 rnM Ca2+ in 
EMEM, by the addition of 16 ilL of 2 M Ca2+ stock solution in dH20. All lenses were 
incubated at 37°C under 0.5% C02, for either 20 h (Cat0059) or 24 h (4583) experimental 
periods. 
Visual image analysis 
All lenses were monitored at the end of the experimental period. Lens opacity grade was 
scored by an image analysis system that was programmed to grade the extent of opacification 
captured by a digital photo image (refer to Chapter 3, 3.2). 
5.3.1.2. Results 
Two novel inhibitors from first generation (Cat0059) and second generation (4583) 
modification ofSJA60l7 were assessed and compared for their ability to prevent 
opacification due to exposure to 5 mM Ca2+ culture medium solution. The loss of 
transparency was significantly prevented by Cat0059 (P < 0.01) and 4583 (P < 0.005) in a 
paired t-test (Figure 5.7). 
Ca2+ with 4583 Ca2+ with Cat0059 
44.6 ± 1.4 **16.7 ± 5.6 
Figure 5.7. Digital image of ovine lenses and their mean opacification grading scores (± sd) on paired 
ovine lenses after culture in EMEM + 5 mM Ca' + (Ca') and EMEM +5 mM Ca'+ + 0.8 f1M inhibitor 
(Ca2+ with 4583 or Ca2+with Cat0059) for 24 h (4583) or 20 h (Cat0059) experimental periods. 
Number of pairs used for each inhibitor were three (n = 3); Opacification scores represent 100 = Full 
opacity, I = clear and transparent. Paired t-test; *p < 0.005 and **p < 0.01 relative to Ca'+ only treated 
eye. 
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5.3.2. Topical application of novel calpain inhibitors to in vivo cataract model 
The purpose of the experiment was to assess the inhibitory effect of topical administration of 
calpain inhibitor molecules (Cat0059 and 4583) on the progress of cataract formation in the 
inherited in vivo ovine model over 11 weeks. 
5.3.2.1 Methods 
Ethics approvals 
Lincoln University Animal Ethics Protocol-ACE#60. 
Preparation of two eye-drops 
A standard eye-drop formula containing 0.1 % w/v( or I mglmL) inhibitor was prepared for 
Cat0059 and 4583 inhibitors. Each inhibitor was dissolved with 14% ethanol to make final 
3 mM concentration (Cat0059) or 2 mM (4583) in a standard eye-drop solution (RD5721). 
Sterile eye-dropper bottles were used to hold approximately 5 mL of the final eye-drops 
formula per bottle, and stored at 4°C. The volume of each eye drop was approximately 40 ilL. 
Topical drug formulation must be tolerated, chemically and microbiologically stable, and 
readily release the active ingredient (Lee & Robinson, 1986; Piercy, 1985). A standard eye-
drop solution (RD5721), therefore, contains; 0.9% sodium chloride (physicochemical 
parameters similar to those of tears to reduce irritation), 0.3% hydroxypropyl methyl cellulose 
(HPMC-RG-10T) (to increase viscosity of the eye drops so to increase the residence time of 
the formulation in the precomeal space), 0.05% disodium EDTA (for microbiologic 
preservation), 0.01 % benzalkonium chloride (stabiliser) and dH20. 
Pre-treatment test for eye irritation with Cat0059 and 4583 eye-drops 
Each eye drop was tested on a single non-cataract lamb (aged 2.5 months). A single eye-drop 
was applied topically to the right eye of the lambs, and the eye inspected after 3 h. Then eye 
drops were then applied every half an hour for the next 5 h. The lamb's eyes were monitored 
closely by Dr Rob Macfalane (Veterinary) for signs of any irritation. 
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Classification (scoring) Jor in vivo ovine cataract 
Lamb eyes were inspected in a darkened room for cataract formation and severity by 
Veterinary Ophthalmologist, Dr Steve Heap. Eye pupils were dilated with atrophine (I % 
atropine sulphate, Sigma Pharmaceuticals, Australia) and the lenses inspected using a slit 
lamp (Kowa, SUS, Japan) and ophthalmoscope (Vista Diagnostic Instruments, Kellar, UK). 
Slit lamp and ophthalmoscope viewing of a lens is the typical clinical examination performed 
on human patients to allow diagnosis of cataract formation. The standard cataract scoring that 
had been previously developed (Robertson et al., 2005) was used in this trial (Figure 5.8). 
Score Description 
o No opacity seen in the lens 
normal lens 
Small opacity detected at either the 
anterior or osterior suture lines 
2 Small opacities detected at 
both suture lines 
3 Opacification at sutures and 
mild cortical involvement 
4 Moderate to severe cortical 
develo ment 
5 Immature cataract involving 
whole lens 
6 Mature cataract 
Figure 5.8 Progression of the ovine inherited cataract and cataract scoring system developed for the 
inherited ovine cataract using ophthalmoscopy and slit lamp microscopy (adapted from Robertson et 
ai.,2005) 
Selection oJ lambs Jor inhibitor trial treatments 
A number oflambs were bred from three cataract sires (I.D. of37/02, 38/03 and 102/03) and 
a flock of normal-eyed unrelated Coopworth ewes. Lambs born around August and 
September 2004, were housed in grass paddocks containing perennial rye grass and white 
clover at Lincoln University, New Zealand. Eyes of all new lambs were assessed for cataract 
progression and their cataract scorings were recorded on the 16th November 2005 by Dr Steve 
Heap. Sixty five had cataracts and fifty eight had normal eyes. 
99 
· Forty young lambs (2-3 months old) with cataract scores between 1 and 3 were selected. Ten 
control lambs without cataract were also selected. There were two eye-drop treatment groups 
(one group treated with an eye-drop containing Cat0059 and the other treated with an eye-
drop containing 4583). Each eye-drop treatment group consisted of20 cataract lambs and 5 
normal lambs. Each group of lambs had a similar proportion of eyes at various stages of 
cataract with scores between 1 to 3, a similar ratio of sex (ram:ewe of 14: 11) and body weight 
distribution (25.7 ± 4.5 kg and 25.9 ± 6.3 kg). Each eye-drop treatment group of25 lambs 
was marked with different colour paint on the head for identification during eye-drop 
administration. Otherwise, the two treatment groups were run as one flock. 
Protocol for eye-drop treatments 
From 1st December 2004 through to mid-February 2005 (total 11 weeks trial), the flock was 
yarded three times daily. The right eyes of all lambs were treated with a single eye-drop, 
while the left eye had no eye-drop applied as an untreated control. The treatment took less 
than 30 min for both treatment groups. Each treatment group received eye-drops together at 
one time, to prevent any handling errors. 
During the 11 week eye-drop experimental trial period, the cataract progression of 50 lambs 
was assessed three times by Dr Steve Heap at 10, 37 and 67 days after the beginning of the 
treatment. Lenses were visualised through atropine-dilated pupils using a slit lamp and an 
ophthalmoscope and scored on a 0-6 point scale (Figure 5.8). 
Sample collections 
For each eye-drop treatment group, twelve lambs (2 non-cataract and 10 cataract lambs) were 
randomly selected and sacrificed within 12 h after the last eye-drop application at the end of 
11 week trial period. The eye globes were then removed. 
Approximately 500 ilL of aqueous humour was collected by corneal puncture with an insulin 
syringe and stored in Eppendorf tubes. Each cornea was dissected and rinsed with dH20 
several times to remove any remaining eye-drop residues. Lenses were dissected from globes 
using a posterior approach and placed in separate labelled tubes. Small portions of liver and 
muscle tissue from 5 lambs per treatment were collected to test for inhibitors in other parts of 
the animal. All cornea, aqueous humour, lens, muscle and liver samples were weighed and 
frozen at -80°C. 
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· Extraction of calpain inhibitors from dissected samples 
Homogenisation of samples: The corneas was cut from eye globes and ground into powder 
using a hand mortar and pestle under 3-5 mL ofliquid nitrogen, and then transferred into a 
tube with 5 mL of dH20. 400 I1L of aqueous humour per lens was mixed with 1 mL of dH20 
prior to addition of 10 mL of ethyl acetate (CH3COOC2Hs). The cortical region of each lens 
was dissected and homogenised in 1 mL of dH20 with a sonicator (Ultrasonic Processor, Heat 
Systems-Ultra Sonics, INC, N.Y.). Neck muscle samples (9 g) and a sample ofliver (13 g) 
were homogenised with 5 mL of dH20 using a Polytron PT 3100 homogeniser with a 
Polytron PT-DA 30121 2T mm aggregate tip for 20 s at 25,000 rpm speed. 
Extraction: 10 mL of ethyl acetate was added to each homogenate and shaken by hand for 
approximately 30 s. The upper phase was collected into a labelled 50 mL tube and the water 
phase was washed with 10 mL ethyl acetate and shaken as before. The upper phase was added 
into the same 50 mL tube. Each extracted sample in a total volume of 20 mL was 
concentrated to 1.5 mL and filtered through a 0.2 11m PTFF membrane into a 2 mL Eppendorf 
tube. The filtrate was evaporated to dryness in a SpeedVac Concentrator (SAVANT 
Instruments INC, N. Y.). Samples were then resuspended in 100 I1L of ethyl acetate for 
HPLC analysis. 
Determination of UV spectrum of inhibitors 
1 mg/mL of calpain inhibitor (Cat0059 or 4583) were solubilized in 50:50 acetonitrile and 
dH20 solution. 2,4,6 or 10 I1L of the inhibitor solution was mixed with I mL dH20 for 
spectrometer reading. These samples were then scanned between 190 nm and 450 nm 
spectrum with a UV Nis spectrometer (UNICAM, UV -400, England) to identify absorbance 
peaks for the inhibitors. 
Measurement of extracted samples by HPLC (High Performance Liquid Chromatography) 
A series of standard solution of known concentration (0, 2, 10,25,50 and 100 ng/I1L) of 
calpain inhibitor (Cat0059 or 4583) were solubilized in 50% HPLC grade acetonitrile 
(CH3CN) and 50% dH20 (unless otherwise stated) solution at room temperature. The 
concentrated sample was filtered through a PTFF membrane with 0.2 11m pore size (BioLab). 
Calibration curves were prepared by injecting the series of different concentrations in 5 I1L of 
standard, including a solvent blank run (50:50 of acetonitrile:dH20). 5 I1L of each filtered 
sample was analysed immediately after the standard solutions. 
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All injection samples were separated by a Proteo (C12) Reverse Phase Column ( Jupiter™ 4Jl 
Proteo 90A, size: 250 x 4.6 mm, with pore size 90A, Phenomenex, Part No. 00G-4396-EO), 
at 40°C. Flow rate was maintained at 1 mUmin. Two mobile phase solvents used for 
separation were filtered 0.2% Trifluoroacetic acid (TFA, C2HF02) in dH20 (PH = 1.8) and 
HPLC grade acetonitrile. Absorbance (AU) of standard (y-axis) was plotted against known 
amount (ng) (x-axis). 
5.3.2.2. Results 
Pre-treatment test for eye irritation with two inhibitor eye-drops 
After 8 hours, no irritation was observed in the treated eye. 
Observation of cataract progression in lambs treated with inhibitors 
The cataract scores for two eye-drop treatment groups were taken two weeks before the start 
of the trial (t = -14) and three times (t = 10,37,67 days) during the total 77 days (11 weeks) 
treatment period. The mean scores of each reading for each eye-drop treatment group are 
illustrated in Figure 5.9. Cataract scores for the Cat0059-treated eyes were the same as the 
untreated eyes over the 37 day treatment period. At the 67 day treatment period, the eyes 
treated with Cat0059 showed a higher cataract score than the untreated eyes (P < 0.05). 
Throughout the 67 day eye-drops application period, the cataract scores from 4583-treated 
eyes were not significantly different from the untreated eyes. 
(A) Cat0059-treated lambs 
6.---------------------------. 
iii Un-treated eye 
5 --------. o Treated eye 
____________________________ b __ 
o 
-14 10 37 67 
Treatment duration (t) 
(B) 4583-treated lambs 
-14 
iii Untreated eye - - - - - - - - - -
o Treated eye a J! _ 
10 37 67 
Treatment duration (t) 
Figure 5.9. A plot of mean scores for two inhibitors untreated eyes and treated eyes 
with calpain inhibitor (Cat0059 (A) or 4583 (B» during 67 days. Different italicised letters within 
examined day indicates significant difference (Paired T-test, P< 0.05). n = 20 lamb per inhibitor. 
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Observation of untreated eyes over the 67 day period 
The rate of cataract fonnation was analysed using the mean cataract scores of the untreated 
eyes of cataract lambs over the 67 day period (Figure 5.10). 
Under the current cataract scoring system (Figure 5.8), the cataract progression of untreated 
lambs eyes with the initial cataract scores of 1 (stage 1) or 2 (stage 2) developed linearly over 
the 2 month period. The average score advanced by 1 score per month. In comparison, the 
progression of cataracts in the lambs with an initial cataract score of 3 (stage 3) advanced by 
1.5 score in the first month, then remained with an unchanged average score in the second 
month. 
Progress of cataract of untreated eyes from 3 initial 
cataract stages (1, 2 and 3) 
a -----------------------------------------
o +------------------,-----------------, 
o 37 67 
Time (days) 
Initial stages 
-A-stage 3 
-ll-stage 2 
~stage 1 
Figure 5.10 A plot of mean cataract scores for untreated eyes over 67 days. Different letters within a group 
started with same initial cataract score indicates significant difference in mean cataract score between 
different days (Paired t-test, P < 0.05). Stage 1 (n = 14), stage 2 (n =13) and stage 3 (n = 8). 
HPLC protocol for Cat0059 
UV spectrum scanning of serial solutions of Cat0059 in acetonitrile revealed a strong 
absorbance at 300 nrn, with minor ones at 190 nrn and 220 nrn (Figure 5.11). 
With the gradient method (40°C column temperature, mobile phase solvents of acetonitrile: 
0.2% TFA in dH20), the HPLC chromatograph at 300 nrn showed a sharp peak with a bell-
shape (1-2 min broad) at ~18.4 min elution time (Figure 5.12). Cat0059 was eluted from the 
HPLC column with a gradient of 50% acetonitrile and 50% dH20 with 0.2% TF A over 
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a 25 min separation phase. Analysis of the UV spectrum of the peak confinned it was 
Cat0059. The peak was collected and confinned as Cat0059 by mass spectrometry. 
Minimum detection of Cat0059 was 3 11M (or 5 ng of Cat0059 in 5 ilL HPLC column 
injection volume). 
0.55 
0.50 
0.45 6 Ilg/mL 
0.40 
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(oJ 
0.30 ::I 
~ 0.25 ~ 
'"' Q 0.20 III 
~ 0.15 < 0.10 
0.05 
0.00 
-0.05 
150 200 250 300 350 400 
Wavelength (nm) 
Figure 5.11 UV spectrum of 2,4 and 61lg/mL Cat0059. The strongest peak was absorbed at 
around 300 nm. 
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Figure 5.12 Chromatogram ofCat0059 (50 ng in 5 ILL injection) at 300 nm UV detection with 
gradient methods used during development for separation and quantitation ofCat0059. The mobile 
phase was run as a gradient with 0.2% TFA in water. 5% (0-25 min), 100% (26-31 min) and 5% 
(35.5-40 min) acetonitrile (CH3CN) (showed as a broken line). 
Detection ofCat0059 in samples 
The presence of Cat0059 was measured in cataractous lambs by HPLC. It was not detected in 
either the treated or non-treated eyes including the cornea, aqueous humour or cortical region. 
HPLC did not detect any Cat0059 in liver or muscle samples from the same lambs. 
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HPLC protocol for 4583 
The UV spectrum scanning of serial solutions of 4583 in acetonitrile revealed a strong 
absorbance at 195 nm and with a minor one at 329 nm. With the gradient method (40°C 
column temperature, mobile phase solvents of acetonitrile: 0.2% TF A in dH20), the HPLC 
chromatograph at 329 nm showed a sharp peak with a bell-shape (1-2 min broad) 
at ~32 min elution time (Figure 5.14). 4583 was eluted from the HPLC column with a 
gradient of75% acetonitrile and 25% dH20 with 0.2% TFA over a 40 min separation phase. 
Analysis of the UV spectrum of the peak confirmed it was 4583. The peak was collected and 
confirmed as 4583 by mass spectrometry. The minimum detection of 4583 was 
approximately 6.4 p,M (or 15 ng of 4583 in 5 p,L HPLC column injection volume). 
0.6 Absorbance ___ _ 
0.5 
0.4 
~ 
CJ 
= 0.3 C'lS 
,.Q 
'"' 0 0.2 
"-' 
,.Q 
< 0.1 
0.0 -
150 200 250 300 350 400 
Wavelength (nm) 
Figure 5.13 UV spectrum scanning results of 2, 4, 6 and 10 flg/mL 4583. There were two major 
absorbance at 195 nm and 329 nm by 4583 (indicated by arrows). 
Detection of 4583 in samples 
The presence of 4583 was measured by HPLC in cataractous lambs. It was not detected in the 
treated or non-treated eyes including the cornea, aqueous humour or cortical region. 
There was a trace amount of 4583 detected in the liver samples collected from 4583-treated 
lambs. Using the 4583 standard curve, the average concentration was 0.05 nM 4583 in the 
liver of treated lambs (or 22.8 ng of 4583 in 1 g wet liver sample present). HPLC of muscle 
samples from the same lambs did not detect 4583. 
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Figure 5.14. Gradient methods used during development for separation and quantitation of 4583. 
Chromatogram of (5 ng in 5 ilL injection) 4583 in ethyl acetate at 329 nm UV detection. The mobile 
phase was run as a gradient with 0.2 % TFA in water. 5% (0-40 min), 100% (42-47 min) and 5% (49-
55 min) acetonitrile (CH3CN) (showed as a broken line). 
5.3.3. Discussion 
Two novel calpain inhibitors were able to decrease the opacification of lenses cultured in 
hyper-Ca2+ (5 mM) culture medium. These two inhibitors were fonnulated and used to treat 
one eye of lambs with inherited cataracts, in the fonn of eye-drop applications that were 
applied three time daily. Unfortunately, there was no evidence that either inhibitor slowed or 
cataract development between the treated and untreated eyes of the lambs during the 67 days 
treatment period. Neither inhibitor was detected in any part of the cornea, aqueous humour or 
the lens. These compounds therefore appear to be unable to reach the lens using the current 
eye-drop application treatment and procedure protocols. 
In recent studies on the topical administration of SJ A60 17, the molecule exhibited some 
inhibitory effects on inherited cataracts in ovine lenses (Robertson, 2003; Robertson et al., 
2005) as an eye-drop application (0.5% of SJA6017 or 15 mM SJA6017) in a phannaceutical 
ophthalmic liposome preparation (supplied by Senju Pharmaceutical Co Ltd, Kobe, Japan). 
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This was 5 times the concentration that could be achieved in the current experiment (0.1 % of 
the novel calpain inhibitor, or 3 mM Cat0059 / 2mM 4583). The liposome based eye-drop 
protocol increases the solubilisation of lipophilic molecules by emulsifying or encapsulating 
lipophilic molecules in liposomes (artificial microscopic vesicles consisting of an aqueous 
core enclosed in one or more phospholipid layers). The high drug concentration ensures there 
is a high gradient across the cornea and, consequently, a high diffusion rate (Havener, 1983; 
Lee & Robinson, 1986). In fact, only compounds dissolved in solution are able to penneate 
barriers (van De Waterbeemd et aI., 2001). The conclusion is that compounds need to have a 
high solubility within an eye-drop solution. 
SJA6017 has subsequently been modified to improve its physiochemical properties, such as 
increasing its water solubility and transcorneal penneability (Nakamura et at., 2003). Such 
molecules with a high trans-corneal penneability, as judged by topical administration to the 
eye of rabbits, significantly retarded Ca2+ -induced opacification in the rodent in vitro model. 
The present data showed that in early stage cataracts with scores of 1 or 2, the development of 
cataracts progressed linearly over the trial period (Figure 5.10). Cataracts with scores of 1 or 
2 are categorised by having a small opacity in the suture lines (Figure 5.8). In contrast, 
cataracts with a score of 3 show signs of mild cortical opacity. The pattern of the cataract 
progression demonstrates that the development of mature cataracts is accelerated once the 
cataract starts to involve the cortical regions of the lens. As observed in the culture 
experiments, which compared the inhibitory effect ofSJA6017 between the OLCO and the 
hyper-Ca2+ medium induced models, the calpain inhibitor was less effective once the 
opacification had progressed beyond the initial stage. 
It is therefore possible that the selection of lambs with inheritable cataract gene before 
cataract development could increases the chance ofthe calpain inhibitors being more effective 
at preventing cataract development, i.e. applying an inhibitor at pre-cataract stage may be the 
most efficient way of preventing the progress of cataract development. 
Drugs can interact with proteins in ocular fluids. This can vary between individuals and 
species and also depend on pathological conditions. Cataractogenesis is characterised by the 
loss of lens proteins into the aqueous humour (Duncan et at., 1994). The protein interaction 
can result in the inactivation and elimination of the drug from the aqueous humour. An 
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, apparent lack of an effect from a medical therapy view point may be the result of such 
interactions as illustrated by the release of proteins into the aqueous humour (Mikkelson et 
at., 1973). This could be a contributing factor which lowers the bioavailability of the calpain 
inhibitors to the lens. 
The calpain inhibitors, Cat0059 and 4583, were dissolved in 14 % ethanol and then 
formulated into an aqueous ophthalmic eye-drop solution. The use of ethanol made the eye-
drop less viscous and reduced the retention time of the eye drops on the surface of the eye. It 
is, however, unknown whether novel calpain inhibitors are metabolised by the lens or how 
quickly the compound is actually cleared from the lens. 
Future calpain inhibitors will require better penetration properties, higher water solubilities 
and lower IC50 level to increase their inhibitory effect through topical administration. The 
alternative would be a higher frequency dosing regime, which is an unrealistic treatment 
option to prevent cataracts in animals or humans. 
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Chapter 6: Drug Profile of the Novel Calpain Inhibitor, Cat0059 
6.1. Introduction 
For a therapeutic agent to be potent, the delivery of a drug to its target site and its 
bioavailability within the target site are two important factors. Topical drug delivery is the 
most common treatment for diseases of the anterior segment of the eye, such as glaucoma 
(reviewed by Schoenwald, 2003). Pharmacokinetics is the process by which a drug is 
absorbed, distributed, metabolized, and eliminated by the body. The relevant compartments 
for pharmacokinetics of ocularly applied drugs are the tear fluid, multilayered cornea, 
aqueous humour, lens, vitreous humour and plasma. The cornea has a lipophilic cell layer on 
the surface and hydrophilic structure in core layers, whilst the aqueous humour and tears are 
aqueous environments. As a consequence, a desirable topical drug must have both lipophilic 
and hydrophilic portions for optimal penetration into the eye. 
The principle route of drug entry into the eye is through the cornea (Ahmed & Patton, 1985; 
Lee & Robinson, 1986; Piercy, 1985; Wang et at., 1991). The cornea is the transparent 
anterior outer covering of the eye and is continuous with the sclera. It consists of three main 
barriers in series: the epithelium, the stroma, and the endothelium. The corneal epithelium and 
endothelium are cellular layers that contain both trans cellular and paracellular pathways for 
transport (reviewed in Havener, 1983); lipophilic molecules preferentially diffuse within cells, 
whereas hydrophilic molecules permeate mostly through the openings between cells. Ninety 
percent of the thickness ofthe cornea consists ofthe corneal stroma, which is a highly 
hydrated fibrous acellular tissue (reviewed in Berman, 1991). The corneal epithelium 
contributes the most effective barrier for drug penetration in the cornea. The corneal 
epithelium has annular tight cellular junctions, which completely surround and effectively 
seal the superficial epithelial cells. As a consequence, it is largely impenetrable to non-
lipophilic agents (Boot et at., 1991; Burstein, 1985; De Kruijf et at., 1987; McDermott et at., 
1990). Then the drug faces a hydrophilic corneal stroma layer to pass through to meet the 
second cellular layer of the cornea, the endothelium, before reaching the aqueous humour. 
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Interaction with proteins in ocular tissues can also markedly influence the pharmacokinetic 
profile of a drug, as binding to proteins can reduce the bioavailability of the drug and result in 
inactivation (Burstein, 1985). Aqueous humour is located in the space in front of the lens and 
behind the cornea (Figure 1.1 in Chapter 1). Aqueous humour has a very low protein content. 
Its protein content needs to be less than 1 % of that found in plasma in order to maintain 
optical clarity and to contribute to minimum light scattering (Davson, 1990). The aqueous 
humour is continuously replaced with material produced through the ciliary body, which 
flows into the anterior chamber and then out through a drainage canal, called the Canal of 
Schlemm. The turnover of aqueous humour production material within the eyeball is 
2.23%/min in the rat (Mermoud et at., 1996) and 2.5%/min in the mouse (Aihara et at., 2003). 
As a consequence, drug elimination by the aqueous humour is a major factor limiting the 
penetration of the drug into the lens. The lens contains the regular arrangement of the lens 
fiber cells with a minimal extracellular space. The highly differentiated fiber cell structure is 
filled with a high concentration of soluble proteins, crystallins. This high concentration of 
soluble lens proteins and the cell membrane structure of the lens can significantly influence 
the pharmacokinetic profile of a drug. 
Several models predict the absorption, distribution, and elimination of drugs in the eye. Some 
ofthese models are very complex and detailed (Friedrich et at., 1993; Grass & Lee, 1993; 
McLaren et at., 1993). Because of the complexity of the eye, however, the only true predictor 
of drug levels in the eye is experimental information. Cat0059 is a potent calpain inhibitor 
(ICso value against calpain II is 30 nM) with improved water solubility characteristics. 
Despite its effectiveness in preventing opacity in the in vitro studies (Chapter 5, 5.3.1.2), 
topical administration ofthe molecule in an in vivo animal model revealed there was no trace 
ofCat0059 in the lens using current techniques (5.3.2.2). As a part of further investigation 
into the drug profile of Cat0059 in a biological system, the current chapter is designed to 
explore the pharmacokinetics of the calpain inhibitor, Cat0059, in ocular tissues and 
compartments within the lens. 
The studies were composed of four experiments. First, the permeability of the drug through 
the first barrier of the eye, the cornea, was determined by measuring the concentration of the 
drug in the aqueous humour after application of the drug to the cornea. 
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Second, the lens penneability of CatO059 was examined using an in vitro culture system. The 
potential cytotoxicity of CatO059 and its stability within the lens culture environment were 
also investigated. 
Third, the binding factors of the drug in the aqueous humour and lens homogenates were 
evaluated. The result of this test should indicate the amount of unbound drug which is 
available to target compounds within the cell. Detection methods for uptake of the drug were 
also evaluated in this experiment. 
Direct injection of a molecule into the eye globe by-passes the barriers of the eye and 
enhances intraocular drug concentration. Thus the technique allows a high concentration of a 
drug to be rapidly reached in intraocular tissues. Intravitreal injections have been used to 
deliver antiviral agents (Baeyens et al., 1997). Water-soluble agents in the vitreous body 
diffuse through the gel-like material and ultimately reach the retina. There may be some 
leaking of the agents into the aqueous humour from where the agents can be taken up by the 
lens. In a final experiment, intravitreal injection of CatO059 was used as an alternative 
method of delivering the drug into the aqueous humour and to the lens. This final experiment 
was designed to investigate the extent that other factors are operating when there is a local 
ocular injection of a drug. 
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6.2. Experiment 1: Corneal permeability of Cat0059 
The purpose of the experiment was to evaluate how much Cat0059 could get through the 
cornea and into the aqueous humour. The trans-corneal permeability of Cat0059 was 
investigated by using an intact ovine globe in constant contact with an eye-drop solution 
containing 3 mM Cat0059 (0.1 % eye-drop solution). 
6.2.1 Methods 
Eyeball preparation 
Eye globes were removed from the eye sockets of young sheep (5 - 8 months old), 
immediately after sacrifice. Within 2 h they were placed in a 50 mL test tube. The diameter 
of the test tube was such that the eye globe fitted snugly within the walls. The anterior 
portion of the eye globe (cornea) was positioned upwards within the tube. Approximately 6 
mL of Cat0059 eye-drop solution (3 mM Cat0059) was added to the test tube containing the 
eye globe, thus submerging the entire cornea. Due to the tight fit of the eye globe within the 
tube, solution only remained in contact with the anterior portion of the eye globe (i.e. entire 
surface of the cornea and small portion of sclera). Hence, the posterior portion ofthe eye 
globe did not come in contact with the Cat0059 solution during the experimental period. 
Experimental protocol 
A total of7 ovine eye globes were set in individual 50 mL test tubes, and the cornea region of 
the eye globe faced uppermost. Five globes were submerged in eye-formula with active 
compound, Cat0059, for 1 h (n = 1),2 h (n = 2) or 24 h (n = 2) incubation periods. The 
remaining eye globes were left in contact with eye-formula solution which contained no 
Cat0059 compound. This was the control group. 
At the end of each incubation period, the eye-formula was discarded and the surface of globe 
was rinsed with dH20 several times. After rinsing, 400 p,L of aqueous humour was harvested 
from each eye globe using a 500 p,L sterilised syringe (Temmo@ Syringe, Temmo Co., 
Philippines). The cornea and iris were then dissected and rinsed with dH20 and weighed 
prior to storage in a tube. Finally, the lenses were harvested and rinsed with dH20 and the 
cortical region of the lens (including capsule, epithelium and outer fiber cells) were collected 
and weighed. 
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Preparation of samples for HPLC analysis 
Aqueous humour was vortexed in 2 mL dH20. Lens samples were sonicated in 2mL dH20. 
Corneal samples were cut into smaller pieces and ground into a powder using a hand mortar 
and pestle under 3-5 mL of liquid nitrogen. The powdered cornea was then transferred into a 
tube containing 2 mL dH20. The homogenisation of the iris followed the same procedure as 
the cornea. The extraction ofhomogenates followed the procedure described in Chapter 5 
(5.3.2.1.). The final, concentrated extract volume was 100 p,L per sample. 10 p,L of the 
extract volume was used for each HPLC analysis. 
A standard series of known amounts ofCat0059 (0,50, 125,250,500 and 1500 ng) in 100% 
ethyl acetate was injected at the same time as the samples (HPLC protocol for Cat0059 refer 
to 5.3.2.2. in Chapter 5). 
6.2.2. Results 
Measurement ofCat0059 presence in lens with HPLC 
The detection and separation ofCat0059 was satisfactory in the 0 and 1500 ng range. The 
correlation with the HPLC Peak Area is shown in Figure 6.1(R2 = 0.99). The separation of 
Cat0059 by HPLC was a reliable technique and has the ability to quantitate up to 1500 ng in 
5 p,L injection volume. 
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Figure 6.1 Standard curve ofCat0059 (n = 4) 
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Detection of unbound Cat0059 from the extracted samples by HPLC 
After the first hour of incubating with corneal region with the eye-drop solution containing 
3 mM Cat0059, 300 nM Cat0059 was detected in the aqueous humour. Thus, about 0.01 % of 
the Cat0059 penetrated to the aqueous humour through the cornea (Table 6.1.). 
After a 2 h incubation period with the eye globe in contact with the Cat0059 solution, there 
was approximately a 120 fold increase of the Cat0059 in the aqueous humour compared to the 
1 h incubation period. However, no Cat0059 was detected in the cortical region of the lens 
after the 1 h or 2 h incubation periods. After a 24 h incubation period, 100 11M Cat0059 was 
detected in the aqueous humour and approximately 0.3 11M Cat0059 in the lens. The latter is 
about 0.3% of the concentration ofCat0059 in the aqueous humour. 
The amount of Cat0059 that penetrated into the different parts of the eye globe was calculated 
after the 2 h incubation period. The total amount of Cat0059 deposited in the three regions of 
the eye: cornea, aqueous humour and iris was approximately 36 Ilg. 
The distribution was 83% in the cornea, 16.5% in the aqueous humour and 0.5% in the iris. 
These figures indicate that most of the Cat0059 was trapped within the corneal region and 
only 17% entered the intraocular environment. 
Table 6.1 Measurement of Cat0059 concentration by HPLC after the cornea of the ovine globe was in 
contact with 3 mM Cat0059 eye-drop formula, for three different periods. (-): results not available. 
*Concentration was calculated in 500 f.tL aqueous humour. #Concentration was calculated in 0.5 g 
cortical region of the lens. Average wet weight used for extraction of cornea =0.4 g and 
iris = 0.35 g. Number of globes used in 1 h, 2 hand 3 h incubation were 1,2 and 2 respectively. 
Concentration of Cat0059 detected in samples after treatment 
Incubation time 1h 2h 24h 
Cornea - 75 Ilg /g -
Aqueous Humour 0.09 Ilg /mL 121lg/mL 361lg/mL 
*0.3 11M *361J,M *100 IJ,M 
Iris - 0.57 1lg/g -
Lens Not detected Not detected O.lllg/g 
#0.3 11M 
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6.3. Experiment 2: Cat0059 in a lens culture system 
The purpose of this experiment was to examine the cytotoxicity ofCat0059 to the lens and to 
assess the permeability of the lens to Cat0059. This experiment mimics the eye-drop 
treatment previously described in the in vivo trials (Chapter 5). The same amount of Cat0059 
(40 I1g) in a single eye-drop solution was directly added to the culture media for a period of 
time. The intact lenses were then exposed to a hyper-Ca2+ solution containing Cat0059 to 
evaluate the efficacy of Cat0059 in preventing opacity . 
6.3.1 Methods 
Lens culture 
Several pairs of eye globes from the same breed (9 - 11 months old) were removed 
immediately after the animals were slaughtered. Lenses were dissected within 2 h of death 
using the posterior approach. All dissected lenses were kept in pairs. A group of lenses 
(Group A) were cultured in AAH (refer to Chapter 3,3.2). Another group of lenses (Group 
B) were cultured in EMEM. The medium was replaced after the first 24 h incubation. 
Preparation of treatment solution 
Cat0059 was synthesised by the University of Canterbury-Chemistry Department and was 
solubilised in DMSO. The final concentration ofDMSO in the culture medium, after addition 
of the inhibitor, was less than 0.05% v/v in both the control and treated groups. For the 
experimental period, adequate volume ofDMSO was also added to a set of lenses (control 
groups) incubated in culture medium, AAH and EMEM, so that DMSO does not attribute to 
inhibitory effect on the lens. 
Experimental Protocol 
After the I h pre-incubation period (Group A), 8 lenses (one lens from each pair) were 
cultured in AAH containing DMSO (as the control group). 8 lenses (the other lens from each 
pair) were cultured in AAH containing 10 11M Cat0059 (40 I1g Cat0059 in 10mL AAH per 
lens). 4 pairs of lenses were cultured for 100 min using the same protocol. This time was 
based on the estimated time for a complete change of the aqueous humour in human eyes (Lee 
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& Robinson, 1986). The remaining lenses were cultured for 5.5 h using the same protocol, to 
maximise the chances of Cat0059 penetrating the lens. 
After the 48 h pre-incubation period (Group B), 3 lenses (one lens from each pair) were 
cultured in EMEM containing DMSO (as the control group). The remaining 3 lenses were 
pre-incubated with 10 ILM Cat0059 in 0.03 % v/v DMSO for 2 h. After this period 2 M Ca2+ 
in ciH20 was added to each of the 6 lenses to make the final concentration 5 roM Ca
2
+. All 
lenses were then cultured for 44 h. 
Cytotoxicity ofCat0059,' LDH Leakage Assay 
At the end of the 100 min and 5.5 h incubation periods (Group A), 5 ml of AAH medium 
from each lens was collected and concentrated to 2 mL with a SpeedVac concentrator. These 
samples were assayed for LDH leakage (3.2, in Chapter 3). 
Stability ofCat0059 in the culture condition 
The stability of Cat0059 in culture media was determined by measuring the amount of 
Cat0059 remaining in the culture medium after each incubation period (Group A). At the end 
of the 100 min and the 5.5 h experimental period (Group A), 5 mL of AAH from each lens 
was collected and concentrated to 2 mL with a SpeedVac concentrator. Cat0059 from the 
sample was extracted in 100 ILL ethyl acetate (the extraction procedure refers to 5.3.2.1 in 
Chapter 5). 
Uptake ofCat0059 in the lens 
At the end of each experimental period (Group A), all the lenses were harvested and rinsed 
with water. Epithelium, cortex and nucleus fractions ofthe lenses were dissected and 
weighed. Each fraction of the lens was homogenised in 1.5 mL of dH20 by sonication. 
Cat0059 from samples was extracted in 100 ILL ethyl acetate (for the extraction procedure 
please refer to Chapter 5). All the extracted fractions from each incubation group (100 min or 
5.5 h) were pooled and further concentrated to 100 ILL. 
At the end of the 44 h experimental period (Group B), the 6 lenses were harvested and rinsed 
with water. Epithelium and cortex fractions ofthe lenses were dissected, homogenised and 
extracted (Chapter 5,5.3.2.1). For further concentration ofCat0059, three-parts-volume from 
each extracted lens sample were pooled and concentrated to 100 ILL. 
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Measurement afthe Cat0059 by HPLC 
10 ilL of extracted samples was injected into an HPLC column for separation and 
quantification of the amount of Cat0059 in the lens (refer to Cat0059 HPLC protocol, Chapter 
5,5.3.2.2). A series of known amounts ofCat0059 (0 - 250 ng) in ethyl acetate were put 
through the HPLC as a standard curve at the same time as the samples. 
6.3.2 Results 
Measurement afCat0059 in the lens by HPLC 
There was no detectable Cat0059 in the lenses incubated for 100 min or 5.5 h. 
LDH leakage during experiment 
Over the 5.5 h of incubation, LDH leakage levels steadily increased (P < 0.05) in both the 
control and Cat0059 treated groups. The level of LDH leakage between the control and 
Cat0059 treated lenses in pairs was not significantly different. This indicates there is no sign 
of cytotoxicity caused by the Cat0059 treatment during the 5.5 h incubation in the culture 
system. 
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Figure 6.2 A plot of mean LDH leakages released (± sd) from ovine lenses (in pairs) during culturing 
in AAH + 10 JlM Cat0059 (Cat0059, capital letter) and AAH (Control, lower case letter) for 5.5 h. 
Different letters indicate significant differences by Paired t-test (P < 0.05). 8 pairs oflens were 
analysed at 100 min, while 4 pairs oflens were analysed at 5.5 h. 
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Stability of Cat0059 in the culture condition 
The total amount of Cat0059 remaining in the medium after the period of incubation showed 
that the different incubation periods did not affect the availability of Cat0059 (Table 6.2). 
Table 6.2 Estimated amount ofCat0059 (± sd) remaining in the culture medium (10 mL) at the end of 
each 100 min and 5.5 h incubation period. Two-sample t-test (n = 4). 
Initial Cat0059 (Ilg) in 10 mL 36.8 36.8 
Lens culture duration after 100 min after 5.5 h 
Remaining CatOOS9 (Ilg) 2S.l ± S.S 26.1 ± 7.0 
Lens Transparency and uptake ofCat0059 in 44 h incubation 
For the 44 h incubation treatment with CatOOS9 in hyper-Ca2+ conditions, opacification was 
prevented in the lenses incubated with 10 IlM ofCatOOS9. 
Despite the visual improvement in lens clarity ofthe CatOOS9 treated lenses, HPLC analysis 
failed to detect any CatOOS9 in either the epithelium or cortical regions of the lens. Analysis 
of pooled and concentrated samples confirmed that CatOOS9 was undetectable by HPLC. 
Treatment Control CaH CaH +CatOO59 
Score 22.2 ± 1.8 45.1 ± 2.9 *27.9 ± 5.5 
Figure 6.3 Digital images and mean opacification scores (n = 3, ± sd) of on ovine lenses after 
culture in EMEM (Control), EMEM + 5 mM Ca2+ (Ca2+ only) and EMEM + 5 mM Ca2+ + 10 11M 
Cat0059 (Ca2+ +CatO059) for 44 h. Opacification scores: 100 = FuJI opacity and 1 = 
clear/transparent lenses. *Paired t-test relative to Ca2+ only lenses (P < 0.003). 
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6.4. Experiment 3: Bioavailability of Cat0059 in an ocular environment. 
The purpose of this experiment was to assess the bioavailability ofCat0059 in two biological 
intraocular environments, the aqueous humour and the lens homogenate. 
A standard protein binding assay for the compound was used to assess the interaction between 
Cat0059 and intraocular compartments (Inoue et al., 2003). 
6.4.1 Methods 
Aqueous humour and lens homogenate sample preparation 
Aqueous humour was collected from 4 normal lamb eye globes within 3 h of sacrifice. 600 
flL aqueous humour from each eye was pooled (2400 flL) to eliminate any variation between 
the individuals. For lens homogenates, six eye globes from the same breed of sheep (9-11 
months old) were collected immediately after sacrifice and dissected within 2 h. Epithelium 
and cortex fractions ofthe 6 lenses were dissected and weighed separately prior to being 
placed in separate labelled tubes. Two homogenisation buffers were used in this study: dH20 
or dH20 with ImM EGTA. Dissected samples from the first 3 lenses were homogenised with 
equal volumes of dH20 (w/v) by sonication. Aliquots ofthese homogenates were diluted 
with dH20 to a final dilution of 1 :6. The three diluted homogenates were then pooled 
together. Dissected samples from the other 3 lenses were homogenised with equal volume of 
dH20 containing ImM EGTA (w/v), by sonication. Aliquots of these homogenates were also 
diluted with dH20 containing 1 mM EGTA for a final dilution of 1:6. The three diluted 
homogenates were then pooled together. The protein concentrations ofthe pooled aqueous 
humour and pooled lens homogenates were measured by the BCA protein assay using bovine 
serum albumin as a standard (refer to 4.2.1, Chapter 4). 
Experimental protocol for Cat0059 binding factors 
To test for the presence of the aqueous humour binding factors for Cat0059, three aliquots of 
300 flL pooled aqueous humour were placed into each of three microcentrifuge tubes and 20 
flL of 0.15 mM Cat0059 in 50% acentonitrile/dH20 solution was added to each tube to make 
a final concentration of 10 flM Cat0059. Another three aliquots of300 flL pooled aqueous 
humours was placed into each of three micro centrifuge tubes and 20 flL of 1.5 mM Cat0059 
in 50% CH3CN/dH20 solution was added to each tube to make a final concentration of 
100 flM Cat0059. 
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To detennine the lens homogenate binding factor, aliquots of pooled lens homogenate 
samples (300 ILL) were fortified with 20 ILL of the 0.15 mM or 1.5 mM Cat0059 (10 ILM or 
100 ILM respectively) solution and vortex mixed, as described previously. All 
microcentrifuge tubes were vortex mixed and incubated in an incubator at approximately 
37°C for 20 min. 
Centrifugal ultrafiltration 
After 20 min incubation, the entire contents of the incubates were transferred separately into a 
Microcon ® YM -10, Centrifuge Filtering Device (1 O,OOODa Mw cut-oft) for centrifugal 
ultrafiltration. The samples were centrifuged at 14,000 g for 40 min until the volume of 
retentate (the upper portion ofthe filtering device, containing compounds larger than Mw 
10,000 Da) was reduced to approximately 5 ILL. The filtrate was then transferred to labelled 
HPLC vials for the HPLC. 
Non-specific binding of Cat0059 to centrifugal ultrafiltration apparatus 
The recovery of Cat0059 through the centrifugal filtration procedure was measured. Three 
aliquots of O.IM phosphate buffer saline (300 ILL, 1 x PBS, pH 7.4) were placed into each of 
three microcentrifuge tubes and 20 ILL of 0.15 mM Cat0059 solution was added to each tube 
to make the final concentration of 10 ILM Cat0059. Another three aliquots ofO.lM PBS 
(300 ILL) was placed into each of three micro centrifuge tubes and 20 ILL of 1.5 mM Cat0059 
solution was added to each tube to make the final concentration of 100 ILM Cat0059. All 
microcentrifuge tubes were vortex mixed and incubated in an incubator at approximately 
37°C for 20 min, prior to the centrifugal ultrafiltration procedure. The resulting filtrate was 
analysed by the HPLC to detennine the percent of non-specific binding of Cat0059 to the 
centrifugal filtration apparatus. 
Evaluation of extraction procedure by the HPLC 
The aqueous humour was collected from an eye globe, immediately after sacrifice. Aliquots 
of 200 ILL aqueous humour were fortified with two different amounts of Cat0059 in 50:50 
acentonitrile/dH20, vortex mixed and incubated for 1 hat RT. These two samples were 
subjected to the extraction procedure (5.3.2.1 in Chapter 5) and concentrated to 100 ttL. The 
retentate and pellet fractions of the lens homogenate after the centrifugal ultrafiltration were 
also collected. These fractions were subjected to the extraction procedure (5.3.2.1 in Chapter 
5) and concentrated to 200 ttL. 10 ILL was analysed by HPLC for the measurement of 
Cat0059. 
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Measurement ofCat0059 by HPLC analysis 
The amount of Cat0059 present in samples was quantitated by the HPLC (Cat0059 HPLC 
protocol, 5.3.2.2, Chapter 5). A series of known amounts (0 - 500 ng) ofCat0059 in 
acetonitrile/dH20 was run through the HPLC column as standards. 
6.4.2 Results 
Protein content 
The average total protein content in sheep aqueous humour was 1.42 ± 0.67 mglmL (n = 4). 
Since the variation was large between aqueous samples, 4 aqueous humours were pooled to 
give a protein concentration of 1.25 mglmL. Lens homogenates of pooled epithelium and 
cortex fractions of the lens (n = 6) contained 45 mglmL total protein content. Therefore, there 
was 270 mg/mL of total protein content in the cortical region of the lens (the homogenates 
were diluted by 1/6). 
Bindingfactor ofCat0059 with aqueous humour 
Non-specific binding of Cat0059 to the centrifugal filtering apparatus was 6.1 ± 0.3% (n = 6). 
The final binding factor of Cat0059 (Table 6.3) was then estimated by subtracting the non-
specific binding factor from the aqueous humour binding factor. The results ofthe final 
binding factor were that 0.5% and 14% of 10 p,M and 100 p,M Cat0059 respectively were 
bound by substances within the aqueous humour. These results indicated that around 86-99% 
of the given concentration ofCat0059 remained unbound in the aqueous humour. 
Table 6.3 Portion (%) of Cat0059 (± sd) bound to pooled ovine aqueous humour containing 
1.25 mg/mL protein. 
Concentration of spiked Cat0059 (p,M) Percentage of bound Cat0059 with 
ovine aqueous humour 
10 0.5 ± 0.01 
100 14.3 ±1.1* 
* Two sample t-test mdIcates sIgmficant dIfference between 10 p,M and 100 IlM WIth P <0.005 (n=3). 
Bindingfactor ofCat0059 with lens homogenates 
After 300 p,L of individual lens homogenates were incubated with 10 p,M Cat0059, no 
Cat0059 was detected. Therefore all extracted samples were pooled and further concentrated 
to increase the sensitivity of the HPLC method. The final binding factor of Cat0059 (Table 
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6.4) was also estimated by subtracting the non-specific binding factor (6.1 ± 0.3%) from the 
lens homogenate binding factor. 
The results show that 10-100 p.M Cat0059 had an estimated binding factor between 75% and 
90% with lens homogenates (Table 6.4). These results indicate that around 10-25% of the 
Cat0059 remained unbound with the lens homogenates containing 45 mg/mL protein 
concentration. When the binding factor of Cat0059 to the lens homogenate was compared 
between different homogenate buffers, the binding percentage of Cat0059 was significantly 
higher in lens homogenates containing 1 mM of the Caz+ chelator, EGTA in dHzO than in 
dHzO only (P <0.005) (Table 6.4). 
Table 6.4 Portion (%) ofCat0059 (10 IlM and 100 IlM) bound to pooled ovine lens homogenates, 
containing 45 mg/mL protein. 
Homogenising buffer Bound Cat0059 (%) to lens homogenates 
10 p.M spiked Cat0059 100 p.M spiked Cat0059 
dHzO 88.9 *84.2 ± 6.9 
dHzO+EGTA 9l.3 *73.9 ± 4.2 
*2-samples t-test (P < 0.005) between two buffers (n = 3). 
Evaluation of extraction procedure 
When aqueous humour was incubated with a known amount ofCat0059, the extraction 
procedure (Chapter 5,5.3.2.1) recovered approximately 90% of the added Cat0059, compared 
to direct injection of a standard Cat0059 onto the HPLC without being subjected to the 
extraction procedure (Table 6.5). 
Table 6.5 Recovery ofCat0059 after extraction process with ethyl acetate. Pooled ovine lens 
aqueous humour samples (AqH 1 and AqH 2) were spiked with two different amounts of Cat0059 
(0.75 and 1.51lg) in 50:50 acetonitrile/dH20 and subjected to the extraction. Two standards (0.75 and 
1.5 Ilg Cat0059 in 50:50 acetonitrile/dH20) were also analysed in HPLC with no extraction. Total 
Peak Area ofHPLC chromatography was used to evaluate extraction recovery. Recovery of the 
e xtraction procedure (%) = (AqH Peak Area/Standard Peak Area) x100. 
Sample Amt of dial Extraction * Total Peak Area Extraction 
in 5 p.l procedure (UV*sec) Recovery (%) 
Standard 0.75 p.g no 2,457,624 -
AqH1 0.75 p.g yes 2,236,676 9l.0 
Standard 1.5 f1,g no 5,388,593 -
AqH2 l.5 p.g yes 4,807,754 89.2 
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When the bound fraction (retentate and pellet after centrifugal ultrafiltration procedure) of the 
lens homogenates were subjected to the extraction process, the HPLC analysis failed to detect 
the presence ofCat0059. These results suggest that the extraction procedure ofCat0059 with 
ethyl acetate only extracts unbound Cat0059 in the samples. 
6.5. Experiment 4: Intravitreal injection of CatOOS9 
The purpose of this experiment was to assess the effect of applying the inhibitor directly to 
the vitreous humour. This was designed to avoid the prime barrier of the eye, the cornea, and 
to increase the concentration of Cat0059 in the aqueous humour; this should promote the 
penetration of Cat0059 into the lens. 
6.5.1. Methods 
Animal sample 
One normal lamb (less than 4 months old) was anaesthetised (Lincoln University Animal 
Ethics Protocol-ACE#109). 
Formulation of 0.1% Cat0059 for intravitreal injection 
0.1 % Cat0059 was solubilized in 10% ethanol and 0.9% NaCI. The solution was filtered with 
0.22 /lm pore size (PES membrane, Millex® GP, MiIIipore, Ireland) into a sterilised injection 
bottle. A single 100 IlL injection of the Cat0059 formulation was administrated by Dr Steve 
Heap directly into the vitreous humour through the sc1erajust above the iris of the eye (using 
a sterile 1mL syringe with a sterile needle, Terumo® Syringe, Terumo Co., Philippines). 
Sample collection 
The lamb was sacrificed 24 h post-injection. Treated and non-treated eye were collected 
immediately post-mortem. First, aqueous humour (AqH) from each eye was collected by a 
syringe with a sterile needle (Terumo® Syringe, Terumo Co., Philippines). Then each eye 
was dissected into lens and vitreous humour (VH) samples. The lens was weighed and 
homogenised in 3 volumes 4°C Buffer-C (refer to Experiment 3, Chapter 4,4.5.1) calculated 
by weight. 
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HPLC measurement ofCat0059 
700 ilL lens homogenate, 1.3 mL vitreous humour and 220 ilL aqueous humour aliquots were 
extracted in 100% ethyl acetate as described in 5.3.2.1 (Chapter 5). 20 mL of each extracted 
sample was concentrated to a final volume of 100 ilL. 10 ilL each sample was injected onto 
the HPLC column for the measurement ofCat0059 (Cat0059 HPLC protocol, in 5.3.2.2, 
Chapter 5). A standard curve was constructed from the initial injection solution with 0, 5, 10, 
20,50 and 100 ng Cat0059 . 
6.5.2. Results 
The detection and separation ofCat0059 between 0 and 100 ng (5 ilL injection volume) was 
correlated to the HPLC Peak Area as shown in Figure 6.4 (R2 = 0.99). 
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Figure 6.4 Standard curve ofCat0059 (0-100 ng). 
At 24 h post-injection, approximately 80 ng of Cat0059 in 1.3 mL vitreous humour was 
detected. The total vitreous humour volume was 3 mL. Thus, the estimated amount of 
Cat0059 in the entire vitreous humour is 180 ng. As the initial amount ofCat0059 injected 
was 100 Ilg, then 0.1 % ofthe injected Cat0059 remained in the vitreous humour 24 h post-
injection. 
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At 24 h post-injection, approximately 170 ng of Cat0059 was detected in 220 ilL aqueous 
humour. The total aqueous humour volume was 410 ilL. Thus, the estimated amount of 
Cat0059 in the entire aqueous humour is 350 ng. This implies a concentration of about 21lM 
of Cat0059 is in the aqueous humour. 
No Cat0059 was detected in the lens samples at 24 h post-injection. 
6.6. Discussion 
Cornea, the biggest barrier for Cat0059 delivery to the intraocular environment 
The cornea is considered to be the major pathway for ocular penetration of topically applied 
drugs. In this research, the cornea also appears to be the major barrier for delivering Cat0059 
to the intraocular environment with topical instillation. Even when there is constant contact 
between the eye and a solution ofCat0059, the diffusion rate ofCat0059 to the aqueous 
humour through the cornea was only 0.01 % over the first hour and 3.6% by the end of a 24 h 
incubation period. The latter illustrates that there is an extremely slow penetration rate 
through the cornea, even with continuous irrigation, which is more effective than a single 
topical drop installation - the preferred in vivo method. 
A high concentration of the molecule in the aqueous eye-drop solutions will increase the 
cornea permeability through the pre-cornea region, the tear film. Cat0059 was designed to be 
more water soluble than SJA6017, but in reality Cat0059 was less water soluble than 
SJA6017. A maximum of Img/mL Cat0059 was soluble in an aqueous solution even with the 
assistance of ethanol (14%). 
In other research on drug diffusion across the cornea (Zhang et aI., 2004), the corneal 
epithelium was shown to be the main barrier to hydrophilic molecules. For hydrophilic 
solutes of approximately 150-450 Da, the relative resistance to diffusion through the corneal 
epithelium, stroma, and endothelium were predicted to be approximately 92%, 1 %, and 7% 
respectively. Lipophilic solutes with the same size range had relative resistance to diffusion 
of75%, 18% and 7% respectively. It is therefore essential that any novel compound for 
topical application must penetrate the corneal epithelium . 
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The synthesis of corneal penneable calpain inhibitors has been investigated by modifying the 
structure ofSJA6017 (Nakamura et al., 2003). The replacement of the pyridine ring or cyclic 
hemiacetal of SJA60 17 improved transcorneal penneability, but both molecules displayed 
reduced inhibitory activities against calpains. This study suggests that both water solubility 
and the active aldehyde group (at PI site, Figure 5.6.) in the inhibitor structure are two factors 
that affect the corneal penneability of SJA6017. Cat0059 is based on the structure of 
SJA6017. It is apparent that future research needs to explore the link between the molecular 
structure of calpain inhibitors and their ability to cross the corneal barrier whilst retaining 
calpain inhibitory activities. 
Aqueous humour, an ocular compartment with minor bioavailability for Cat0059 to the lens 
After passage through the cornea, drugs are distributed in the anterior chamber by aqueous 
humour circulation, and from the anterior chamber, diffusion into the lens and other ocular 
tissues (Burstein, 1985). A standard drug protein binding assay to plasma (Inoue et ai., 2003) 
has been successfully adapted in this research as a simple drug bioavailability test. The test 
was used to detennine the pharmacokinetic profile ofCat0059. 
Under non-pathological conditions, approximately 10% of Cat0059 was bound to the ovine 
aqueous humour components (Table 6.3). 90% was unbound and free for diffusion into the 
lens. The low interaction of the Cat0059 with the aqueous humour was attributed to the low 
total protein concentrations of the aqueous humour (1.42 ± 0.67 mglmL). It is unclear why 
the proportion of 10 J1.M Cat0059 bound to the aqueous humour was lower than 100l-tM 
Cat0059. The opposite would have been expected if an equilibrium existed. 
Lens, another major barrier for the bioavailability ofCat0059 to calpain 
The phannacokinetic profile of Cat0059 is influenced by interaction with the high protein 
concentration and structural components in the lens. For example, the concentration of ovine 
cortical lens proteins (270 mglmL) was approximately 180 fold higher than the protein 
concentration of its aqueous humour and 5 fold higher than the level of serum proteins in 
other animals. For instance, bovine serum contains approximately 50 - 80 mglmL of proteins 
(Johnson et al., 1993). 85 - 90% ofCat0059 bound with diluted lens protein (45 mglmL) was 
similar to the standard protein binding profile figures of SJA6017, using mouse, rat, monkey, 
dog and human plasma (50 - 70 mglmL protein concentration) (Inoue et al., 2003). 
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It would be expected that the binding factor of85-90% for Cat0059 (diluted lens homogenate) 
would increase when Cat0059 enters the intact lens with 270 mg/mL protein. However, when 
1.28 mg/mL aqueous humour and 45 mg/mL lens homogenates were incubated with the same 
amount of Cat0059, the Cat0059 binding factor was only increased by 9 fold even though 
there was a 24 fold difference in the protein concentration of the samples. This suggests one 
possibility that the binding of Cat0059 to the lens might have its maximum/saturated point 
with a binding factor of 85 - 90%, or another possibility that there might be different binding 
proteins present in different ocular components. If any of these possibilities were true, then it 
could be assumed that a portion of Cat0059 that enters the lens from the aqueous humour 
route would still be available despite its high protein concentration. 
The diffusion properties of CatO059 between the aqueous humour and the lens were 
investigated by incubating the eye globes in contact with 3 mM Cat0059 solution for 24 h 
(Table 6.1). The results showed that 0.3% of the initial3mM CatO059 solution in the aqueous 
humour was in an unbound form after a 24 h incubation period. The diffusion rate of 
unbound Cat0059 between the aqueous and lens environments is, therefore, O.013%/h. This 
diffusion rate was calculated assuming; diffusion of free Cat0059 only (assumed that bound 
Cat0059 was saturated with the lens components), the penetration and distribution ofCat0059 
were homogeneous within the cortical region ofthe lens (50% oflens wet weight) and the 
aqueous humour stayed unchanged during 24 h. 
Uptake of Cat0059 in the lens culture and its protective effect on lens transparency 
The inclusion of 10 JlM Cat0059 in the culture medium prevented the development of lens 
opacification (Figure 6.3). Cat0059 was, however, not detected in the lens. Based on the 
estimated diffusion rate and the binding factors discussed above, the amount of unbound 
Cat0059 can be calculated. Assuming that the amount of unbound Cat0059 entering the 
intracellular lens environment is by diffusion facilitated by passive transport and that no 
active transport is involved, the diffusion rate is 0.013% per h between the aqueous humour 
(media) and the cortical region of the lens. With this assumption, at the end of the 44 h 
incubation period, the cortical region of the lens should contain 55 nM concentration of 
unbound Cat0059 in a normal lens. 55 nM ofCat0059 equates to approximately 9 ng of 
Cat0059 available in the cortical region of the lens. If all 9 ng was extracted in the minimum 
vial containing volume (100 JlL) and loaded onto the HPLC column with maximum inj ection 
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volume (10 -20 p,L), this would yield 0.9-1.8 ng. For an effective detection ofCat0059 on the 
HPLC, a minimum of 5 ng injectable Cat0059 is needed (Chapter 5, results 5.3.2.2). The 0.9-
1.8 ng would be below the HPLC detection limits. On the other hand, 55 nM Cat0059 could 
meet the concentration ofCat0059 to reach the half maximum enzymatic inhibitory activity 
evaluated by in vitro assay (ICso of Cat0059 = 30 nM). This calculation demonstrates that the 
effective Cat0059 concentration level to protect the lens from opacification may not be 
detectable by the current HPLC technique. 
Unlike the aqueous humour environment where a drug is assumed to be uniformly distributed, 
the compound may not be homogeneously available within the cortical region of the lens. For 
example, the diffusion rate of 0.013% per h to the lens was made on the assumption that the 
concentration of Cat0059 was uniformly distributed within the cortical region. In fact, a more 
likely situation is that the highest diffusion rate occurs at the surface ofthe lens (near to the 
epithelium) and the diffusion decreases on progression to the inner part of the lens. Kojima et 
al.(1992) demonstrated the route of drug penetration into the eye and drug distribution pattern 
in bovine (in vitro culture system) and rabbit lenses (in vivo topical administration). By using 
a micro lens sectioning and HPLC detection technique, the drug was detected in the surface of 
the posterior and anterior of the lens and equator. No drug was detected in the deeper cortex 
or nucleus. The restriction of drug penetration to a particular region of the lens may be 
explained by recent studies on the fiber cell plasma membrane specific membrane protein, 
MP20. During fiber cell differentiation, the insertion of the second most abundant lens 
membrane protein, MP20, into the fiber cell coincides with the creation of a barrier that 
restricts the diffusion of molecules into the lens core via the extracellular space (Grey et at., 
2003; Louis et al., 1989). 
In lenses cultured in a hyper-Ca2+ media solution, it was observed that the induced opacity 
was localised on the epithelium and superficial region of cortical fiber cells (Chapter 5 and 
Chapter 6). Incorporation of very low levels ofCat0059 (0.8 p,M) into the culture medium 
protected the lens from developing opacity under the hyper-Ca2+ medium solution (Figure 5.4, 
Table 5.2 in Chapter 5). If it is assumed that this surface region is 0.1 % of 1 g wet weight of 
a whole lens and that the diffusion rate is 10% (much higher than 0.013%), the concentration 
of Cat0059 (0.08 p,M at equilibrium) in this region would still be non-detectable by the 
current HPLC technique, but high enough to inhibit calpain activity. 
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In this chapter, metabolism of the Cat0059 within the ocular environment has not been 
considered in estimating the diffusion rates. Drug breakdown and metabolism in the eye is 
probably limited, but representative of phase I (i.e. oxidising and reducing) and phase II (i.e. 
conjugating) drug-metabolizing enzymes that have been found in ocular tissues (Burstein, 
1985; Urtti & Salminen, 1993). In other research, supporting evidence for the occurrence of 
limited metabolism is that the portion of unchanged drugs being released from the eye into the 
systemic circulation following local administration is quite significant (Maurice & Mishima, 
1984; Mishima, 1981). Cat0059 contains an aldehyde group which forms a hemithioacetal 
with the active SH group on the cysteine residue of calpain. The chemical reactivity of the 
aldehyde is considered to be high and the reaction with various substances under 
physiological conditions may also be high (Nakamura et al., 2003). 
Limitation to the extraction procedure 
The evaluation ofthe extraction procedure used in current studies showed that ethyl acetate 
(Robertson et al., 2005) only extracted unbound Cat0059 and was unable to extract the total 
amount of Cat0059 that had penetrated to the lens. The possibility that a significant amount 
of Cat0059 actually enters the lens but remains undetected must be considered. 
Cytotoxicity ofCat0059 and stability in physiological aqueous condition 
Cat0059 did not significantly influence the lens viability at a 10 JlM concentration over 
a 5.5 h incubation period (Figure 6.2). Cat0059 was reasonably stable under the current 
culture conditions over the different incubation periods. A 25% decrease of Cat0059 in the 
culture medium during the initial 1 h incubation period is probably due to Cat0059 binding to 
the lens surface. 
Is EGTA an enhancer for bioavailability o/the drug? 
There are different binding factors depending on whether EGTA is included or excluded from 
the buffer when producing lens homogenates. The presence ofCa2+ chelator (hnM EGTA) in 
the lens homogenate reduced the influence of the Cat0059 binding factor (Table 6.4). 
Consequently, more free Cat0059 was available to the lens. 
Cat0059 binds to the active site of the activated calpain for its inhibitory action and the 
activation of calpain requires Ca2+. The difference in the binding factor, in the presence and 
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absence of EGTA, was 10%. The question is whether the differences are linked in some way 
to the activated and non-activated forms of calpains. The 10% difference is calculated to be 3 
nmoles in a total 300 ILL lens homogenate. There is approximately 14 mg protein present in 
the lens homogenate (268 mglmL x 116 DF x 3/10). Ifwe assume 0.1 % oftotallens proteins 
are calpains, this only equates to 0.13 nmoles (Mw=130,000 glmol). This indicates that the 
binding of Cat0059 to activated calpain is not responsible for the 10% increase in the Cat0059 
binding factor. 
Ovine aqueous humour protein concentration 
Other studies have reported very low protein contents in the aqueous humour. For instance, 
the total protein content of the anterior chamber of the aqueous humour was 0.5 mglmL in 
sheep (Francois et al., 1958),0.42 ± 0.04 mglmL in rabbits (Langford et al., 1997),0.77 ± 
0.09 mglmL in calves (Pavao et al., 1989) and 0.33 ± 0.06 mglmL in monkeys (Gaasterland et 
al.,1979). Other research has shown that carefully drawn surgical aqueous humour samples 
eliminate any individual variations (0.12 ± 0.02 mglmL). Samples collected from post-
mortem eyes showed a high degree of variability in the total protein content of human 
aqueous humour (0.56 ± 0.12 mg/mL) (Tripathi et ai., 1989). The large protein variation 
observed in ovine aqueous humour (1.42 ± 0.67 mglmL) may be due to changes occurring in 
the post-mortem eyes in the 3 h after sacrifice . 
Intravitreai injections 
The direct injection of Cat0059 into the vitreous humour showed there was some slow release 
of the drug from the reservoir. The data revealed that at 24 h post-injection, there was a 
marked reduction in the concentration ofCat0059 concentration in the vitreous humour with 
only 0.2% remaining. There was, however, 2.2 IlM unbound Cat0059 detected in the aqueous 
humour at 24 h post-injection (Experiment 4). 
The tum-over rate of ovine aqueous humour is estimated to be one hour based on rat 
observations (Mermoud et al., 1996). The presence ofCat0059 in the aqueous humour at 
24 h post-injection is evidence that the vitreous humour can potentially act as a reservoir of 
Cat0059. A sustained release of a drug molecule from the vitreous humour could ultimately 
provide a chance of the molecule penetrating to the lens ifthe level of drug concentration in 
the aqueous humour is high and consistent. 
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Topical administration of drugs in the future 
Despite the inefficiency of drug absorption, the topical application of medications is still the 
most desirable way to treat ocular diseases, including treatment of cataracts with anti-cataract 
agents, as there are few side effects. The cornea in the intraocular environment can also retain 
drugs and has the potential to release them to the aqueous humour as a reservoir tissue. This 
was demonstrated by most of the unbound CatO059 (83%) being deposited within its tissue in 
comparison to the aqueous humour and iris (Table 6.1). Some of the commercially available 
formulations have an extended pharmacodynamic effect. There is an initial release of a large 
amount of drug, which is taken up and retained in ocular reservoirs like the cornea, and the 
drug is then slowly released (Burstein, 1985; Havener, 1983; Piercy, 1985). In other studies, 
coupling a lipophilic component to a more hydrophilic drug has offered a more successful 
approach where an active moiety can be liberated after passage through the cornea (known as 
a pro-drug delivery system) (Lee & Robinson, 1986; Maurice & Mishima, 1984). 
In the current chapter, the diffusion rates through cornea penetration and lens penetration have 
been identified as essential factors that influence the potency of anti-cataract agents and their 
use as therapeutic agents in the future. 
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-"-.--- --': Chapter 7: Overall Conclusion and Future Directions 
7.1. Overall Conclusion 
The absolute clarity of the lens of the eye is vital in the visual system. Unique structural and 
physiological properties of the lens are tightly integrated with highly ordered protein content 
to allow the lens to remain transparent. Cataracts are a universal pathological response to a 
variety of insults to the lens, and ageing is the most common factor for cataractogenesis in 
humans. In both ageing and cataractous human lenses, the elevation of intracellular Ca2+ 
levels (Duncan & Bushell, 1975) and post-translational modification oflens proteins (Hanson 
et al., 2000) have been reported. While the complete mechanism leading to cataract 
formation is largely unknown, extensive research using rodent cataract models has shown that 
the calpain proteolytic cleavage of soluble crystallins, as a result of an elevation of Ca2+, may 
contribute products that induce light scattering. Proteolysis has been proposed, therefore, as 
an underlining mechanism of cataractogenesis in these models (Azuma & Shearer, 1992; 
David & Shearer, 1993; Shearer et al., 1997). 
Hypothesis (i): Ca2+ homeostasis is vitalfor lens transparency. 
This thesis has shown that the elevation of intracellular Ca2+ concentration is detrimental to 
maintain transparency in ovine lenses (Chapter 4). Sustained Ca2+ influx to the lenses caused 
the development of opacification. The nature of the opacity was characterised by the 
formation of a turbid fraction and cell death in the lens, reflecting a disturbance in the fine 
physiological balance of its unique structure. In conclusion, elevated intracellular Ca2+ leads 
to cell death in the lens and cataractogenesis. 
Hypothesis (ii): The loss of Ca2+ homeostasis leads to a malfunction in the regulation of 
calpain activity. 
The present research adapted methods to determine whether calpain action is involved in 
cataractogenesis. Methods included: examining whether autolysis of calpains occurred as an 
indicator that the calpains are active, determining whether polypeptides which are known 
calpain substrates in vitro are cleaved, and using exogenous calpain inhibitors to identify 
which properties of cells are affected. 
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There was increased calpain autolysis associated with the progress of opacification, indicating 
increased calpain activity (Chapter 4). Spectrin and vimentin, which are known to be highly 
susceptible to calpain cleavage, were degraded in response to a ci+ flux (Chapter 4). 
Degradation of spectrin and vimentin was prevented by synthetic calpain inhibitors (Chapter 
5). Addition of calpain inhibitors to the hyper-Ca2+ medium prevented the opacification and 
degradation of cytoskeletal proteins. All of these data suggest that there is uncontrolled 
calpain activation when the lens loses Ca2+ homeostasis and Ca2+ concentrations increase. 
Hypothesis (iii): Deregulation of calpain activity is one of the key mechanisms contributing to 
cataract formation. 
The most significant finding of the current research is the importance of the lens cytoskeletal 
structure to lens transparency. The exposure of ovine lens to a sustained Ca2+ influx induced 
the development of lenses with opacity. The development of opacity was associated with 
major degradation of the cytoskeletal structure and with limited proteolysis of crystallins. 
This makes the OLCO model different to other in vivo cataract models where degraded 
crystallins were the major contribution to lens light scattering. Cytoskeletal elements of cells 
are well-known substrates of calpains (Shoeman & Traub, 1990), and the importance ofthe 
interaction between cytoskeletal proteins and crystallins in maintaining the lens transparency 
has been suggested by Clark et al. (1999). This thesis supports the idea that cytoskeletal 
proteins are important in maintaining lens transparency. The present data demonstrate an 
important role of the cytoskeletal elements, especially in differentiating fiber cells, in 
maintaining lens transparency. 
Proteolysis of cytoskeletal proteins initiated the breakdown of the integrity ofthe lens 
structure, which eventually resulted in the destruction of the lens system if the elevation of 
intracellular Ca2+ was sustained. This was confirmed by partial protection of opacification in 
the OLCO model by adding a cal pain inhibitor to the incubation medium. The data suggest 
that the proteolysis of cytoskeletal elements, by uncontrolled calpain activation, may be 
responsible for the lens progressing down a pathological pathway. Therefore this studies 
propose that the deregulation of calpain activity can be an initial trigger for a series of 
cascading events in the OLCO model. On the other hand, lens opacification induced by the 
hyper- Ca2+ culture medium model involved surface localised light scattering, which was 
prevented by applying exogenous calpain inhibitors to the incubation medium (SJA6017 and 
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two novel calpain inhibitors) (Chapter 5). These two Ca2+-overloaded lens models (OLCO 
model and hyper- Ca2+ culture medium model) provide evidence that calpain is possibly one 
ofthe key mechanisms in cataractogenesis. 
Potential in the use of calpain inhibitors as anti-cataract agents 
The penetration of calpain-inhibiting molecules into the lens was a major factor limiting the 
investigation of the involvement of calpains and assessing the efficacy of applying calpain 
inhibitors to eyes to prevent cataract progression (Chapter 5 and Chapter 6). Topical 
administration of novel anti -calpain molecules failed to retard the progression of cataract 
formation in the in vivo ovine inherited cataract model (Chapter 5). In Chapter 6, further 
investigations on drug penetration showed that the permeability of the molecules across the 
cornea and the ability of the molecules to penetrate to the lens were limited. Consequently 
their potential as anti-cataract agents is low using the current delivery system. A more 
sensitive detection method for determining molecules in tissues is also required if the features 
of their pharmacokinetics are to be understood. 
7.2. A model for Cataractogenesis: 
Taken together, the current thesis suggests a model for cataract formation when Ca2+ 
homeostasis is disturbed in the lens. The mechanism proposed for cataractogenesis is 
summarised in Figure 7.1, which illustrates the existing research findings (red arrows) and 
incorporates the new research findings in this thesis (black bold letters). 
It is suggested that the process is initiated (1) by the loss ofCa2+ homeostasis and the 
elevation of intracellular Ca2+, which (2) results in deregulation of the calpain system and, 
consequently, over-activation of calpain. (3) Excessive activation of calpain results in 
uncontrolled proteolysis of cytoskeletal proteins (calpain inhibitor prevented the degradation 
of the cytoskeletal proteins and opacification). (4) Proteolysis of cytoskeletal elements of the 
lens is then accelerated in lens structural homeostasis by further destruction of the lens 
membrane and a disturbance. (5) Cataracts (the opacity of the lens) are, therefore, a 
pathological response to the loss of Ca2+ homeostasis and the effect of death of the cells in the 
lens. 
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Figure 7.1. A proposed diagram of cataractogenesis in response to changes in Ca'+ homeostasis 
(modified version of Figure 2.1). The confumation and novel contribution of the present studies to the 
hypothesis (2.2) are illustrated by bold numbers and letters respectively. Red solid arrows indicate the 
major fmdings of the current study that leads to the pathway for cataractogenesis, whilst the red 
broken arrows indicate other findings that support the pathway of the current proposed model of 
cataractogenesis. 
7.3. Future directions 
Calcium ionophores are a valuable tool for manipulating intracellular Ca2+ homeostasis. The 
characteristics of an increase in intracellular Ca2+ level can differ, however, depending on the 
type of cells and the ionophore concentration (Galitzine el al. , 2005). Unlike single cell line 
culture studies, the action of Ca2+ ionophores on the lens involves more pathways according 
to the physiological and biochemical properties of different regions within the lens 
(physiological zones). There has been limited use ofCa2+ ionophores in the whole lens 
system. More sophisticated detection methods to measure Ca2+ distribution in response to the 
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distribution of ionophores are required in future research to obtain a clear understanding of 
the changes in Ca2+ levels in different physiological zones and their linkage to Ca2+ ionophore 
changes. 
Studies on Ca2+ regulation in specific regions of the lens, particularly in differentiating fiber 
cells, need to accompany the whole lens studies since the current studies showed that the 
opacification was limited to differentiating fiber cells during changes in Ca2+ homeostasis. 
One approach is the use of a cell culture system in which the epithelial cells differentiate into 
lentoids which closely mimic early fiber cells (Churchill & Louis, 2002; Tenbroek et at., 
1994). Using this approach, recent studies have revealed a sustained elevation in the resting 
intracellular Ca2+ in the lens fiber cells in normal lens cell differentiation (Churchill & Louis, 
2002). Calpain activity is reported to be higher in the cortex region than the nucleus 
(Robertson et at., 2005; Yoshida et at., 1984). Therefore understanding Ca2+ regulation in the 
differentiating fiber cells associated with calpain would assist understanding the significance 
of Ca2+ homeostasis in these outer shell fiber cells. 
Although introduction of calpain inhibitors into cells contributed to determining the cellular 
function of calpains, the specificity of synthetic exogenous calpain inhibitors has often been a 
limiting factor in studying the physiology ofthe calpain system (reviewed by Wang and 
Yuen, 1998). So far, calpastatin (an endogenously synthesised inhibitor) is the only specific 
natural molecule to inhibit calpains. To determine the involvement of calpains in cellular 
events, alternative approaches need to be developed to provide more sensitive biochemical 
methods for detecting changes in calpain activities in response to insults. For example, the 
use of selective antibodies, such as the one that specifically labels the calpain-c1eaved 
fragments of the substrate spectrin, have been used in other calpain-associated pathological 
conditions (Saido et at., 1993b). Development of methods to detect spectrin breakdown 
before cataracts are visible would help to confirm the role of calpains in cataractogenesis. 
In the current thesis, the formation of high molecular weight products by cross-linking was 
detected. Such aggregation could affect the integrity of the lens structure as much as 
proteolysis ofthe cytoskeleton. For a comprehensive understanding of the importance ofCa2+ 
homeostasis in maintaining lens transparency, the role of transglutaminases in association 
with calpain activation needs to be examined, as they often compete for the same endogenous 
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substrates. Transglutarninase activity has been observed in the human lens (Lorand et al., 
1981). Research has also demonstrated that vim entin, another cytoskeletal element, is also a 
substrate for lens trans glutaminase (Clement et al., 1998). It would be interesting to 
investigate the interaction between transglutarninase and calpain activities in cataractogenesis. 
The opaque region of the cataractous lens is the result of complex pathology of the lens and 
the loss oflens transparency. Both effects are permanent. This thesis supports the 
involvement of calpains at an early stage of cataract formation in response to increased 
cytosolic Ca2+ levels. Consequently, prevention of potential cataract formation, even before 
visual signs, should be a key goal for cataract treatment. The ovine heritable in vivo cataract 
flock provides a great opportunity to test anti-cataract agents, particularly if the responsible 
gene is identified and therefore allows prediction of potential cataract lambs. 
It is also important to measure the penetration of the novel anti-cataract agents within the eye. 
Structural modifications to novel calpain inhibitors may include features which will enhance 
the ability to detect the compounds within the tissues. For instance, inclusion of heavy 
isotopes as a part of the synthesis of inhibitors (Nagata et al., 2001) or compounds that 
incorporate a probe that can later be reacted with other agents to produce a feature which 
would increase the sensitivity ofHPLC to detect inhibitors. 
For therapeutic success with topical administration, the synthesis of corneal permeable 
calpain inhibitors must be investigated by modifying the structure of current calpain inhibitors 
to improve their penetration properties, increase their water solubility and lower their ICso. 
Non-specific binding of calpain inhibitors to other cysteine proteases would not only reduce 
their efficacy, but could also make it difficult to determine the involvement of calpains in 
cataractogenesis. Increaseq specificity of novel calpain inhibitors is needed to explore the 
role of calpains in normal physiological events. Future tasks are to identify systems that 
enhance inhibitory efficacy. It is therefore apparent that future research needs to explore the 
link between the molecular structure of calpain inhibitors and their ability to cross the corneal 
barrier whilst retaining their calpain-specific inhibitory activity. The application of effective 
anti -cataract agents to the millions of people worldwide, before the development of cataract, 
will be the most desirable approach to prevent or slow down cataract formation as a non-
surgical therapeutic option. 
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